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Abstract 
The effect of photodynamic therapy (PDT) on neural cells is important when 
tumours are adjacent to or within the nervous system. The primary purpose of this 
study was to investigate PDT treatments using the photosensitiser meta-(tetra-
hydroxyphenyl) chlorin (m-THPC) on cells of the peripheral nervous system. There 
is evidence that, during clinical PDT-treatment of tumour sites near important 
nerve structures, peripheral neural cells respond differently to m-THPC-mediated 
PDT than do tumour cells. In this study, the response to PDT-treatment of rat 
dorsal root ganglia (DRG) neurones co-cultured with satellite cells were compared 
with separately cultured human breast adenocarcinoma cell line (MCF-7) in 
innovative in vitro culture systems. 
Epi-fluorescence microscopy confirmed that m-THPC was incorporated into 
all cell types, excluding photosensitiser uptake as a reason for differences in the 
response to m-THPC-mediated PDT in vitro. Sensitivity of cells exposed to m-
THPC-mediated PDT (0-10 ~g/ml m-THPC with 1 J/cm2 white light) was 
determined in a 1 mm thin bespoke 3-dimensional (3D) collagen hydrogel culture 
system. Cell death was quantified using propidium iodide (PI) exclusion and DRG 
neurones were identified in co-culture using immunocytochemistry for ~III-tubulin. 
MCF-7 cells, DRG satellite cells and astrocytes (of the central nervous system) 
were significantly more sensitive to m-THPC-mediated PDT treatments than were 
DRG neurones. Importantly, the dose of interest, 4 f.lg/ml m-THPC-mediated PDT, 
caused no significant DRG neurone death in comparison with untreated controls, 
but was sufficient to elicit substantial cell death in the other cell types The cell 
death protocol was validated using a second photosensitiser, hypericin (0-3~g/ml 
with 1 J/cm2 white light), which caused substantial DRG neurone death equivalent 
to other cell types studied. 
vii 
Following m-THPC-mediated PDT treatments, ORG neurones displayed a loss of 
their neurites. An assessment of the ability of these cells to regenerate neurites 
after m-THPC-mediated PDT treatments was performed and neurite extension 
was found to be equivalent to that in untreated controls, demonstrating that the 
treated ORG neurones were viable and retained their neurite projecting function. 
Inhibiting specific cell antioxidant pathways gave an insight into the mechanism by 
which neurones survived m-THPC-mediated PDT. The results suggested that 
ORG neurones were protected from the phototoxic effects of m-THPC-mediated 
PDT by superoxide dismutase-1 (500-1) and the glutathione synthase antioxidant 
pathways. 
DRG neurones used in this study survived m-THPC-mediated PDT under 
conditions sufficient to kill tumour cells and other nervous system cells. Identifying 
and understanding this phenomenon could provide the basis for developing PDT 
treatments that reduce nerve damage during cancer therapy. The question of 
whether m-THPC-mediated PDT has different effects on ORG neurone survival 
and/or function depending on which part of the cell is illuminated is of particular 
interest. Preliminary experiments are described in which 20 and 3D tissue 
engineered nerve cultures were developed and assessed for use in evaluating 
focally applied m-THPC-mediated PDT treatment to different parts of DRG 
neurones. These peripheral nerve culture systems have controllable cellular 
environments that make them attractive experimental tools for further 
investigations into the effect of PDT on peripheral nerves. 
viii 
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Chapter 1: Introduction 
This introduction begins with a short general introduction to photodynamic therapy 
(PDT). This is followed by an overview of neural cell biology, and the relationship 
between neurones and glial cells (the main cell types used in this study); 
descriptions of the mechanism of PDT action; types of cell death; background on a 
selection of antioxidant pathways; a review of the literature about the effects of 
PDT on neural tissue; and the aims of this project. 
1.1 Introduction to PDT 
PDT or photochemotherapy (Mandys et a/., 1998) is a well-established treatment 
for a variety of malignant and non-malignant diseases (Laveille et a/., 2003). 
Castano et a/. (2005) and Krasnovsky Jr. (2007) reported that over the past 
century PDT has developed from the phenomenon 'photodynamic action' reported 
in 1900 by Raab and Tappeiner, to PDT as it is today; a dynamiC physicochemical 
method for focal treatment, which combines the use of a light sensitive agent 
(known as a photosensitiser) with laser light to treat cancer. Initially, PDT was 
used to treat skin and superficial cancers that were associated with the lining of 
internal organs. This limitation to PDT use was due to restrictions in methods of 
light delivery. However, following the introduction of optical fibre light guides, PDT 
is now used in the treatment of small solid in situ and micro-invasive tumours, e.g. 
prostate cancer (Rousset et a/., 2000; Marchal et a/., 2004; Plant, 2007b), and for 
treating patients with inoperable tumours in which conventional treatments have 
proven ineffective (Rousset et a/., 2000). 
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The mechanism by which PDT destroys unwanted tissue is by overproduction of 
toxic oxygen species (i.e. reactive oxygen species (ROS), molecules with unpaired 
electrons such as superoxide anions (02.-) and hydroxyl radical (HO·); and singlet 
oxygen C02). Therefore, PDT utilises targeted or focally applied oxidative stress to 
cause selective killing of tumours (Figure 1.1). However, detailed mechanistic 
information is sparse for photosensitisers used in PDT, and also tissue-specific 
responses have not been completely characterised (Dabrowski et a/., 2006). 
PDT as a treatment method does have some side effects, which can include some 
pain and swelling in the treated area (Plant, 2007b). However, PDT is known to 
cause less damage in comparison to conventional surgery; and it allows future 
treatment options for diseased sites; it has better functional results; and it may 
also be delivered away from a hospital setting (Nyst et a/., 2009). PDT has also 
been reported to have no cumUlative toxicity (Castano et a/., 2005; Plant, 2007b) 
or known maximum cumulative dose associated with it; this is in contrast with the 
use of ioniSing radiation and chemotherapy. It is also thought that much of the 
resistance that emerges (due to mutations) after treating cancer cells with 
radiation and chemotherapy, does not lead to cross-resistance to PDT (Oleinick et 
a/., 2002; Heinzelmann-Schwarz et a/., 2003; Castano et a/., 2005). In addition; 
meta-tetrahydroxyl-phenyl-chlorin (m-THPC)-mediated PDT on a human breast 
adenocarcinoma cell line (MCF-7 cells) does not induce resistance to subsequent 
cycles of PDT (Hornung et a/., 1998). This makes PDT a useful adjunctive 
treatment after treating patents with these conventional methods. 
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(A) Drug 
administered 
(C) light 
administered & 
' 0 2 produced, 
destroying 
tumour 
Figure 1.1 
(8 ) Drug taken 
up by all cells 
in body 
(0) Drug excreted 
from body before 
patient allowed 
out into light 
An illustration of the treatment of a tumour with PDT. 
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Higher drug 
concentration 
(A) Photosensitiser injected into patient; (8 ) photosensitiser taken up by tumour and non-
tumour cells in the body. Over time a greater accumulation of the photosensitiser in 
tumour cells can occur due to faster metabolic rate of tumour cells and increased 
vascularisation of the tumour; (C) Light is directed only at tumour to cause focal PDT and 
(0 ) photosensitiser is excreted from the body. (Adapted from 
http://www.bmb.leeds.ac.uklpdtlPDToverview.htm) 
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Despite the availability and many advantages of treatment modalities such as 
PDT, most cancers are still treated by surgical intervention, radiotherapy, 
chemotherapy or cryotherapy. These conventional cancer treatments can cause 
major damage to nearby tissues such as blood vessels and peripheral nerves. 
Such damage can result in urinary incontinence and erectile dysfunction when 
used to treat prostate cancers (Huang et al., 2005; Mason, 1999; Plant, 2007a; 
Nyst et al., 2009). However, use of the photosensitiser m-THPC has consistently 
shown clinical evidence for peripheral nerve sparing after PDT of prostate cancers 
(Chang et al., 1996; Chang et al., 1999; Huang et al., 2005; Moore et al., 2006), 
head/neck cancers (Lou et al., 2004; 8etz et al., 2007; Nyst et al. , 2009) and chest 
malignancies (Ris et al. , 1996; Ris et al. , 1997). Nerve sparing is clinically 
important because it reduces the likelihood of patients losing sensory or motor 
function at the treatment site and associated areas. The potential for nervous 
system damage would also have implications in the use of PDT to treat tumours in 
association with important CNS structures (e.g. the spinal cord or brain). 
It is clear that understanding the effect of PDT on the nervous system is important 
for the future of clinical cancer treatment. This therefore requires study of th~ 
cellular and molecular responses of nerves to m-THPC-mediated PDT treatment, 
which is the basis of the work described in this thesis. 
1.2 Mammalian nervous system 
The mammalian nervous system is subdivided into 2 main parts; the central 
nervous system (CNS) and the peripheral nervous system (PNS). The CNS 
consists of the brain and the spinal cord, and the PNS consists of all nervous 
tissue situated outside the CNS (Figure 1.2a). The PNS includes cranial nerves 
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and branches; spinal nerves and branches; sensory, autonomic and enteric 
ganglia and the processes arising from the cells of these ganglia. The PNS can be 
functionally subdivided into the somatic nervous system (SNS), which controls 
voluntary actions; the autonomic nervous system (ANS), which controls 
involuntary actions; and the enteric nervous system (ENS), which specifically 
controls gut functions. 
Various parts of the peripheral nervous system may be exposed to PDT during 
cancer treatment, although the motor, sensory and autonomic nerves that. 
innervate the urinogenital regions are most likely to be exposed during PDT 
treatment of prostate cancer. This study focused on the effects of PDT on the 
sensory ganglia. 
1.2.1 Tissues and cells of the somatic nervous system 
1.2.1.1 Sensory ganglia 
Sensory ganglia are small masses of nervous system tissue that are closely 
associated with cranial and spinal nerves (Figure 1.3). The sensory ganglia 
primarily contain neuronal cell bodies and supporting glial cells (satellite cells). 
Dorsal root ganglia (DRG) (Figure 1.3), used in this study, are small sensory 
ganglia situated parallel to the spinal cord. 
1.2.1.2 Somatic nerves 
There are two types of nerves in the voluntary nervous system; afferent (sensory) 
and efferent (motor) nerves (Figure 1.3). Sensory nerves conduct impulses from 
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{brain 
eNS 
spinal cord 
peripheral 
nervous ~1-IfIf111--+~~:1~~ 
system 
(a) 
Figure 1.2 
(b) 
\ 
from CNS 
(efferent) 
A simplified illustration of the human nervous system. 
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This illustration shows (a) the central nervous system (brain and spinal cord) and the 
somatic part of the peripheral nervous system; and (b) a bundle ofaxons showing the 
direction of nerve signals. This illustration only shows the somatic part of the nervous 
system, it does not reflect the autonomic or the enteric parts. (Taken from Toates, 2004) 
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Key: 
1. Dorsal root ganglion (DRG) 
2. Dorsal root (sensory nerve) 
3. Dorsal horn 
4. Ventral horn 
5. Ventral root (motor nerve) 
Figure 1.3 
A simplified illustration of a transverse section through the spinal cord and 
associated PNS nerves and ganglion. 
Illustration shows a cross section of a spinal cord with dorsal and ventral horns, sensory 
nerve, motor nerve and a DRG. Each DRG neuronal cell body projects a single axon 
which branches into 2; one extends towards the dorsal horn into the spinal cord, while the 
other extends towards the periphery. 
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sensory receptors in the periphery (e.g. skin, etc.) to the CNS (Figure 1.2b); 
whereas motor nerve fibres conduct impulses from the CNS to skeletal muscles. 
Somatic nerves (sensory and motor) are grouped together into fascicles ofaxons 
(Figure 1.4); these fascicles are in turn grouped together into larger bundles, or 
nerve trunks. Fascicles and nerve trunks are protected by connective tissue and 
nerve trunks receive a blood supply. The main connective tissue layers of nerve 
trunks are the endoneurium, perineurium and epineurium. 
Endoneurium 
Endoneurium contains axons, connective tissue cells (e.g. fibroblasts), immune 
system cells (e.g. mast cells and macrophages) and hypertonic endoneurial fluid. 
It also contains parallel type I collagen fibrils, Schwann cells, myelin and ground 
substance. Ground substance is the extracellular matrix that imbeds fine bundles 
of fibrous connective tissue, and contains primarily collagen running longitudinally 
in the nerve. It further contains amorphous viscoelastic gel made of anionic 
polysaccharides (glycosaminoglycans): hyaluronic acid, dermatan sulphate, and 
chondroitin-6-sulphate that binds water and is produced and degraded by 
fibroblasts and mast cells (Winsz-Szczotka et a/., 2006). These macromolecules 
are involved in cell migration, adhesion and proliferation of nerve cells (Winsz-
Szczotka et a/., 2006). Within the region of the matrix of the ground substance is 
the Schwann cell basal lamina, which is a continuous tube surrounding axons. It is 
composed of myelin, the extracellular matrix component laminin-2, heparansulfate 
proteoglycans (e.g. perlecan, argin, etc), collagen type IV, and fibronectin (Martini, 
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blood vessel ~----
Schwann cell 
I nucleus 
axon 
Fascicle 
Perineurium Epineurium 
Endoneurium 
Figure 1.4 
A simplified illustration of the integral structures of a human peripheral nerve trunk. 
Illustration shows that axons are protected by a series of layers epineurium, perineurium, 
endoneurium and Schwann cells. The illustration also shows the presence of blood 
vessels in the nerve trunk. (Adapted from Phillips and Harle, 2008) 
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2005). The endoneurium is surrounded by a further cell layer, termed the 
perineurium (Figure 1.4). 
Perineurium 
The perineurium is composed of specialised perineurial cells that form a layer of 
tight-junction-connected flattened cells. The perineurium forms a diffusion barrier 
which separates the endoneurial fluid from the surrounding layers controlling the 
endoneurial environment, by blocking the passage of most macromolecules into 
the nerve (Layton and Sastry, 2004; Standring et a/., 2005, Topp and Boyd, 2006) 
(Figure 1.4). 
Epineurium 
The epineurium is a layer of connective tissue, which groups the fascicles 
together. Human nerves tend to be multi-fasciculated (several fascicles) (Figure 
1.4); while in some parts of the rat sciatic nerves used in this study, there is only 
one fascicle (Layton and Sastry, 2004). The epineurium contains fibroblasts and a 
large amount of basket-like woven collagen, and is a loosely connected outer layer 
of the nerve trunk. 
Blood supply 
Blood vessels supplying nerves form a capillary plexus in the epineurium (Figure 
1.5); these pierce the perineurium and run parallel with the nerve fibres in the 
endoneurium. They have short transverse vessels linking them to form a vascular 
mesh. Capillaries in the endoneurium are generally larger and further apart 
compared to those in other tissues. Basal nerve blood flow is high relative to 
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metabolic requirements, and this coupled with the unusual capillary arrangement 
ensures nerves are richly supplied with blood. There is a blood-nerve barrier within 
the endoneurium with tight junctions between the endothelial cells (Le. this is like 
the blood-brain barrier (BBB) in the CNS). The efficiency of the blood-nerve barrier 
is known to vary anatomically, for example ganglia and distal parts of peripheral 
nerves are situated outside the protection of this blood-nerve barrier (Stand ring et 
al., 2005). This leaves neuronal cell bodies and satellite cells more exposed to 
stressors than axons and Schwann cells contained in nerve trunks. 
1.2.2 Neurones 
1.2.2.1 Neurone structure 
The function of the neurone is to receive, process and to transmit electrical and 
chemical signals to another neurone or to a secretory cell or to a muscle. In 
general neurones can be classified into 1 of 3 major types (Figure 1.6). 
Motor neurones are multipolar (Figure 1.6A), whereas primary sensory neurones 
are bipolar (axons extensions in two directions) (Figure 1.68) or pseudounipolar (a 
CNS branch and a PNS branch) (Figure 1.6C and 1.7). Primary sensory neurones 
have large round neuronal cell bodies of between 25 and 50 JJm in diameter 
(McHugh and McHugh, 2004). Pseudounipolar sensory neurones (e.g. in DRGs), 
are specialised to be sensitive to a particular physical stimulation (e.g. touch, 
pressure or pain) (Kandel, 1991) (Figure 1.7). 
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Extrinsic artery 
Mesoneurum 
Epineurial vessels 
Figure 1.5 
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Perineurial sleeve around capillary 
Perineurium 
Endoneurial vessels 
(Tight junctions) 
A simplified illustration of the peripheral nerve trunk capillary network. 
The blood vessels are intimately woven into the structures of the nerve trunk to form a 
mesh of capillaries in the endoneurium. (Adapted from Robinson and Bryant, 2006) 
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A Multipolar neurone B Bipolar neurone C Pseudounipolar neurone 
Sensory ending 
t--- Trigger zone 
It---Axon 
Trigger zone (peripheral process) 
Axon 
It---Axon 
(central process) 
Axon 
Figure 1.6. 
Simplified illustrations of different types of neurones. 
(A) Multipolar neurone, (8) Bipolar neurone and (C) Pseudounipolar neurone. (Taken 
from Michael-Titus et al. , 2008) 
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(a) Sensory 
neurone with free 
nerve endings 
Cold --. 
stimulus 
(b) Sensory 
neurone with 
encapsulated 
nerve endings 
Pressure 
--. stimulus 
Free nerve endings 
(dendrites) 
Triggers 
Generator 
potential 
Encapsulated 
Axon 
• 
Axon 
(C) Sensory Dendrite nerve ending 
neurone with 
sensory 
receptor 
synapses 
Neurotransmitter 
Sugar 
--. molecule 
Dendrite 
Triggers Release of . Triggers 
-+ neurotransmltter -+ 
from sensory 
Receptor receptor 
potential 
Figure 1.7 
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Propagate 
• Nerve intoCNS 
Impulses 
Axon 
Propagate 
• intoCNS 
Nerve 
Impulses 
Simplified illustrations of types of pseudounipolar sensory neurones and their 
relationship with sensory receptors. 
Primary sensory neurones are pseudounipolar neurones, which have a single dendrite 
and axon arising from a common site of the neuronal cell body. Axons of sensory 
neurones enter the spinal cord and a peripheral process that receives the sensory 
information projects to the periphery, which may be skin , internal organ etc (Taken from 
Tortora and Derrickson, 2006b) . 
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There are three types of sensory neurones in DRGs, which are classified on the 
basis of their neurochemistry (expression of peptides and receptors), morphology 
(diameter size and myelination state), trophic factor requirements and sensory 
modality (peripheral mechanoreceptors or nociceptive types) (Tonge et al., 1997; 
Tucker et al., 2005). These three types of sensory neurones were further defined 
by Nascimento et al. (2008) on the basis of cytoplasmic densities. DRG 
pseudounipolar neurones have an axon branching into the CNS with similar 
structural features as the PNS portion, with the exception that the CNS portion of 
the DRG nerve is not ensheathed with an epineurium layer. 
1.2.2.2 Ultrastructural characteristics of neurones and axons 
Axons arise from projections of the neuronal cell body called axon hillocks. The 
axoplasm (axon cytoplasm) has been reported to have smooth endoplasmic 
reticulum (ER) throughout the mammalian axon (Goldberg, 2003), however it has 
also been stated that the axoplasm does not contain ER by Bancroft and Stevens 
(1990c) and Tortora and Derrickson (2006a). The axoplasm contains 
mitochondria, microtubules and neurofibrils; and it is surrounded by the axolemma 
(plasma membrane of the axon). 
1.2.2.3 Neuronal transport 
Transport of molecules along axons occurs by transport within vesicles along 
microtubules. Neuronal transport occurs from neuronal cell bodies to the nerve 
endings and vice versa by both slow and fast transport mechanisms. Slow 
transport conveys axoplasm in one direction from neuronal cell bodies towards 
axonal terminals; and fast transport conveys organelles and material in both 
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directions along the surface of microtubules, by protein motors called dynein and 
kinesin (reviewed by Goldstein and Yang 2000; Hirokawa and Takemura, 2005) 
(Figure 1.8). These microtubules contain ~III-tubulin and neurofilaments (NF, 
composed of neurofilament protein), both of which can be used to identify 
neurones immunocytochemically in culture and in tissue sections. 
1.2.3 PNS glial cells 
Peripheral glial cells include enteric glial cells (in enteric ganglia), satellite cells, 
Schwann cells and teloglia (reviewed by Jessen, 2004). Figure1.9 shows the 2 
types of glial cells in the part of the PNS of interest in this study, satellite cells and 
Schwann cells. Schwann cells completely surround axons in the nerve trunk, while 
satellite cells surround neuronal cell bodies in the DRG. Specific marker used for 
satellite cells and Schwann cell identification is the immunocytochemical detection 
of the S1 00 protein in culture and in tissue sections. 
1.2.3.1 Satellite cells 
Satellite cells have extensive cytoplasm and completely ensheath neuronal cell 
bodies in DRGs. They provide structural support and regulate exchange of 
material between neuronal cell bodies and the interstitial fluid. Satellite cells and 
DRG sensory neurones are involved in non-synaptic cell-to-cell cross-excitation 
within the DRG (Shinder et al., 1994). Nascimento et al. (2008) have recently 
further defined 3 types or states of satellite cells: satellite cells with 
heterochromatic nuclei and electron-dense cytoplasm; satellite cells with 
euchromatic nuclei and electron-lucent cytoplasm; and satellite cells that are not in 
contact with any neurones. 
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(A) Axonal transport 4 • 
Growth cone 
(B~ 
Microtubule 
Figure 1.8 
A simplified and generalised ultrastructure of a neurone and transport molecules. 
(A) The axon contains highly organised microtubule and microfilament structures, which 
provide internal support and transfer proteins from the neuronal cell body to the axon 
terminal ; (8) Examples of transport complexes . KIF (kinesin superfamily proteins) and 
KIF2A (controls microtubule dynamics and the extension of axon collaterals). (Adapted 
from Hirokawa and Takemura, 2005) 
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Neuronal cell body 
Axon 
Figure1.9 
A simplified isolated unit of satellite cells and Schwann cells interacting with a DRG 
neurone. 
Neurone (green) , satellite cells surrounding neuronal cell body (red) and Schwann cell 
(orange/yellow) wrapped around axon. (Adapted from Tortora and Derrickson, 2006a) 
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Satellite cells play an important role in controlling the survival ofaxotomised 
sensory neurones, although their behaviour and phenotype in conditions of 
degeneration and regeneration of neurites of sensory neurones has received 
insufficient study (Raginov et a/., 2004). Further studies of isolated satellite cells 
are necessary to better clarify differences among these cells (Nascimento et ai, 
2008) 
1.2.3.2 Schwann cells 
Schwann cells encircle peripheral axons several times, and form myelin sheaths; 
each Schwann cell myelinates only one axon, however a single Schwann cell can 
also surround many axons without actually myelinating them (Syroid et a/., 1996; 
Mirsky and Jessen, 1996; Topp and Boyd, 2006; Michael-Titus et a/., 2008; 
Standring et a/., 2005). These glial cells are situated in the nerve trunk, and act as 
electrical insulation by wrapping around individual or clusters of nerve fibres 
(Standring et a/., 2005), facilitating saltatory conduction. Schwann cells guide the 
growth ofaxons during peripheral nerve development (Stand ring et a/., 2005; 
Ndubaku and de Bellard, 2008) and are also known to influence axon regeneration 
(Standring et a/., 2005; Tortora and Derrickson, 2006a). They aid the digestion of 
dying neurones, and leave an empty tube through which a new axon can grow 
from a severed neurone end (Stand ring et a/., 2005; Syroid et a/., 1996). Schwann 
cells and other nerve cells (Le. fibroblasts) distal to nerve damage sites are known 
to change their metabolism as a result of losing contact with axons; thereby 
producing signals which stimulate nerve regeneration (Standring et a/., 2005; 
Tonge et a/., 1997). 
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1.2.3.3. Teloglia 
The third type of glial cells are the terminal glial cells, also called teloglia or 
perisynaptic glial cell, which help to maintain stability of the neuromuscular 
junction and regulate synaptic transmission (reviewed by Jessen, 2004; Martini, 
2005). 
1.2.4 eNS glial cells 
During CNS development, glial cells have a dominant role in setting up the basic 
scaffolding of the brain. There are 3 main types of glial cell in the CNS: astrocytes, 
oligodentrocytes and microglia (reviewed by Jessen, 2004; Standring et al. 2005; 
Michael-Titus et al., 2008). In regards to the CNS, the focus here is on astrocytes, 
because they are the cells that have been studied in order to gain an insight into 
the response of CNS cells to m-THPC-mediated PDT. 
Astrocytes are the most common glial cells in the CNS (Figure 1.10) and they play 
a very important function in the differentiation, survival, pharmacological properties 
and resistance to injury (de 8ernardo et al., 2004) of the brain and the spinal cord. 
Astrocytes are distinguished from neurones in the brain by their expression of glial 
fibrillary acidic protein (GFAP). One of the most important roles of astrocytes is 
their involvement in the formation of the 888. The 888 is formed when astrocyte 
processes are in association with blood vessels and protects the CNS from 
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A simplified illustration of an astrocyte in association with a eNS neurone and 
capillary forming the blood-brain barrier. 
The BBB is created by the tight apposition of endothelial cells lining blood vessels in the 
brain, forming a barrier between the circulation and the brain parenchyma. Blood cells 
such as lymphocytes, monocytes and neutrophils cannot penetrate this barrier. A thin 
basement membrane, comprising laminin, fibronectin and other proteins, surrounds the 
endothelial cells and associated pericytes, and provides mechanical support and a barrier 
function . (Taken from Francis et a/., 2003) 
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unwanted substances in the general blood circulation (reviewed by Francis et a/., 
2003; Standring et a/., 2005) 
1.2.5 Neuronal-glial cell communication 
Fields and Stevens-Graham (2002) reported that there is a 2-way communication 
system between neurones and their supporting glial cells. This interaction plays an 
important role in the development, function and survival of the nervous system. 
Glial cells provide neurones with nutritional support and protection, and facilitate 
conduction of impulses in neurones. They are also involved in neurone 
development, are critical participants in synaptic transmission, and are key 
regulators of neurotransmitter release (Stand ring et a/., 2005; Ndubaku and de 
Bellard, 2008). In this study, satellite cells and pseudounipolar sensory neurones 
of the ORG were investigated; however other types of neurones may also be 
exposed to PDT, for example during PDT in the brain. In addition to satellite cells 
and sensory neurones, the responses of astrocytes to m-THPC-mediated PDT 
were investigated because they are the predominant glial cell types in the CNS, 
and are vital to CNS neuronal function and survival. 
1.3 PDT 
PDT is a non-invasive, focal cancer therapy, which allows for repetitive clinical 
administration to treatment sites. It results in damage to cancerous and non-
cancerous cells, by apoptotic and/ or necrotic cell death modes (Ball et a/., 1998; 
Becker and Bonni, 2004). Clinical PDT can kill tumour cells by the uptake of more 
photosensitiser over non-tumour cells, and/or by causing microvascular injury 
resulting in the tumour being starved of nutrients and oxygen (Marshal et a/., 
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2004). PDT is a promising therapy for a wide variety of tumours, skin conditions, 
bacterial and viral infections. Clinical PDT utilises the administration of a 
photosensitiser orally, by intravenous injection (Lv.) (Plant, 2007b) or by topical 
administration to the skin. In a laboratory setting, the administration of a 
photosensitiser is by incubation with cells or tissue culture systems, as was 
performed in this study. 
An excited photosensitiser molecule is one that has absorbed a quantum of light. 
The first law of photochemistry states that 'Only light absorbed by a molecule can 
produce photochemical changes in that molecule'. PDT involves the use of lasers 
or other light sources in combination with photosensitisers and molecular oxygen 
e02) present in tissues and cells to destroy unwanted cells. In most cases lasers 
have been used as the light source for clinical and experimental PDT, because of 
their emission of monochromatic light, high power output and easy delivery of light 
by optical fibres. The development of high power diode lasers with appropriate 
wavelength have been a major step forward for clinical application of PDT (Berg, 
2007). In a laboratory setting, simple light sources are commonly used in order to 
activate photosensitisers in vitro. PDT therefore offers a method by which tumour 
cells can be specifically targeted in a localised manner. This is an invaluable 
feature which is not offered with standard systemic chemotherapy treatments 
(Dabrowski et a/., 2006; Nyst et a/., 2009). 
There are 2 main generations of photosensitiser commonly referred to as first and 
second generation photosensitisers. The first generation photosensitisers are the 
first set of photosensitisers used in the establishment of PDT (e.g. Photofrin®). The 
second generation of photosensitisers are those most commonly used to date, for 
example m-THPC (Vrouenraets et a/., 1999; Morlet et a/., 1997; Laville et a/., 
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2003; Marchal et al., 2005; Sasnouski et al., 2006) and hypericin. Second 
generation photosensitisers are more effective and are the clinically preferred 
photosensitisers over first generation photosensitisers, because they have 
increased photodynamic efficiency with reduced phototoxic side effects (Ochsner, 
1997). Two second generation photosensitisers m-THPC and hypericin have been 
investigated in this study. 
1.3.1 Photochemistry of PDT 
1.3.1.1 Jablonski energy level diagram 
A Jablonski energy level diagram is commonly used to illustrate the process of 
energy transfer from a light source to ground state photosensitiser (oS) (Figure 
1.11) (reviewed by Macdonald and Dougherty; 2001; Wilson, 2003; Lichtman and 
Conchello, 2005), which takes place during PDT. The short-lived, excited singlet 
state of the photosensitiser CS) changes to a lower energy level called an excited 
triplet state eS), which occurs by a process called intersystem crossing (the spin 
of an excited electron reverses) (reviewed by Macdonald and Dougherty, 2001; 
Lichtman and Conchello, 2005; Wilson, 2003). Auto-fluorescence properties of 
photosensitisers are generated from the excited 1 S changing directly back into Os 
(Lichtman and Conchello, 2005; Wilson, 2003). 
1.3.1.2 Molecular orbital theory 
Molecular orbital theory can be used to explain the electronic structures of 302 
utilised in PDT (Zhao, 2001). 302 in its primary or triplet ground state ergO) is the 
lowest electronic state of oxygen, which involves 2 unpaired electrons in the 
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highest occupied orbital (reviewed by Macdonald and Dougherty, 2001; Zhao, 
2001; Lane, 2002). This is converted into 102 or singlet state CAg), which consists 
of a pair of electrons in the highest occupied orbital. Because these electrons are 
paired, 102 is not considered as a free radical (Dugan and Choi, 1999) (Figure 
1.12). 102 is also not 'spin restricted' and therefore can accept pairs of electrons 
making 102 react quickly (Lane, 2002). This quicker reaction is in contrast to spin 
restriction of 02 which makes it prefer to accept electrons one at a time; therefore 
explaining why 02 reacts sluggishly with most non-radicals. 
as are activated clinically by visible, non-thermal, tissue-penetrating light of a 
specific wavelength. This activation energy is transferred to 302 present at 
treatment sites. This photochemical reaction as shown in Figure 1.12 is generally 
known to predominantly result in the conversion of non-toxic 302 into toxic 102, by 
transfer and pairing of electrons in a lower orbital with the use of energy from 35 
(Huang et al., 2005; Zhao, 2001). 
1.3.1.3 Photodynamic action 
In the 1960s, Schenck et al. formulated the concept that photodynamic action 
occurs by 2 different types of primary processes, type I or type \I (Krasnovsky Jr, 
2007). 
Type I process 
Under hypoxic conditions excited triplet state photosensitisers eS) will generate 
cytotoxic radicals (ROS) including HO· and 02·· (Dabrowski et al., 2006). 
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Simplified Jablonski energy level diagram of photosensitiser in combination with 2 
types of PDT processes which result in cell death . 
The Jablonski energy level diagram shows the electronic states following absorption of 
light by the photosensitiser. This pathway shows Os (ground state photosensitiser) being 
excited to short-lived 1S. 1S changes to a lower energy 3S (triplet state photosensitiser) . 
Electron transfer occurs between the 3S and 20 3 (molecular oxygen) , producing toxic 
10 2/ROS and returns photosensitiser to oS. 10 2/ROS generated by type I or type II 
process (see section 1.3.1.3) causes tissue/cell damage or death . Also a transition from 
1S directly to Os can also occur, this result in the emission of auto-fluorescence from the 
photosensitiser, which can be detected by fluorescence microscopy (Adapted from 
Macdonald and Dougherty, 2001). 
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Figure 1.12 
Orbital structures of triplet and singlet state oxygen. 
Illustration shows how electron orbital occupancy changes when 30 2 (triplet ground 
state oxygen) is converted into 10 2 (singlet state oxygen) (left to right) , by using energy 
provided by 38 (triplet state photosensitiser). This is a reversible reaction , and as such 10 2 
is shown to be converted back into 30 2 with the use of H20 (water) , which removes energy 
from the 10 2 (right to left). (The moving electrons are the black circles , with energy 
transfers represented with 'lightening bolts'). 
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Photosensitiser molecular structures that are readily oxidised (e.g. phenols and 
amines) or reduced (e.g. qui nones) will facilitate the type I process under hypoxic 
conditions (Ochsner, 1997). 
ROS are small, short-lived and highly reactive molecules that are formed by 
incomplete one-electron reduction of oxygen (Scherz-Shouval and Elazar, 2007). 
The type I process generates ROS in one of two ways: 1) the transfer of electrons 
between the excited 3S and substrates (e.g. proteins, lipids and DNA), or 2) by 
hydrogen or electron transfer from reductants (e.g. Nicotinamide adenine 
dinucleotide phosphate (NAD(P)H), L-ascorbic acid (Vitamin C) and glutathione 
(GSH» to the excited 3S (Ochsner, 1997; Melnikova et a/., 1999c; Girotti, 2001; 
Berg, 2007) (Figure 1.13). ROS generated in this hypoxic condition are then auto-
oxidised (Melnikova et a/., 1999c; Girotti, 2001) by 102 already present in the 
system to generate products of oxidation (Figure 1.13). 
In addition the type I process can also dominate the PDT process under conditions 
of high photosensitiser concentrations associated with the cell (MacDonald and 
Dougherty, 2001). 
Type /I process 
PDT usually involves the type II process which requires oxygen rich conditions, 
and in contrast to type I process generates singlet state oxygen (Singlet oxygen; 
102). The mechanism of the type II process is as follows. The excited 3S transfers 
energy to a nearby 302 and generates 102, which rapidly reacts with organic 
molecules (substrates) (Lane, 2002; Girotti, 2001; Zhao, 2001; Wilson, 2003) 
(Figure 1.12 and 1.13). 
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However, in practice a combination of both types I and II processes may occur 
during treatment (Ochsner, 1997; Zhao, 2001). In addition to type I and/or type II 
processes occurring, a type II process can be changed to a type I process during 
PDT. This may be as a result of local hypoxia developing at the treatment area 
(Ochsner, 1997). Therefore a good oxygen supply is essential for type II PDT 
processes to persist. 
1.3.2 Photosensitisers used In this study 
Various different types of photosensitisers are used in PDT, each for their specific 
properties. Table 1.1 shows a list of commonly used photosensitisers in PDT. 
1.3.2.1 General features of m-THPC and m-THPC-mediated PDT 
m-THPC is derived from chlorin and gets its fluorescence properties from 
aromatic rings (benzene rings and porphyrin structures) (Figure1.15A). m-THPC is 
lipophilic and non-polar (MOiler et a/., 1998), received regulatory approval in 2002 
in the European Union for human patients for advanced palliative treatment of 
head and neck cancers, and has since been shown to be effective in treating early 
squamous cell carcinoma (Laville et a/., 2003; Sasnouski et a/., 2006). 
m-THPC has strong absorption in the visible light region of 650- 652 nm with an 
absorption coefficient of 22400 IImol/cm (MOiler et a/., 1998) (Figure 1.14). m-
THPC also has high photochemical efficiency, which means that lower light doses 
and/or shorter illumination times are required to display a tumouricidal effect of 
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Figure 1.13 
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Products of oxidation 
Type I and II PDT processes leading to oxidation products. 
Light energy absorbed by ground state photosensitiser (OS) results in excited triplet state 
photosensitiser eS) . 3S fuels either the type I or the type II process; both these processes 
can result in oxidative tissue damage due to the generation of products of oxidation. 
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Photosensitisers Details 
Levulanlll> (5- Aminolevulinate; 5-ALA) Pro-drug of the photosensitiser protoporphyrin-
IX (PpIX): Absorption at 635 nm. Used for 
superficial tumours, actinic keratosis, the 
detection of certain bladder tumours, and tested 
for prostate cancer treatment. Causes pain 
during PDT treatment. 
Foscan"" (Temoporfin; m-THPC) A chlorin derivative: Absorption at 652 nm. A 
very photodynamically active photosensitiser. 
Used for head & neck tumours (oesophageal, 
and laryngeal) thoracic, lung, prostate & skin 
cancers. 
Talaporfin (Monoaspartyl chlorin e6, Npe6) A synthetic chlorin derivative: Absorption at 664 
nm. Used on adenocarcinoma of breast, basal 
cell carcinoma, squamous cell carcinoma & for 
destroying retina neovasculature. Clears rapidly 
from the system and accumulates in the skin. 
Photofrinllll (Porfimer sodium or HpD) Mixture of porphyrin oligomers: Absorption at 
630 nm. Used successfully against many 
cancers, no systemic toxicity, not carcinogenic 
or mutagenic at used doses, and no multiple 
drug resistance. Accumulates in the skin. 
Lu-Texlll> or Antrinllll (Lutetium texaphyrin) Non-porphyrin photosensitiser: Absorption at 
732 nm. Highly selective for tumour tissues. 
Used for treating malignant melanoma, & to 
prevent re-stenosis of vessels after cardiac 
angioplasty. 
Visudynellll (Verteporfin) Benzoporphyrin derivative monoacid ring A 
(BPD-MA): Absorption at 690 nm. Low tumour 
selectivity, unfavourable for PDT of some 
cancers (clears too quickly from system), and 
tested for vertebral metastases. Used for 
treating wet form of age-related macular 
degeneration by destroying neovasculature. 
Hypericin Natural compound extracted from 
St John's Wort Absorption at 599 nm. 
Promising photosensitiser agent for pituitary 
and prostate tumours 
Photosens (AIPcSn) Sulphonated aluminium phthalocyanine: 
Absorption at 675 nm. Tested for brain and liver 
tumours, and age-related macular 
degeneration. 
Table 1.1 
Some frequently administered photosensitisers. 
(Chang et al. 1997;Colasanti et al. 2000; reviewed by Macdonald and Dougherty, 2001; 
Algermissen et al. 2003; Burch et al. 2003; Moore et al. 2006; Betz et al. 2007; Cole et al. 
2008; Nyst et al. 2009) 
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(A) 0.5 I-Ig/ml m-THPC incubated for 24 h in MEM with 10 % serum, peak absorption at 
652 nm wavelength (Adapted from Ma et a/., 1994) and (8) 1 I-Ig/ml hypericin dissolved in 
DMSO and then culture medium, peak absorption at 592 nm wavelengths. (Taken from 
Colasanti et a/., 2000) 
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OH 0 OH 
OH 0 OH 
Chemical structures of photosensitisers used in this study. 
(A) m-THPC (Adapted from Klein et a/. , 1997). This is the photosensitiser of interest in this 
study, its structure shows 4 benzene rings (Blue circles) attached to a porphyrin ring 
(green square), and (8) hypericin (Adapted from Saw et a/., 2005). This is a 
photosensitiser also used in this study; it has benzene ring structures (a polyphenol 
molecule). 
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m-THPC-mediated PDT in comparison to other photosensitisers (Morlet et al., 
1997; Vrouenraets et al., 1999; Moan et a/.,1999; Marchal et a/., 2005; Moore et 
al., 2006). 
A side-effect of m-THPC use is its induction of skin photosensitisation due to its 
long-lasting localisation in skin tissues (Moore et a/., 2006; Morlet et a/., 1997). 
Sasnouski et al. (2006) reported that upon Lv. injection, m-THPC will first 
encounter blood plasma proteins; binding to high density lipoprotein (HDL) as its 
major carrier in the blood. A vascular compartment for m-THPC storage in vivo 
influences the rate of m-THPC redistribution in the body and gives m-THPC a 
lower rate of redistribution in comparison to other photosensitisers. m-THPC is 
redistributed in the blood by binding to different plasma proteins, this is while it 
remains tightly bound to lipoproteins and HOL. HDLs are large complexes which 
prevent a rapid diffusion of m-THPC through the blood vessel walls and into the 
surrounding tissue, and so also results in the long retention of m-THPC in the 
vasculature (Sasnouski et a/., 2006). This long retention in the vasculature can be 
additionally used in PDT as a means of destroying blood supply to tumours. 
m-THPC-mediated PDT has been shown to cause photodamage, at least in part, 
by a type II process in vitro (Figure 1.11 and 1.13); as determined with the aid of 
molecular scavengers (Ma et a/., 1994; Melnikova et al., 1999b). This dependence 
on oxygen to display tumourcidal effects; therefore makes m-THPC-mediated PDT 
very sensitive to oxygen concentration at treatment sites (Sasnouski et al., 2006). 
However, Ochsner (1997) has also reported that m-THPC-mediated PDT may act 
not only by a type II process, but by both type I and type II processes in vitro. 
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1.3.2.2 General features of hypericin and hypericin-mediated PDT 
Another photosensitiser used in PDT is hypericin (Figure 1.15B). Hypericin is a 
naturally-occurring polycyclic quinone photosensitiser compound, which can be 
extracted from the herb Hypericum perforatum (St. John's Wort) (reviewed by 
Kubin et al. 2005; Mikes et al., 2007). Hypericin has aromatic benzene ring 
structures (a polyphenol molecule) which gives this compound its fluorescent 
properties (Figure 1.15B), and is sparingly soluble in water (hydrophobic) (Saw et 
al., 2005; Van De Putte et al., 2006). Like m-THPC, hypericin has been 
investigated for its usefulness in treating prostate cancer (Colasanti et al., 2000; 
Xie et al., 2001), bladder cancer (Kamuhabwa et al., 2004), breast cancer (Blank 
et al., 2004) and brain associated tumours: pituitary (Cole C.D. et al. 2008) and 
gliomas (Miccoli et al., 1998; Ritz R. et al., 2005; Ritz R. et al., 2007). 
Kubin et al. (2005) reported hypericin as a compound with diverse uses. In 
addition to its use as a photosensitising agent in PDT it is commonly tested and 
used as an anti-depressive, anti-retroviral, anti-neoplastic, and as a 
photodiagnostic agent. Hypericin is also reported to have anti-inflammatory 
properties (Pajonk et al., 2005) and, on light activation, anti-viral and anti-tumour 
activity (Oas K. et al., 1999). 
Hypericin-mediated PDT has been reported as occurring by a type II process 
(Kubin et al., 2005). But, Mikes et al. (2007) have reported high efficiency in the 
production of both 102 (type II) and O2.- (type I) after visible light illumination of -
600 nm wavelength (Figure 1.14), and hypericin has low or no dark toxicity. These 
findings were similar for m-THPC-mediated PDT. 
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1.3.3 Effects of 102 /ROS on biological molecules of the cell 
Under normal conditions, cytosolic ROS can be generated in eukaryotic cells 
during normal energy metabolism (e.g. mitochondrial electron transport and 
oxidative phosphorylation) and by metabolism of redox-cycling xenobiotics (e.g. 
anthracyclines) (Girotti, 2001; Du et al., 2001; Scherz-Shouval and Elazar, 2007). 
These ROS are usually kept under control by antioxidant molecules such as 
glutathione (GSH) and antioxidant enzymes such as superoxide dismutase (SOD), 
and therefore do not cause toxic effects in cells. 
Superoxide (02'-) is the major type of ROS generated in mitochondria and can 
interact with nitric oxide (NO') to form reactive non-radicals (Le. peroxynitrite 
(ONOO-», which may also damage cells by promoting membrane lipid 
peroxidation and nitration of proteins on tyrosine residues (Keller et a/., 1998). O2'-
is usually considered as a precursor of more reactive species; it is known to 
promote the production of secondary derivatives such as hydrogen peroxide 
(H20 2), and HO' in intracellular oxidative chain events (Du et al., 2001). Reductant 
species also produce these cytotoxic species (Melnikova et al., 1999c; Girotti, 
2001) (Table 1.2). 
However, the high level of 102/ROS generated by PDT is known to affect many 
biological molecules within the cell. Nucleic acids, proteins and unsaturated lipids 
are prominent targets of 102/ROS attack in cells exposed to PDT (Girotti, 2001). 
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Free radicals ions Reactive non-radicals 
Superoxide O2.' Hydrogen peroxide H20 2 
Hydroxyl HO· Lipid hydroperoxide LOOH 
Hydroperoxyl HOO· Cholesterol ChOOH 
hydroperoxide 
Lipid peroxyl LOO· Peroxynitrite ONOO' 
Nitric oxide NO· Singlet oxygen ' 0 2 
Thiol radicals RS· 
Table 1.2 
Simplified table of some reactive radical and non-radical molecules that commonly 
form in cells . 
Increased formation of these cell toxic molecules occurs during the application of PDT. 
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1.3.4 Subcellular localisation of PDT-induced oxidative stress 
In biological systems, PDT generated 102 diffuses short distances from the point of 
generation, and hence principally causes damage close to the site of production. 
102 has a half-life of < 0.04 \-IS, and a radius of action of approximately 0.01-0.02 
~m (Agostinis et a/., 2004; Buytaert et a/., 2007; Berg, 2007). 
PDT-induced oxidative stress can cause damage to specific organelles including 
plasma membranes, mitochondria, Iysosomes and ER (8all et a/., 1998; Castano 
et al., 2005). If the photosensitiser used in PDT is amphiphilic (having both 
hydrophilic and hydrophobic properties) (reviewed by Macdonald and Dougherty, 
2001) and localises in the lipid bilayer, membrane lipids such as phospholipids and 
cholesterol, which are known targets for oxidative modification, may be affected. 
Lipid hydroperoxides (LOOHs) are formed, resulting in membrane damage and 
cell death (Girotti, 2001; Wang et al., 2001). LOOHs including cholesterol 
hydroperoxide (ChOOH) are key reactive non-radical intermediates in the 
mechanism of PDT (Girotti 2001; Wang et a/., 2001) (Table 1.2). LOOHs are also 
involved in the mediation of signalling cascades, which either fortify antioxidant 
defences of cells or evoke apoptotic cell death if the oxidative pressure is too 
great. In addition, cholesterol hydroperoxide (ChOOH) is generated by both type I 
and type II processes (Girotti, 2001). 
1.4 Mechanisms of PDT-induced cell death 
Cell death primarily occurs through 2 pathways: apoptosis and/or necrosis. There 
is also a third mode of cell death, which is known as autophagic cell death. 
Ionising radiation and chemotherapy can induce apoptosis in cancer cells by 
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damaging DNA. In contrast, PDT produces an acute stress response that can lead 
to apoptosis, necrosis and/or autophagy. In this section, the main characteristics of 
these different cell death mechanisms are summarised, followed by a description 
of how PDT activates these processes. 
1.4.1 Apoptosis 
Apoptosis is a regulated complex process, which involves the activation of a 
cascade of proteases, known as caspases (Banasiak et al., 2000). Apoptotic 
caspases act in 2 main pathways: the intrinsic pathway in which mitochondria play 
a central role; and the extrinsic pathway which is triggered by binding of death 
ligands to cell plasma membrane death receptors (DR) (Gupta, 2002; Agostinis et 
al., 2002; Simstein et al. 2003; Agostinis et al., 2004; Artal-Sanz and Tavernarakis, 
2005; Castano et al., 2005; Buytaert et al., 2007) (Figure 1.16). 
Apoptotic cell death involves a characteristic sequence of morphological, 
biochemical and energetic changes. Initial stages of this active cell death show 
little damage to the organelles, and plasma membranes remain intact (Becker and 
Bonni, 2004; Plaetzer et al., 2003; Buytaert et al., 2007). Cells dying by apoptosis 
are known not to adversely affect neighbouring cells, because cell contents are 
digested and not released. In vivo, apoptotic cells are characterised by cell 
rounding and loosening from their surroundings. Morphological features of 
apoptotic cell death also include cell shrinkage, shrunken nuclei with condensed 
chromatin, DNA fragmentation at inter-nucleosomal sites, formation of autophagic 
vacuoles in the dying cell cytoplasm, cell surface membrane blebbing, and plasma 
membrane breakdown in later phases (Collins et al., 1997; Willingham, 1999; 
Neodt et al., 1999; Banasiak et al., 2000; Leung et al., 2002; Inbal et al., 2002; 
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Zong and Thompson, 2006; Buytaert et a/., 2007). Also in the later phase of 
apoptosis, condensed apoptotic bodies develop, which contain cytoplasm, whole 
organelles and nucleic fragments (Noodt et a/., 1999; Inbal et a/., 2002; Zong and 
Thompson, 2006). 
In relation to PDT, ROS generated from a type I process is more likely to result in 
the activation of an intrinsic apoptosis pathway in cells, rather than 102 generated 
from a type II process (Buytaert et a/., 2007). 
1.4.2 Autophagic cell death 
In mammalian cells, autophagy is generally known to promote cell survival by 
removing damaged organelles, toxic metabolites and intracellular pathogens by 
delivering them to Iysosomes for recycling (Buytaert et a/., 2007; Scherz-Shouval 
and Elazar, 2007; Chen et a/., 2008) (Figure 1.17). However, unregulated 
autophagy can result in cell death rather than cell survival. During autophagic cell 
death, structures called autophagosomes (double membrane structures) are 
formed from membranes enclosing cytoplasm; these fuse with Iysosomes to be 
degraded by the cell (Mizushima et a/., 2002). 
The main features of autophagy are appearances of abundant autophagic 
vacuoles in the cytoplasm, which are accompanied by mitochondrial dilation, 
enlargement of ER and Golgi apparatus, nuclear pyknosis, membrane blebbing, 
and heterophagic elimination (Inbal et a/., 2002). 
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Death Signals 
(oncogenes, UV, drugs, PDT, .. . ) 
CytoC ~. 
• Procaspase-9 
Illustration shows a simplified diagram of the intrinsic and extrinsic apoptotic 
pathways, 
Apoptotic cell death involves many molecular 'players' , some of which are shown in this 
diagram. Bcl-2 (a family of proteins that regulate apoptosis) , which includes Bid (BH3 
interacting domain death agonist) and Bax (Bcl-2- associated X protein) , are involved in 
this mechanism of cell death. Fas (death receptor, DR), FasL (DR ligand) , FADD (Fas-
associated protein with death domain), Cyto C (Cytochrome C) (Adapted from Agostinis et 
al., 2004) 
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Figure 1.17 
Illustration of the mechanism of autophagy in mammalian cells. 
Parts of the cytoplasm are enclosed by autophagic isolation membrane. This forms 
autophagosomes. These then fuse with endosomes or Iysosomes to degrade enclosed 
materials (e.g. mitochondria). (Taken from Mizushima et a/., 2002) 
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Autophagy has an important role in the cellular responses to oxidative stress 
(Scherz-Shouval and Elazar, 2007). It may be induced by PDT in cells as a 
mechanism to repair PDT damage to key organelles, but this response may turn 
into a cell death signal if uncontrolled (Buytaert et al., 2007). 
1.4.3 Necrosis 
Necrosis is a third mode of cell death and it is associated with disruption or break-
down of the plasma membrane. Unlike apoptosis it results 'in damage to 
neighbouring cells, and in vivo it results in the development of inflammation due to 
uncontrolled leakage of intracellular material into the extracellular space (Ball et 
al., 1998; Plaetzer et al., 2003). Necrosis is often thought of as a rapidly occurring 
event, the primary cause of which is the consequence of loss of membrane 
integrity and alterations or loss in metabolic homeostasis control, due to 
peroxidation of membrane lipids and proteins (Banasiak et al., 2000; Plaetzer et 
a/., 2003). Therefore necrotic cell death occurs due to deregulation of normal 
cellular activities, for example after exposure to extreme stress conditions (Artal-
Sanz and Tavernarakis, 2005), resulting in intracellular adenosine triphosphate 
(ATP) depletion to a level that is incompatible with cell survival or with apoptosis 
(Plaetzer et al., 2003; Buytaert et al., 2007). Necrosis is therefore generally 
thought to be a passive form of cell death (Plaetzer et al., 2003; Ball et al., 1998). 
However, recent studies have indicated that necrotic cell death may be actively 
propagated as part of a signal transduction pathway (Buytaert et al., 2007). 
Necrosis can also occur late in apoptosis (Heinzelmann-Schwarz et al., 2003); this 
type of necrosis is referred to as apoptotic necrosis or secondary necrosis (Zong 
and Thompson, 2006). 
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Morphological characteristics of necrosis includes vacuolisation of the cytoplasm, 
cell swelling and breakdown of the plasma membrane, ill-defined cytoplasm, 
coarse chromatin pattern, karyolysis and dilation of the ER (Leung et al., 2002; 
Plaetzer et al., 2003; Artal-Sanz and Tavernarakis, 2005; Buytaert et al., 2007). In 
addition, electron microscopy can identify necrotic cell death as defined by 
electron-lucent cytoplasm, swelling of cellular organelles, and loss of plasma 
membrane integrity (Zong and Thompson, 2006). 
Buytaert et al. (2007) reported that 102 produced during PDT at the membranes of 
ER and Golgi apparatus is able to mediate necrosis in PDT treated cells. While no 
definitive biochemical pathway mediating necrosis following PDT has been 
identified as yet, certain factors such as Ca2+ overload and the origin and type of 
generated ROS may be decisive in promoting a necrotic cell death pathway. 
Further to this, with the use of membrane-associated photosensitisers, a shift from 
apoptotic to necrotic cell death is usually provoked by an increase in oxidative 
stress generated during PDT (e.g. by increasing either applied light, and to some 
extent photosensitiser concentration or incubation time) (Plaetzer et al., 2003; 
Agostinis et al., 2004; Buytaert et al., 2007). 
1.5 A review of nerve response to PDT 
Since 1996, most research published on the effect of PDT on peripheral nerves in 
vitro has been performed by Uzdensky et a/. Their research mainly focused on the 
use of an isolated crayfish abdominal stretch receptor (mechanoreceptor) nerve 
culture system that consists of 2 sensory neurones enwrapped by satellite cells 
(Uzdensky et a/., 2005; Uzdensky et a/., 2007; Fedorenko and Uzdensky, 2008; 
Fedorenko and Uzdensky, 2009) (Figure 1.18). 
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__ Perikaryon 
Figure 1.18 
An isolated crayfish mechanoreceptor. 
(a) Brightfield micrograph; (b) Fluorescence micrograph; (c) Fluorescence micrograph of 
the stretch receptor; and (d) Diagram of the nerve culture system preparation. Hoechst 
DNA nuclei stain (blue-green) , propidium iodide (PI) dead cell nuclei stain (red) . RM 
(receptor muscle) , MT (microtubules) , DE (dentritic ending) , N (nucleus) , NI (nucleolus) 
and Aff .Ax (afferent axons) and scale bar is 50 IJm. (Taken from Fedorenko and 
Uzdensky, 2009) 
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Work of this research group touched briefly on the effects of m-THPC-mediated 
PDT on isolated crayfish nerves. They have shown high PDT efficiency at 0.001-1 
!-1M (0.007-7 !-Igml) m-THPC, in relation to loss of nerve firing potential. In general 
the life time of neuronal survival in these crayfish nerves was found to depend on 
the concentration of the photosensitiser used for PDT treatment. The use of some 
concentrations of photosensitisers tested by this group showed reversible 
cessation of neural activity; however, it was found that with m-THPC-mediated 
PDT, the concentration of m-THPC did not correlate with neuronal death. Instead, 
m-THPC-mediated PDT was observed to cause irreversible cessation of neurone 
activity at nanomolar or nanogram concentrations (Uzdensky et. al. 2004). 
In addition to m-THPC, hypericin was studied in the crayfish nerve culture system 
(Bragin et al. 2003). Hypericin was also initially studied as a protein kinase C 
(PKC) inhibitor, and then later as a photosensitiser in its own right (Bragin et a/., 
2003; Uzdensky et al., 2003). Hypericin was found to be toxic to crayfish nerves at 
concentrations higher than 20 !-1M (11 !-Ig/ml), and was predominantly located in 
glial cells surrounding the neurone. Only a smaIJ amount of hypericin was detected 
in the neurone perinuclear region, which is known to be rich in organelles, and on 
illumination hypericin was found to be redistributed from the plasma membrane to 
intracellular organelles (Uzdensky et a/., 2003). 
The photosensitiser Photosens (AIPcSn) was the most extensively studied 
photosensitiser by this group, and like hypericin, also showed predominant 
localisation in glial cells. This finding suggested that glial cells would be more 
vulnerable to photodamage than neurones during PDT with this photosensitiser. 
This observation opened up the possibility of selective PDT killing of malignant 
glial cells in the nervous system (e.g. in the brain); therefore possibly allowing 
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neurones to remain undamaged after Photosens-mediated PDT (Uzdensky et al., 
2005). Further to these studies, Kolosov and Uzdensky (2006) have shown that 
neurones in this crayfish nerve culture system were possible protecting glial cells 
from Photosens-mediated PDT-induced apoptotic cell death. There were also 
indications that this possible protection was mediated by the release of signalling 
molecules from neurones. 
Photosens-mediated PDT on intact isolated crayfish nerve showed irreversible 
functional inactivation (nerve firing) and necrosis in neurones (Uzdensky et al., 
2007). Using dissociated neural cells from these crayfish nerves revealed a 
combination of necrosis, apoptosis and proliferation of satellite cells in vitro 
(Lobanov and Uzdensky, 2005). Crayfish satellite cells were found to be more 
sensitive to photosens-mediated PDT treatments than neurones (Lobanov and 
Uzdensky, 2005). Uzdensky et al. (2002) also demonstrated with photosens-
mediated PDT, that different death modes were achievable with the administration 
of different concentrations of a photosensitiser. Intense photosensitisation resulted 
in necrosis, and weaker photosensitisation resulted in apoptosis. Recent studies 
by this group reported slight changes in neuronal ultrastructure in neurones 5 min 
post-PDT treatment for example alterations in some mitochondria and 
vascularisation of cytoplasm, and compensatory changes such as formation of 
Iysosomes and autophagosomes. However, after 30 min post-PDT they detected 
more marked changes such as abolition of neurone firing, and destruction of 
mitochondria and Golgi apparatus (Fedorenko and Uzdensky, 2008). 
Other research in relation to the effect of PDT on peripheral nerves includes the 
work of KObler et al. (2003), who reported that 24 h after the administration of 0.3 
mg/kg m-THPC to rabbits in vivo, followed by the illumination of nerves in the neck 
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and groin area, damage to connective tissue was observed, and there was 75 % 
demyelination to the nerve that did not result in any clinical symptoms. Also, Ris et 
al. (1997) has reported that virtually all intrathoracic tissue were severely 
damaged, but not the nerves, 12 h to 6 days after the administration of 0.1 mg/kg 
m-THPC-mediated PDT in minipigs. 
1.6 Cellular antioxidant protective pathways 
Low levels of ROS are normally reduced by non-enzymatic and enzymatic 
antioxidising agents (Le. GSH, thioredoxin, SOD, catalase and peroxidises), in 
order to keep cells alive (Table 1.3) (Scherz-Shouval and Elazar, 2007). The 
interplay of SOD, catalase and GSH with the aid of glutathione peroxidise (GPx) 
controls the intracellular accumulation of H202 (Figure 1.19) and therefore protects 
the cells against oxidative damage induced by H202 itself or by HO·. 
1.6.1 Glutathione synthase intracellular antioxidant pathway 
1.6.1.1 Glutathione synthase pathway 
The y-glutamyl cycle (Meister, 1994; Marks et al., 1996a), also known as the 
glutathione synthase pathway, generates the antioxidant molecule GSH 
(Mytilineou et al., 1999). This pathway regulates the cytoplasmic and mitochondrial 
localised GSH antioxidant pools, which represent the mammalian cells main redox 
buffer against oxidative stress (Nicole et al., 1998; Nicholls and Budd, 2000); 
therefore modest changes in GSH concentration can strongly alter the redox state 
of cells (Nicole et al., 1998). GSH is the most abundant intracellular small 
molecule thiol present in mammalian cells (Mytilineou et al., 1999; Scherz-Shouval 
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Antioxidants Functions 
GSH Reacts with a number of oxidising agents 
SOD Catalyses the formation of H20 2 from ROS 
GPx Catalyses the breakdown of H20 2 by reacting with 
GSH 
Catalase Catalyses the breakdown of H20 2 
Vitamin E Important in limiting damage to membrane during 
lipid peroxidation 
Vitamin C Deactivating ROS and aiding Vitamin E 
Thioredoxin Facilitates reduction using cysteine thiol-
disulphide exchange 
Table 1.3 
Primary antioxidant defences. 
Table shows a list of antioxidant defence molecules which act in unison to protect the 
body against cell damage. GSH (N-(N-L-y-glutamyl-L-cysteinyl)glycine) or glutathione), 
SOD (superoxide dismutase), GPx (glutathione peroxidise) , H20 2 (hydrogen peroxide), 
ROS (reactive oxygen species) , Vitamin C (L-ascorbic acid) and Vitamin E (a-tocopherol) . 
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and Elazar, 2007; Lewis-Wambi et al., 2008), it is present in cells at a millimolar 
concentration, and is the main alternative target for ROS apart from protein-
sulfhydryl (-SH) groups in cells (Witold and Grzegorz, 2000). In the brain GSH 
concentration has been reported at a level of 1 to 2 mM (Mytilineou et al., 1999). 
GSH functions to detoxify peroxides and ROS from cells, providing cells with a 
reducing ability (Nicole et al., 1998; Mytilineou et al., 1999; Lewis-Wambi et al., 
2008). 
In this study the inhibition of the rate-limiting step enzyme y-glutamyl-cysteine 
synthetase (y-GCS) (Figure 1.19 and1.20) was investigated for its effect on PDT 
induced cell death of neural cells. 
1.6.1.2 Glutathione oxidation-reduction pathway 
The glutathione oxidation-reduction pathway links the glutathione synthase 
pathway to the SOD pathway (Figure 1.19). The main half of the glutathione 
oxidation-reduction pathway involves the formation of glutathione disulfide (GSSG) 
from the oxidation of the protein-SH group (an electron donor) of GSH, when H202 
is reduced to H20 with GPx (GSH peroxidase) (Meister, 1994; Marks et al.,1996b; 
Nicole et al., 1998; Alberts et al., 2008), a direct reaction of GSH scavenging for 
free radicals. 
The second half of the glutathione oxidation-reduction pathway involves the re-
formation of the antioxidant molecule GSH using nicotinamide adenine 
dinucleotide phosphate (NADPH+) and a proton (H+) from the pentose phosphate 
pathway (Meister, 1994; Marks et al., 1996b), in combination with GR (GSH) 
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Figure 1.19 
A simplified illustration of the interactions of the glutathione synthase, SOD and 
catalase intracellular antioxidant pathways. 
GSH (reduced glutathione), GSSG (oxidised form of GSH-glutathione disulfide 
glutathione) , GS (Glutathione synthase), y-GCS (Y-Glutamyl-Cysteine synthetase) and 
(SOD) superoxide dismutase. 
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Illustration of the glutathione synthase pathway. 
Illustration shows that GSH is exported through the cell membrane and is metabolised by 
the membrane-bound GGT (y-glutamyltransferase) and MBD (membrane bound Cys-Gly 
dipeptidase). This cleaves GSH into its component amino acids (cysteine, glycine and 
glutamine), which are ultimately recycled to form new GSH molecules. In the extracellular 
space y-glutamyl covalently bonded to amino acids is transported into the cell through 
amino acid transporters. Amino acids are then removed from the y-glutamyl-amino acid 
molecule by y-GCT (y-glutamyl-cyclotransferase) forming 5-0xoproline. 5-0xoproline is 
cleaved releasing glutamyl. This glutamyl molecule is linked to cysteine by y-GCS (y-
glutamyl-cysteine synthetase) to form y-glutamylcysteine. This ATP-dependent reaction is 
the overall rate-limiting step in the pathway. GSH synthetase is used to link Gly to y-
glutamylcysteine forming GSH. GSH is either exported out of the cell directly by GSH 
transporters or combines with xenobiotics using GST to form GSX for cell export (Taken 
from Martin et al., 2007). 
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reductase) (Meister, 1994; Marks et al., 1996b; Nicole et al., 1998) (Figure 1.19), 
directly from GSSH. 
1.6.2 SOD antioxidant pathways 
SOD isoenzymes are the first and most important line of endogenous antioxidant 
enzyme defence against ROS in mammalian cells (Zelko et al., 2002; Oimayuga et 
al., 2007) (Table 1.3). SODs include: the dimer copper-zinc SOD (Cu2+,Zn2+-S0D 
or SOO-1), a nuclear, cytosolic and intermembrane mitochondrial space localised 
enzyme; homotetrameric SOO-2 (Mn2+ -SOD or SOO-2); a mitochondrial matrix 
localised enzyme (Keller et al., 1998; Zelko et al., 2002; Antonyuk et al., 2009; 
Perry et al., 2009); and copper (Cu2+)- and zinc (Zn2+)-containing glycoprotein 
dimer (extracellular-SOD or SOO-3), a soluble extracellular enzyme (Zelko et al., 
2002; Antonyuk et al., 2009; Perry et al., 2009). These enzymes are critical in 
controlling levels of ROS within cells (Perry et al., 2009). SOD scavenges O2.-
(Tanioka et al., 2005; Ochsner, 1997), preventing its accumulation by converting it 
to H202 (Keller et al., 1998), by catalyzing the reaction shown in Figure 1.19. Toxic 
H202 generated from the SOD pathway is further metabolised to H20 by either the 
glutathione oxidation-reduction pathway or the catalase pathway (Alberts et al., 
2008) Figure 1.19. 
In this study, the inhibition of SOD enzymes (Figure 1.19) was investigated for 
their effects on PDT-induced cell death of neural cells. 
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1.7 Research aims and objectives 
The overall aims of this research project were to provide scientific insight into the 
biological basis of peripheral nerve sparing during PDT; to increase the 
understanding of the interactions of m-THPC-mediated PDT with the adult 
mammalian peripheral nervous system at a cellular level; and to develop suitable 
nerve models for use in this study and future nerve PDT investigations. No 
previous cell culture research on the effects of m-THPC-mediated PDT on 
mammalian peripheral nerves has been performed, so this work represents the 
first reported study. 
The objectives of the work were first, to determine the cell-specific effects of PDT 
on neural cells in comparison to tumour cells. This led to a second objective; to 
determine why DRG neurones were less susceptible to m-THPC-mediated PDT in 
comparison to other cell types (satellite cells, astrocytes and the human breast 
cancer cell line MCF-7). A third objective was to develop 2-dimensional (20 or 
monolayer) or 3D tissue engineered nerve culture systems, suitable for use in 
evaluating the effects of focally applied PDT. The culture system would enable 
different parts of the neurone to be exposed to PDT (Le. neuronal cell bodies, 
neurites or growth cones). 
Results from this project will be of interest to both researchers and clinicians who 
are involved in the study and treatment of tumours in close association with nerve 
structures. 
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Chapter 2: Materials and Methods 
2.1 Suppliers and materials 
Generally all reagents were of tissue culture and! or analytical grade: 
2.1.1 Photosensitisers 
bioLiTEC PHARMA Ltd AG, Jena 
(Germany) 
Gift of Dr Alexander MacRobert 
(National Medical Laser Centre, 
(UCL») 
Foscan® containing 4 mg/ml 
temoporfin, Meta-(tetra-
hydroxyphenyl) chlorin (m-THPC) 
TOCRIS bioscience, Tocris Cookson 1 ,3,4,6,8,13-Hexahydroxy-1 0,11-
Ltd (UK) dimethylphenanthro[1, 1 0,9,8-
opqra]perylene-7, 14-dione (hypericin) 
2.1.2 Primary antibodies (Ab) 
COVANCE, California (USA) 
DakoCytomation (Denmark) 
Sigma Aldrich (UK) 
(Cat. no.1520) 
Mouse Monoclonal Antibody Anti-
Neurofilaments Hypophosphorylated 
(SMI 35) (Cat. no. SMI-35R) 
Rabbit Polyclonal Antibody Anti-S-100 
(Cat. no. Z0311) 
Mouse Monoclonal Antibody Anti-~­
tubulin Isotype III, Clone SDL-3010 
(Cat. no. T-8660) 
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Rabbit Polyclonal IgG Anti-Laminin 1 
(Cat. no. L-9393) 
Upstate Cell Signalling Solutions Mouse Monoclonal IgG1 Anti-phospho-
(USA) Serffhr-Pro, P-MPM-2 (Cat. no. 05-368) 
2.1.3 Fluorescently conjugated secondary antibodies 
Sigma Aldrich (UK) 
2.1.4 Fluorescent cell probes 
Molecular Probes ™ 
Invitrogen Ltd (UK) 
Sigma Aldrich (UK) 
2.1.5 Inhibitors 
Sigma Aldrich (UK) 
Goat Antibody Anti- rabbit IgG FITC 
conjugated (Cat. no. F-6005) 
Goat Antibody Anti-rabbit IgG TRITC conjugated 
(Cat. no. T -5268) 
Sheep Antibody Anti-mouse IgG FITC 
conjugated (Cat. no. F-6257) 
Goat Antibody Anti-mouse IgG TRITC 
conjugated (Cat. no. T-5393) 
LysoTracker® Green DND-26 (Cat. no. L-7526) 
MitoTracker® Green FM (Cat. no. M-7514) 
Bisbenzimide H33258 (Cat no. 14530) 
Propidium Iodide (Cat. no. 81845) 
Acridine Orange (Cat. no.01662) 
Colchicine (A gift from (Mr Va Gao) (Cat. no. 
27650) 
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Diethyldithiocarbamic Acid sodium Trihydrate 
crystalline (Cat. no. 0-3506) 
DL-Buthionine-(S,R)-Sulfoximine (Cat. no. B-
2640) 
2-Methoxyestradiol (Cat. no. M-6383) 
BOH Laboratory Supplies (UK) Chromium (III) Potassium Sulphate 
12-Hydrate (Prod. 2775845) 
Iso-Pentane (Cat. no. 294526 G) 
Bright Instrument Company Ltd (UK) Cryo-M-Bed 
CALBIOCHEM® (USA) TdT-FragEL™ DNA Fragmentation 
Citifluor Ltd (UK) 
DakoCytomation (Denmark) 
First link (UK) Ltd. 
Fisher Scientific (UK) Ltd 
Hayman Ltd (UK) 
Mikrobiologie, MERK (Germany) 
Sigma Aldrich (UK) 
Detection Kit, Colorimetric-TdT Enzyme 
(Cat. no. QIA33) 
Citifluor AF2 
Swine Serum (Normal) (Cat. no. 
X0901F) 
Type I Rat Tail Collagen 
Sucrose (Code S/8600/60) 
MgS04 (Code M/1050/53) 
Absolute alcohol 100, ethanol 
Gelatine (Cat. no. 4070) 
Bovine serum albumin (Cat. no. A-7906) 
Collagenase, Crude (Cat. no. C-9407) 
Deoxyribonuclease 1 Type \I (Cat. no. 
04527 -40KU) 
- 57 -
TAAB (UK) 
Chapter 2-Materials & Methods 
2', 7'-Dichlorofluorescin Diacetate (Cat. 
No. D-6883) 
Dimethyl Sulfoxide (DMSO) (Cat. no. 
D2650) 
0-( + )-Glucose (Cat. no. G5400) 
Laminin (Cat no.) 
Menadione (Vitamin K3) (Cat. no. 
M57405) 
Phosphate Buffer Saline Tablets (Cat. 
No. P4417-100TAB) 
Poly-D-Lysine Hydrobromide (Cat. no. 
P7280) 
Poly-L-Lysine Hydrobromide (Cat. no. 
P-1274) 
Triton® X-100 (Cat. no.T8787) 
Trypan Blue (T-8154) 
Trypsin/EDTA solution (x1) (Cat. 
no.T3924) 
Soybean trypsin inhibitor (x1) (Cat. 
no.T6414) 
Paraformaldehyde EM (Code P001) 
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2.1.7 Culture media reagents 
All reagents in this section were supplied by Sigma Aldrich, UK. Foetal calf sera 
(FCS) were supplied by Sigma Aldrich, UK and GIBCQ, UK. 
Dulbecco's Modified Eagles Medium with L-glutamine and phenol red (Cat. no. 0-
6429) 
Dulbecco's Modified Eagles Medium without L-glutamate and phenol red (Cat. no. 
0-5921 ) 
Pen/Strep solution containing 10,000 U/ml penicillin and 10 mg/ml streptomycin) 
(Cat. no. P0781) 
Foetal calf serum (Cat. no. F7524) 
200 mM L-glutamine (Cat. no. G-7513) 
Minimum Essential Medium (x10) (Cat. no. M0275) 
Ca2+ - and Mg2+ - free Earle's Balanced Salt Solution (Cat. no. E6267) 
2.1.8 Tissue and cell culture materials 
Nerve tissue of adult Sprague Dawley rats (250-350 g), on average 6 months old, 
was obtained from the Open University in-house animal breeding unit. 
2.1.8.1 Dissected tissue materials 
• Sciatic Nerves 
• Dorsal Root Ganglia 
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In addition, sciatic nerves were dissected and collected from 200 g female Wistar 
rats pre-injected for 24 h with 0.3 mg/kg Foscan®, (A Gift from Dr Josephine 
Woodhams, National Medical Laser Centre, UCL) 
2.1.8.2 Cells 
A Gift of Drs James B. Phillips & Primary astrocyte cultures 
Emma East. (The Open University) 
ECACC Oestrogen-dependent human breast 
A Gift of Dr Marliena Loizidou (Dept adenocarcinoma cell line (caspase 3 -1-) 
of Surgery, UCL) (MCF-7) 
2.1.9 Imaging equipment: 
Leica (Germany) 
Olympus (UK) 
2.1.10 Other equipment 
Beckman Coulter Ltd (UK) 
SOH Laboratory Supplies (UK) 
Leica DMIL light microscope. 
Leica TCS NT fluorescence scanning 
confocal microscope, with Leica confocal 
software 
Olympus SX61 fluorescence microscope, 
with a CCD camera and analySIS imaging 
software 
Olympus SZ40 (Dissection microscopes) 
with Volpi, Intralux® 6000 (Optical fibre light 
source) 
Centrifuge (BECKMAN T J-6) 
Rectangular Cover Glass, 22 x 50 mm 
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FALCON (UK) 
GRI Lab Care Services 
Imaging Research Inc 
JENCONS Pic (UK) 
Laser Line (UK) Ltd 
(Borrowed from The National 
Medical Laser Centre, UCL) 
Leica (Germany) 
NUNC (UK) 
Scanbur BK (Denmark) 
Sigma Aldrich (UK) 
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(Cat. no. 406/0188/42) 
BiOQuell, HERAsafe Class II cabinet 
Fumehood with TEL AFA 1000 
Disposable 24 multiwell plates, clear and 
flat bottomed 
Alphalmager & High Performance 
Transilluminator UVP, model TFM-26, 25W 
Transilluminator: For digital imaging 
NorthernLight Illuminator, adjustable day 
light white light of 1000-6500 Calvin, evenly 
illuminated, no flicker, stable light output 
within ± 0.1 %, stable temperature. 
Spectrafuge 24D 
LICON IX model 55PM Light Meter 
(portable) 
Leica Cryostat eM 1900 
Disposable 12 multiwell plates, clear and 
flat bottomed (Ref. no. 150628) 
Tissue Culture Flasks (T25 & T75) filtered 
and non-filtered 
Scantainer filter cabinets 
Slides, Microscope, Frosted one end, size: 
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25 mm x 75 mm (Cat. no. S8400-1 PAK) 
The Open University (UK) 633 nm (red) Laser Light source 
VWR International Circular Cover Glass, 19 mm circular, 
thickness no.1.5, Borosilicate glass. Cat# 
631-0156 
Super Premium Microscope Slides, 1,0-1,2 
mm ThicklTwin-Frost (Cat. no. 631-0112) 
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2.2 Methods 
2.2.1 Primary cell cultures 
2.2.1.1 Dorsal root ganglia cultures 
All animal tissue was obtained according to UK Home Office regulations following 
approval by the Open University Animal Ethics Advisory Group. Dorsal root 
ganglia (DRGs) were dissected from 250-350 g adult Sprague Dawley rats culled 
using carbon dioxide (C02) asphyxiation. Thoracic sections of rat spinal columns 
were removed within 5 min post-mortem and stored in 0.01 M phosphate buffered 
saline (PBS) at pH 7.4 to preserve tissue viability (All PBS used in this study was 
of this concentration and pH value). Tissue explants were placed in Petri dishes 
for micro-dissection using an Olympus SZ40 microscope with a Volpi, Intralux® 
6000 optical fibre light source. Spinal columns were divided longitudinally into two 
sagittal hemi-sections. Spinal cords were discarded, and approximately 26 DRGs 
were dissected from each intervertebral foramen per spinal column with fine-
forceps. Curved micro-surgical scissors were used to trim DRGs of all nerve 
processes. 
Trimmed DRG explants were pooled together in Dulbecco's Modified Eagle's 
Medium with L-glutamine (DMEM) supplemented with 100 U/ml penicillin and 100 
\Jg/ml streptomycin (pen/strep) solution and 10 % (v/v) foetal calf serum (FCS) 
(DMEM-complete culture medium). Trimmed DRGs were dissociated in 
approximately 2 ml 0.125 % (w/v) collagenase solution (prepared in serum-free 
OM EM medium supplemented with 100 U/ml/100 !-Ig/ml pen/strep solution) for 90 
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min under standard cell culture conditions (370 C in a 5 % C02 humidified 
incubator). Collagenase-treated explants were mechanically dissociated 
(triturated) into single cell suspensions with a 1 ml Gilson pipette. Collagenese 
was removed from cells by rinsing twice with approximately 20 ml DMEM-
complete culture medium. Cell pellets were collected by centrifugation with a 
BECKMAN T J-6 centrifuge at 100 x g for 5 min at room temperature. Collagenase 
was decanted and cell pellets re-suspended in appropriate volumes of DMEM-
complete culture medium for use in the various culture systems where neurones 
were required. This methodology was adapted from Oelree et a/. (1989) and 
Phillips et a/. (2005). 
2.2.1.2 Satellite cell-enriched cultures 
DRG cell suspensions as described above were used in the preparation of satellite 
cell-enriched (Satellite cell) cultures. DRG cultures in OMEM-compiete culture 
medium (section 2.2.1.1) were seeded into 75 cm3 culture flasks which had been 
pre-coated for 60 min at room temperature with 20 ~g/ml poly-L-Iysine (PLL). After 
2 days under standard cell culture conditions, culture medium was replaced with a 
1:3 DRG-conditioned culture medium (3 parts fresh OM EM-complete culture 
medium mixed with 1 part DMEM-complete culture medium from a previous ORG 
culture). ORG-conditioned medium supplied satellite cells with naturally secreted 
growth factors, which helped maintain satellite cell populations. Cells were 
cultured under standard cell culture conditions until approximately 80 % confluent, 
as observed under phase-contrast microscopy. Satellite cells were vigorously 
shaken by hand to dislodge neurones, and rinsed with autoclaved PBS to remove 
neurones. Cells were further expanded to dilute residual neurone content by 
exposing cultures to several cycles of trypsinisation. Neurones are post-mitotic 
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and therefore will not proliferate in culture (Becker and Bonni, 2004). Each time, 1 
flask was shaken by hand to dislodge neurones, washed briefly with PBS, then 
satellite cells trypsinised (0.25 % Trypsin-EDTA, 5-10 min at 37° C), collected by 
centrifugation at 100 x g for 5 min at room temperature, re-suspended in fresh 
culture medium and plated into 2 new flasks pre-coated with PLL. Satellite cells 
were maintained in culture with 1 :3 DRG-conditioned medium. After 
immunocytochemistry for ~1I1-tubulin/FITC positive cells, satellite cell cultures had 
no detectable neurones. Cells were used at passage number 2 and above. 
2.2.1.3 Schwann cell/fibroblast cultures 
Sciatic nerves in 250-350 g adult Sprague Dawley rats culled by CO2 asphyxiation 
were exposed at mid-thigh, excised with fine-forceps and micro-dissection scissors 
within 5 min post-mortem and stored in PBS. Dissected nerves were de-sheathed 
(stripped of their epineurium and outer layers of their perineurium) under a 
dissecting microscope. Nerve explants were twice rinsed in warmed DMEM-
complete culture medium (section 2.2.1.1), before being chopped transversely into 
1 mm pieces with a curved scalpel blade. Nerve pieces were then incubated for 4 
days in DMEM-complete culture medium under standard cell culture condition, to 
encourage denervated Schwann cells to adapt a proliferative state (Li et al., 1998; 
Funk et al., 2007). Following 4 days incubation, explants were incubated in 0.125 
% (w/v) collagenase solution for 18 h under standard cell culture conditions. 
Explants were mechanically triturated with a 1 ml Gilson pipette and collagenase 
was removed by centrifugation with a BECKMAN T J-6 centrifuge at 100 x g for 5 
min at room temperature. Pellets (each from 1 pair of sciatic nerves) were re-
suspended in approximately 20 ml DMEM-complete culture medium and seeded 
into a 75 cm3 culture flask pre-coated with PLL. Every 2 days half the culture 
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medium was replaced with fresh DMEM-complete culture medium. Cells were 
cultured under standard cell culture conditions until they were approximately 80 % 
confluent, as observed under phase-contrast microscopy, then passaged by 
trypsinisation with 0.25 % trypsin-EDTA solution for 5 min at 37° C. These cells 
were re-suspended in required volumes of DMEM-complete culture medium for 
use in the various culture systems in this study. This methodology was adapted 
from Li et al. (1998) and Phillips et al. (2005). Schwann cell/fibroblast (Schwann 
cells) cultures were characterised using immunocytochemistry with anti-S-100 (S-
100 is a protein found in Schwann cells but not fibroblasts), for the percentage of 
Schwann cells present. 
2.2.1.4 Sciatic nerve fibroblast-enriched culture 
Schwann cell cultures above were used as the starting culture for nerve fibroblast-
enriched cultures. Fibroblast-enriched (fibroblast) culture preparation was adapted 
from Bampton and Taylor et al. (2005). Schwann cell cultures were repeatedly 
allowed to proliferate to 100 % confluency for 2 weeks before passaging as 
described above. Fibroblast cultures were used at passage number 3 and above. 
2.2.1.5 Astrocyte-enriched cultures 
Mixed glial cell cultures were prepared from cerebral cortices of 2 day old 
Sprague-Dawley rats culled by decapitation according to the methods of Dutton et 
al. (1981) and Fallon (1985). The cerebral cortices were removed, cleaned of 
meninges and vasculature with fine-forceps under a dissection microscope, and 
then placed in a few drops of sterile disaggregation medium (14 mM glucose, 3 
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mglml bovine serum albumin (BSA) and 1.5 mM MgS04) prepared in Ca2+ - and 
Mg2+ - free Earle's Balanced Salt Solution. 
Cortices were chopped using a sterile scalpel blade before being transferred to a 
centrifuge tube containing 250 !-Ig/ml trypsin-EDT A prepared in 10 ml 
disaggregation medium for 15 min under standard cell culture conditions. 10 ml of 
a solution containing 21 J..Ig/ml soybean trypsin inhibitor, 6 J..Ig/ml 
deoxyribonuclease 1 (DNase) and 240 J..IM MgS04 in disaggregation medium was 
then added in order to neutralise trypsin. Tissue suspensions were sedimented 
using a BECKMAN T J-6 centrifuge at 100 x g for 2 min at room temperature. 
Supernatants were removed and pellets collected and re-suspended in a further 
500 J..II of solution containing 133 J..Ig/ml soybean trypsin inhibitor, 40 J..Ig/ml DNase 
and 1.5 mM MgS04 in disaggregation medium. Tissue suspensions were 
mechanically dissociated by gentle trituration with a 1 ml pipette and then debris 
allowed to settle and the supernatant cell suspension was collected. This 
dissociation step was repeated twice. The final cell suspension was under laid with 
2 ml 4 % (w/v) BSA in disaggregation medium. Intact cells were pelleted through 
the BSA underlay by centrifugation at 100 x g for 5 min at room temperature. Cell 
pellets were collected and re-suspended in OM EM-complete medium to give a 
plating density of 1-2 cortices in 20 ml per 75 cm2 culture flasks pre-coated with 20 
!-Ig/ml poly-D-Iysine (POL). Cultures were maintained under standard cell culture 
conditions for 14 days until confluent. (Cultures were prepared in this manner by 
Drs E. East and J.B. Phillips, The Open University, UK.) 
Under standard cell culture conditions, microglia were detached from 
astrocyte/microglia monolayer cultures by shaking culture flasks on a rotary shaker 
(ELMI Sky Line Shaker S-3.16L) at 150 rpm for 4 h at 37° C. The culture medium 
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containing microglia was disposed of and remaining astrocyte-enriched culture 
(astrocytes) were collected by trypsinising cells with 5 ml 0.25 % trypsin-EDTA 
solution for 10 min at 37° C. These astrocyte cultures were re-suspended in 
required volumes of DMEM-complete culture medium (section 2.2.1.1). This 
process yielded approximately 95 % astrocytes as determined by 
immunocytochemistry for GFAP positive cells in monolayer cultures pre-coated 
with 20 !-Ig/ml PDL (East et al., 1999). 
2.2.2 Human breast cancer cells 
MCF-7 cells are tumour cells which are known to be oestrogen-dependent (MOiler 
et al., 1998). They express the oncogene Wnt7B (Huguet et al., 1994) and have 
inactivated GSTP1 which encodes pi-class glutathione-S-transferase (GST) 
(Figure 1.21) similar to prostate and liver cancers (Lin and Nelson, 2003). MCF-7 
cells were used in this study as a control for tumour cell death after treatment with 
m-THPC or hypericin-mediated PDT. 
MCF-7 cells obtained as a gift from Dr Marliena Loizidou, Department of Surgery, 
UCL, UK, were propagated in vitro in DMEM-complete culture medium. Master 
and working cell banks of this cell line were prepared at passage 303 and 1 x 106 
cells/ml stored at _80° C in freezing medium (DMEM; 10% (v/v) Dimethyl Sulfoxide 
(DMSO); 20 % (v/v) FCS and 2 mM L-glutamine). MCF-7 cells were reconstituted 
by defrosting quickly at 37° C in a water bath then DMSO concentration was 
reduced by the drop wise addition of 10 ml DMEM-complete medium. MCF-7 cells 
were cultured in 25 cm3 culture flasks overnight, and then culture medium was 
completely replaced with 10 ml fresh DMEM-complete medium. Confluent 25 cm3 
culture flasks were trypsinised with 0.25 % trypsin-EDTA solution for 5-10 min at 
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37° C then plated into three 75 cm3 culture flasks. In this study MCF-7 cells were 
used at passages 305 to 321. 
2.2.3 Standard monolayer and collagen gel cultures 
2.2.3.1 Determination of cell numbers 
After trypsinisation of cell cultures to be used in culture systems, total viable cell 
numbers were determined with the use of Trypan blue exclusion. A 50:50 mixture 
of 0.4 % (w/v) Trypan blue solution with cell suspension was made and incubated 
for 2 min at room temperature. Culture samples were then viewed under phase 
contrast microscopy and quantified using a haemocytometer. Dead cells were 
blue-brown with this assay which distinguished them from viable cells. 
2.2.3.2 Standard monolayer cultures 
Monolayer culture preparations are quick and easy to prepare and are commonly 
used as experimental tools. These cultures were used in some cases to 
characterise cell culture preparations, and to assess photosensitiser uptake and 
localisation. 
1 00 ~I cell suspensions (typically between 100,000 and 200,000 cells per ml) were 
plated onto cover-glasses (19 mm in diameter) which had been pre-coated for 60 
min at room temperature with 20 ~g/ml PLL or laminin, in 12-well culture plates. 
Under standard cell culture conditions, cells were allowed to settle and adhere for 
30 min, before incubation with 1 ml culture medium per well. 
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2.2.3.3 Standard cell-seeded collagen cultures 
A key aim of this work was to establish accurate sensitivity profiles for the effects 
of different doses of PDT on different cell populations. A common problem with 
using traditional monolayer cultures for cell death assays such as these is that 
dead cells tend to be lost from the culture surface. This prevents the inclusion of 
accurate dead cell counts, and restricts analysis to monitoring numbers of 
remaining attached cells, which can be misleading. Furthermore, subsequent 
characterisation of dead cells (e.g. to identify cell type in a mixed culture) is hard to 
achieve. Here, a 3D collagen hydrogel culture system was developed which 
effectively trapped all cells (live and dead) throughout treatment, subsequent cell 
death analysis and identification of cell types. 
Type I rat-tail collagen (2 mg/ml in 0.6 % acetic acid) and 10x Minimum Essential 
Medium (MEM) were combined and allowed to equilibrate for 30 min at 4° C, 
before neutralisation with drop-wise addition of 1 M sodium hydroxide (NaOH). 
During neutralisation, indicated by a colour change in medium phenol red pH 
indicator (from yellow to orange/red), collagen/MEM solution was swirled 
constantly to maintain an even distribution of collagen/MEM solution. Cell 
suspensions were mixed into neutralised collagen/MEM in a final mixture ratio of: 
80 % (v/v) collagen; 10 % (v/v) 10x MEM and 10 % (v/v) cell suspension (primary 
neural and MCF-7 cells) prepared in DMEM-complete culture medium (Eastwood 
et a/., 1998; Porter et a/., 1998; Phillips et a/., 2005). 
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Medium 
Cell-seeded 
.. - - collagen gel in 
culture 
Mounting slide 
~.----~---- Labelled cell-seeded 
collagen gel 
rmlllll /'III IP"I,""I" I 1,"lljl1TlJlliTll1m/lIIlllIIl, II 11111 II, I II! I ~~ 1 2 3 41' 5 6 7 
Cell-seeded collagen cultures. 
(A) Gels in base of 24-well culture plates and (6 ) Gel mounted between a glass slide and 
a cover-glass ready for microscopic analysis. 
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Collagen/cell suspensions were gently mixed to ensure even cell distribution then 
pi petted into moulds for setting. Aliquots of 200 IJI collagen/cell suspensions were 
dispensed into wells of 24-well culture plates. Culture plates were swirled to 
distribute collagen/cell suspensions evenly and gels were allowed to set for 5-10 
min under standard cell culture conditions to produce an approximately 1 mm thick 
cell-seeded collagen gel disc. Each disc was covered with 1 ml culture medium 
(Figure 2.1). Pilot studies showed no difference in response to m-THPC-mediated 
PDT between MCF-7 cell-seeded collagen cultures maintained for 1 or 4 days 
prior to PDT (data not shown); therefore the 1 day option was chosen in this study 
to minimise the time for proliferation of these rapidly dividing tumour cells. Primary 
DRG cells were routinely maintained in culture for 4 days and astrocytes for 1 day 
prior to PDT treatment. Cell seeding densities and time in culture for each cell type 
are listed in Table 2.1. 
2.2.4 Photodynamic therapy (PDT) treatment parameters 
2.2.4.1 Photosensitiser preparations 
The test photosensitiser ethanol-soluble (m-THPC, C44H30N404), was supplied as 
a 4 mg/ml temoporfin (MW 680.24, the active ingredient) in solution with ethanol 
and anhydrous propylene glycol (BioLiTEC PHARMA Ltd, Ireland). A second 
photosensitiser used as a comparator, hypericin, (a polycyclic aromatic quinine) 
was supplied as powdered 1,3.4,6,8,13-Hexahydroxy-10,11-
dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione (MW 544.98, active 
ingredient) (TOCRIS Cookson Ltd, UK) and was made into a stock concentration 
of 10 mM in ethanol. Hypericin, like m-THPC, is a lipophilic photosensitiser and, 
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Cell types Approximate seeding densities Culture period (days) 
DRGs (neurones and 2.0 x1 04 cells/ 200 ~I gel 4 
satellite cells) (equivalent of 1 DRG/ 200 ~I) 
Astrocytes 4.0 x105 cells/ 200 ~I gel 1 
MCF-7 cells 2.0 x 104 cells/200 ~I gel 1 
Table 2.1 
Cell seeding densities in collagen cultures. 
Culture period refers to the number of days cells were maintained in collagen gels prior to 
PDT treatment. 
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when used in PDT, generates a large quantum yield of singlet oxygen/ROS (Paba 
et al., 2001; Ritz et al., 2005; Theodossiou et al., 2004; Mikes et al., 2007). 
Photosensitiser stocks were stored at -200 C protected from light. Working 
dilutions were prepared in serum- and phenol red- free DMEM culture medium 
supplemented with 100 U/ml/1 00 ~g/ml pen/strep and 2 mM L-glutamine. Serum-
free culture medium at pH 7.4 was used to prepare working dilutions of 
photosensitisers because 10 % serum is thought to reduce m-THPC uptake by 80-
90 % due to the formation of photosensitiser aggregates (Friberg et al., 2003). 
Phenol red-free medium was used to prevent any interference by phenol red in the 
PDT process or fluorescence investigations. 
Photodynamic therapy (PDT) doses are defined as the product of photosensitiser 
concentration and applied light-fluence. In these experiments the photosensitiser 
concentration was altered and light-fluence was maintained at a constant level. 
Incubation time for 4 ~g/ml m-THPC use was assessed using monolayer cultures. 
m-THPC was incubated on DRG cells for 4, 7 and 24 h before being fixing with 4 
% (w/v) PFA for 10 min. 5 neuronal cell bodies were assessed in 2 cover glasses 
per time pOint. m-THPC fluorescence intenSity was assessed form fluorescence 
micrographs using Analysis® software-pixel value tool, in 3 random points per 
neuronal cell body (but not including the nuclear region). 
2.2.4.2 Light source (white light) 
The Iight-fluence (a measure of applied light energy) for m-THPC recommended 
by the supplier for clinical use is 20 J/cm20f 652 nm. The light-f1uence used in vitro 
is much lower as cells are directly exposed to light without the protection of 
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surrounding tissue layers. In this study a light-fluence of 1 J/cm2 (Figure 2.2) was 
applied unless otherwise indicated. 
A transilluminator with adjustable white light of 1000-6500 Calvin, evenly 
illuminated, with no flicker, a stable light output within ± 0.1 % and stable 
temperature was used for all experiments unless otherwise indicated. This light 
source was set at its maximum setting and the energy emission assessed to be 
3.6 mW with an optical power meter. Samples were exposed to this light source 
for a period of 10 min by placing multiwell plates containing monolayer or cell-
seeded collagen cultures onto the surface of the illuminator. 
The PDT light dose in this study was calculated using a model for light-fluence 
calculation adapted from Li et al. (2008). This calculation was used with the 
assumption of uniform photosensitiser concentration in samples (Figure 2.2). 
Samples for light exposure were placed within a rectangular region of 14 cm x 20 
cm, marked out at the centre of the illuminator. Multiple readings using an optical 
power meter with readout in Watts (W) indicated no variability in the light levels at 
different positions within this area. 
2.2.4.3 PDT treatment 
Concentrations and times used in this study were chosen on the basis of previous 
work with these photosensitisers performed by other groups: 0-10 J..Ig/ml m-THPC 
(Rousset et al., 2000; Kunz and MacRobert, 2002; BourrE~ et al., 2002) for 4 h 
(BourrE~ et al., 2002; Kiesslich et al., 2007) and 0-2.7 J..Ig/ml hypericin for 7 h 
(Theodossiou et al., 2004; Kiesslich et al., 2007). Culture medium was replaced 
with 1 ml incubation solution containing the photosensitiser under test and 
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samples were protected from light during photosensitiser incubations at 37° C. 
Photosensitiser solutions were subsequently replaced with 1 ml phenol red-free 
culture medium (phenol red-free DMEM supplemented with 100 U/ml/1 00 ~g/ml 
pen/strep and 10 % FCS). Test samples were exposed to 1 J/cm2 white light and 
control samples (no light controls) were treated in the same manner but wrapped 
in aluminium foil to exclude light from the transilluminator (Vandenbogaerde et al., 
1997). Samples were then incubated under standard cell culture conditions for a 
further 24 h post PDT in the dark and assayed for cell death using a propidium 
iodide (PI) exclusion assay and specific cell types were identified with 
immunocytochemistry. In some cases, cells were maintained in culture for longer 
or shorter times than 24 h post-PDT (Le. 1, 8, 16, and 36 h in a time course 
assay). 
2.2.5 Cell survival evaluation 
2.2.5.1 Cell death detection using PI exclusion 
PI is a membrane-excluded nuclear DNA dye, which is non toxic to cells and 
commonly used as a marker of cell death because it only enters cells with 
damaged plasma membranes (Le. those undergoing late apoptotic, and necrotic 
cell death) (Sattler et al., 1997; Leung et a/., 2002; Baski6 et al., 2006). PI 
intercalates with double-stranded DNA and undergoes a fluorescent enhancement 
upon binding to nucleic acids and is relatively resistant to photobleaching (Sattler 
et a/., 1997). PI fluorescence is detectable at excitation around 493 nm and 
emission around 630 nm. Bisbenzimide H33258 (Hoechst 33258) was used as a 
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Ught-fluence = (fluence rate x exposure time) 
Power of white light source was 0.0036 W over a detector area of 2.3 cm2 
Therefore energy emission (Fluence rate) 
=0.0036/2.3 W cm-2 
=0.002 W cm-2 
Exposure time = 10 min 
Light fluence 
= 0.002 x 600 W sec cm-2 
= 1.2 J/cm2 , rounded down to 1 J/cm2 
Figure 2.2 
Calculation of light-fluence. 
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counterstain in order to establish total cell numbers, since it is a plasma 
membrane permeable fluorescent nuclear DNA probe detectable at approximate 
excitation 345 nm and emission 455 nm. Apoptotic cell death results in cells with 
condensed, bright red and/or fragmented PI-stained nuclei, and necrotic cell death 
results in non-condensed, bright red PI-stained nuclei. Live cells are only stained 
with Hoechst 33258 (blue) because PI (red) is excluded by live cell plasma 
membranes (Leung et al., 2002; Rancan et al., 2005; Mikes J. et al., 2007). 
200 1-11 of a 200 j..Jg/ml PI solution (in PBS) were incubated on monolayer and 
collagen gel cultures for 10 min (20 min on thicker collagen gels such as tethered 
glia-seeded collagen cultures) at room temperature under subdued light. Cultures 
were rinsed 3 times with PBS to remove excess unbound PI, and then fixed 
overnight with 4 % (w/v) PFA at 4° C. Cultures of astrocytes and MCF-7 cells were 
counterstained for 45 min with 10 j..JM Hoechst 33258 in PBS at room temperature. 
DRG cultures were immunostained for ~III-tubulin/FITC positive cells and 
counterstained with Hoechst 33258. Samples were stored in 1 ml PBS and 
analysed using fluorescence microscopy. Representative images were captured 
with a charged-coupled device (CCO) camera (ColorView Soft Imaging System). 
Collagen gels were coded and randomised prior to cell death analysis to ensure 
the operator was blinded with respect to treatment conditions. The numbers of live 
and dead satellite cells, MCF-7 cells and astrocytes were determined by manually 
counting and scoring all cells in 3 fields of each gel or cover glass (typically a total 
of -160 cells per gel). Fields were chosen at random using a x40 objective. For 
collagen gels, the operator focussed through all planes of the gel during the 
counting process, so that each field was a cylindrical sample through the gel from 
top to bottom. Pilot experiments confirmed that sampling 3 fields in this way was 
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sufficient to provide an accurate representation of the whole gel. There were 
considerably fewer neurones than satellite cells in each gel, hence all of the ~"I-
tubulin/FITC immunoreactive cells in each gel (typically up to 50 neurones) were 
identified and classified as being live or dead. For statistical analyses, live/dead 
cell counts from the 3 pooled 3D fields (MCF-7 cells, satellite cells and astrocytes) 
or all the neurones in each of the 9 independent gels (m-THPC) or 6 independent 
gels (hypericin) were analysed using one-way analysis of variance (ANOVA) with 
Tukey's post-hoc test to compare groups. 
Microsoft® Office Excel 2003 and GraphPad Prism® 4.03 software were used to 
analyse data sets. Differences were defined as significant when p<0.05 (*), and 
highly significant when p< 0.01 (**) or p< 0.001 (***). 
To validate these approaches, the ability to detect 100 % dead cells, and 
specifically to detect dead neurones, was tested on cell-seeded collagen gels 
equivalent to those used in these experiments. Culture medium was replaced with 
200 1-11 5 % (v/v) Triton® X-100 detergent for 10 min at room temperature to 
permeabilise plasma membranes of cells, before incubation at room temperature 
with PI. All cultures were rinsed between incubations with PBS. The effect of the 
permeabilisation would be to allow entry of PI into all cells; therefore resulting in 
100 % cell death. 
The effect of fixing cells with 4 % (w/v) PFA on the results of the PI exclusion 
assay was assessed. Culture medium was removed from cell-seeded collagen 
cultures and 400 IJI 4 % (w/v) PFA was incubated for 10 min at 4°C. Cultures were 
treated with PI before or after fixing cells with PI, to determine whether fixation 
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resulted in permeabilisation of plasma membranes and entry of PI. Cultures were 
rinsed between incubations with PBS. 
Other live/dead detection methods including Acridine orange in combination with 
Hoechst 33258 counterstaining and trypan blue in combination with Hoechst 
33258 counterstaining were tested and rejected as they were deemed unsuitable 
for this experiment. 
2.2.5.2 Apoptotic cell death detection using a TdT-FragEL™ assay kit 
The presence of early apoptosis in DRG cultures after m-THPC-mediated PDT 
was detected using a terminal deoxynucleotidyl transferase-Fragment End 
Labelling (TdT-FragEL™) assay kit to label free 3'-OH groups at the end of DNA 
fragments which were generated by apoptosis. This allowed for the detection of 
apoptotic cells on the catalytic addition of biotin-labelled deoxynucleotides. These 
biotinylated nucleotides were detected using streptavidin-horseradish peroxidase 
conjugates. An insoluble coloured substrate was generated at the site of DNA 
fragmentation by the addition of diaminobenzidine (DAB) which reacted with the 
labelled sample. Here, fixed DRG seeded-collagen gels at 8 h post m-THPC-
mediated PDT were tested with this TdT-FragEL™ kit; for the presence or 
absence of apoptotic cells (e.g. neurones) (see Appendix I). 
2.2.6 Immunocytochemisty 
2.2.6.1 Cell staining 
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After fixation of PI-stained samples with 4 % (w/v) PFA at 4° C, these samples 
were permeabilised by being incubated with Triton® X-100 followed by non-specific 
binding blocking by incubating with normal swine serum, before primary antibodies 
were applied. These samples were incubated at room temperature, and all 
reagents used were prepared in PBS. Samples were rinsed 3 times with PBS 
between all reagent incubations (as described in Table 2.2). 
Primary antibodies used were: mouse anti-~-tubulin isotype III Clone SDL-3D10 
(anti-~III-tubulin) to identify neurones and! or polyclonal rabbit anti-S-100 (anti-S-
100) to identify glia (satellite and Schwann cells), which were incubated for 60 min 
at room temperature on monolayer and cell-seeded collagen cultures. 1: 1 00 
TRITC or FITC conjugated anti-mouse IgG, or anti-rabbit IgG secondary 
antibodies were incubated for 45 min along with 10 I-IM Hoechst 33258. 
Incubation times were doubled for immunostaining the thicker tethered glia-seeded 
collagen gels, and for ex-vivo nerve models in collagen gels, and primary antibody 
was incubated at 4°C overnight. Following immunostaining, collagen gels were 
stored in PBS, while monolayer cultures were mounted with aqueous Citifluor AF2 
mountant and sealed with nail varnish, refrigerated at 4° C and protected from 
light. 
Representative fluorescence images of Hoechst 33258 labelled nuclei were 
captured using excitation filter 350 nm and emission filter 455 nm (blue). Images of 
the same field were captured of PI-labelled nuclei, using excitation filter 595 nm 
and emission filter 615 nm (red). Neurones were identified by examining samples 
for ~11I-tubulin/FITC immunoreactivity in DRG cultures using approximate 
excitation of 494 nm and emission of 518 nm (green). 
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Reagents Concentration Incubation time 
or dilution (min) 
Triton X-1 00 0.5 % (v/v) 10 
Swine Serum 5 % (v/v) 10 
Primary antibody mouse anti-l3l1l-tubulin 1 :400 or 1 :200 60 
or rabbit anti-S-1 00 
Fluorescently conjugated secondary Ab 1 :100 45 
Hoechst 33258 1 :1000 45 
Table 2.2 
Summary of conditions for immunocytochemistry. 
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Confocal microscopy was performed in some cases using a Leica TCS-NT laser 
scanning microscope with an oil immersion objective to capture images of PI 
fluorescence and ~1I1-tubulin/FITC immunostaining 
2.2.6.2 Mitotic cell staining 
In order to determine the cause of an observed change in the morphology of 
satellite cell and MCF-7 cell nuclei in experiments with hypericin, mitotic cell 
markers were used to determine whether cells were entering a mitotic state or 
whether nuclear morphology changes were due to apoptotic DNA fragmentation. 
Colchicine was used to arrest cells in mitosis for use as a positive control of cells 
in the mitotic phase of the cell cycle. Anti-phospho-SerlThr-Pro (P-MPM-2) 
recognises epitopes of phosphoproteins (MAP2, HSP70, cdc25, and DNA 
topoisomerase 110) phosphorylated during the onset of mitosis. This mouse 
primary antibody was then detected with a secondary antibody conjugated with 
FITC fluorescent fluorochromes. Hoechst 33258 was used in order to identify and 
quantify total cell numbers. All reagents were prepared in PBS, and there were 
three PBS washes between each step. DRG-seeded collagen gels were treated 
with either 1.6 \-Ig/ml hypericin-mediated PDT (as described in Section 2.2.4.3) or 
incubated with 50 nglml colchicine in DMEM-complete culture medium for 17 h 
under standard cell culture conditions. Samples were then immunostained as 
described in Section 2.2.6.1 using the mouse primary antibody P-MPM-2 (1 :200) 
for 45 min. 
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2.2.7 Photosensitiser uptake and compartmental distribution 
m-THPC and hypericin have innate fluorescent properties which means that their 
uptake and distribution could be studied in specific cells types using fluorescence 
microscopy. The association of these photosensitisers with specific organelles 
was investigated using MitoTracker® Green FM (MitoTrk-green) and LysoTracker® 
Green DND-26 (LysoTrk-green) which was first assessed for their ability to label 
mitochondria and Iysosomes respectively. 
MitoTrk-green is concentrated by active mitochondria, becoming fluorescent only 
once it has accumulated in the lipid environment of the mitochondria and become 
oxidised (Peng et a/., 2005; Rancan et a/., 2005; Stasio et a/., 2005; Ji et a/., 
2006; Marchal et 81., 2007; Kiesslich et a/., 2007; Ke et a/., 2008). LysoTrk-green 
selectively labels and tracks spherical acidic organelles (Le. Iysosomes) in live 
cells, by becoming fluorescent on contact with Iysosomes. This probe consists of 
fluorophores linked to a weak base that is only partially protonated at neural pH. 
In addition, the lipophilic fluorochrome CM-Oil (CeIlTrk-red) (Brandt et a/., 1995 
and Andrade et a/., 1996) was used in cell labelling to test its usefulness in live 
neurite staining and tracking. 
Monolayer neural and MCF-7 cultures (as prepared in Section 2.2.3.2) were 
incubated with 4 !-Ig/ml m-THPC for 4 h; or 1.6 !-Ig/ml hypericin for 7 h or their 
respective no drug controls. MitoTrk-green and LysoTrk-green probes were 
prepared in phenol red- and serum- free OMEM culture medium. Pilot studies were 
performed with a range of doses of MitoTrk-green (25-300 nM) or LysoTrk-green 
(25-500 nM) with incubation times of 10-60 min. Cultures were fixed for 10 min 
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with 4 % (w/v) PFA at 4°C before being fluorescently labelled with 10 JJM Hoechst 
33258 for 45 min at room temperature. 
To show the extent of co-localisation between the fluorescent probes and 
photosensitisers, fluorescence images were displayed as green and red, false 
coloured micrographs and electronically overlaid to visualise dual localisation 
using AnalySIS® software. When probes and photosensitisers localised in the 
same regions the fluorescence appeared yellow-orange. Co-localisation of 
photosensitisers with MitoTrk-green in cells was estimated using the polygon line 
tool, producing independent fluorescence spectra of red (photosensitiser) and 
green (MitoTrk-green) fluorescence intensities (Teiten et al., 2003b; Gallagher et 
al., 2005; Stasio et al., 2005; Marchal et al., 2007). 
2.2.8 102/ROS detection 
The cell permeable, non-fluorescent probe 2', T-Dichlorofluorescin diacetate or 2', 
T-Dichlorodihydrofluorescin diacetate (H2DCF-DA) was used here as a detector of 
intracellular oxidising reactions, for example the detection of 102/ROS production 
in cells exposed to m-THPC-mediated PDT or an oxidative stress inducer such as 
mendione, a redox cycling agent that results in ROS production in cells (Hempel et 
a/., 1999; Kunz and MacRoberts, 2002; Kiesslich et a/., 2005; Watts et a/., 2005; 
Oberdanner et a/., 2005; Miller et a/., 2007). When H2DCF-DA comes into contact 
with products of oxidising reactions it is converted by hydrolysis to highly 
fluorescent Dichlorofluorescin (OCF). 
Prior to using H2DCF-DA in conjunction with PDT, oxidative stress was generated 
within cells using menadione. Monolayer cultures of MCF-7 cells were incubated 
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with 100 \-1M menadione for 60 min then H2DCF-DA for 60 min, both in phenol red 
and serum-free DMEM culture. All incubations were performed under standard cell 
culture conditions and samples were rinsed in PBS between incubations. Cultures 
were then fixed with 4 % (w/v) PFA at 4° C, before being incubated with 10 \-1M 
Hoechst 33258 for 45 min at room temperature then mounted with Citifluor AF2 on 
glass slides and sealed with nail varnish. 
For experiments which used H2DCF-DA to probe oxidative stress following PDT, 
monolayer neural and MCF-7 cultures were first exposed to m-THPC or 
appropriate control incubations (as described in Section 2.2.4.3) followed by 
incubations with or without H2DCF-DA at parameters of either 25 \-1M for 30 min or 
100 \-1M for 60 min under standard cell culture conditions. Samples were rinsed in 
PBS between incubations, test samples were exposed to 1 J/cm2 light and then 
fixed with 4 % (w/v) PFA at 4° C. Cell samples were then labelled with 10 \-1M 
Hoechst 33258 and neurites were identified using ~1II-tubulinITRITC 
immunostaining. Samples were mounted with aqueous Citifluor AF2 on glass 
slides then sealed with nail varnish. After immunostaining the presence of 
102/ROS in cell types was determined from fluorescence images. Images of 
photosensitiser were captured using excitation 595 nm and emission 615 nm. 
Green DCF fluorescence was captured using excitation of 494 nm and emission of 
518 nm. 
2.2.9 Confirmation of neuronal survival after m-THPC-mediated PDT 
To assess the ability of neurones which had been subjected to 3, 4 and 10 \-Ig /ml 
m-THPC-mediated PDT to regenerate their neurites, cells were extracted from the 
collagen lattice 24 h post PDT treatment by digestion with 0.125 % (w/v) 
- 86-
Chapter 2-Materials & Methods 
collagenase for 30 min under standard cell culture conditions. DMEM-complete 
culture medium was added and cell pellets collected with 5 min centrifugation at 
100 X g, re-suspended in appropriate volumes of DMEM-complete culture medium, 
then cells from 2 gels were combined with 1 x 104 satellite cells (as described in 
Section 2.2.1.2) in a total of 100 1-11 DMEM-complete culture medium. Co-cultures 
were seeded onto PLL coated cover-glasses, and maintained in culture for 2 days 
under standard cell culture conditions then fixed in 4 % PFA at 4° C and 
immunostained for ~1I1-tubulin/FITC positive neurites (as described in Section 
2.2.6.1 ). 
All the neuronal cell bodies detected on each of two cover-glasses per treatment 
condition were assessed for the presence or absence of neurite growth. In 
addition, the mean detectable neurite length per cover-glass was assessed by 
tracing all neurites visible with ~1I1-tubulin immunostaining (green) on digital 
micrographs (Figure 2.3). The mean total length (in mm) of all detectable neurites 
per cover glass (n=2) were calculated per treatment. The data was collected in this 
way because not all neurones expressed neurites. 1-way ANOVA with Dunnett's 
post test were used to compare treatment conditions to controls. 
2.2.10 Inhibition of neuronal survival pathways 
In order to investigate the mechanism by which neurones were being protected 
during m-THPC-mediated PDT, specific cellular antioxidant pathways involving 
GSH and SOD were inhibited prior to m-THPC-mediated PDT treatment 
(administered as described in Section 2.2.4.3). 
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The glutathione synthase pathway was inhibited with 500 \-1M OL-Buthionine-(S, 
R)-Sulfoximine (L-BSO) incubated for 24 h (Roychowdhury et al., 2002). L-BSO 
inhibits glutathione synthesis by irreversible inhibition of the enzyme y-glutamyl 
cystein synthetase (Brezis et a/., 1983, Meister, 1995; Vandenbogaerde et al., 
1997; McNaught and Jenner, 1999; Roychowdhury et al., 2002; Gegg et al., 2005; 
Kiesslich et al., 2005; Wang et al., 2006). The 2 SOD antioxidant pathways 
involving constitutive SOO-1 and inducible SOO-2 were inhibited using 50 \-1M 
Oiethyldithiocarbic acid sodium trihydrate (~OC) for 1.5 h (Rothstein et al., 1994; 
Ou et al., 2001; Miller et a/., 2007) or 1 \-1M 2-Methoxyestradiol (2-MeOE2) for 24 h 
respectively (Golqb et a/., 2003). Inhibitors were prepared in 1:3 ORG-conditioned 
medium for ORG cultures or OMEM-complete culture medium for MCF-7 cultures 
and incubated with cells in the thin collagen gels under standard cell culture 
conditions prior to PDT. Cell death was assessed 24 h post-PDT as described 
previously. In some instances the inhibitor treatments were combined to assess 
the effect of blocking multiple antioxidant pathways simultaneously. 
2.2.11 Development of advanced nerve culture systems for investigating 
focal PDT treatment 
In order to investigate the effect of directing POT towards a particular part of a 
neurone in culture (i.e. either the cell body or somewhere along the neurite), more 
advanced culture systems were required. Unlike the simple 30 and monolayer 
neuronal cultures described previously, these would guide neurite growth away 
from the neuronal cell body in a linear manner, providing a distinct 'neurite' or 
'neuronal cell body' zone towards which light treatment could be directed. 2 
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Figure 2.3 
Example of neurite length determination using analySIS® software. 
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approaches were explored, using either 2D or 3D cell culture technology to align 
neurite growth. 
2.2.11.1 20 glial substrate culture system 
Monolayer cultures were developed in which neuronal cell bodies were located in 
one distinct region, with neurites extending across the rest of the culture surface. 
To support neuronal survival and neurite projection, a supporting layer of glial cells 
(2 x 105 cellsl ml Schwann cell or satellite cell cultures) was first seeded onto PLL-
coated glass surfaces and allowed to reach confluence. Medium was removed 
from confluent cultures, then 20 IJI DRG cell suspension (1 x 104 cel\s/ml) was 
applied to a small region at one end of the culture surface (Figure 2.4A). DRG 
cells were allowed to adhere for 30-60 min in a humidified incubator before 
medium was replaced and neurites were allowed to grow for 8 days. 
In this study the use of satellite cell cultures was chosen to be a more effective 
substrate layer than Schwann cell cultures. After 8 days neurite growth, glial 
substrate culture systems were incubated with photosensitisers (as described in 
Section 2.2.4.3), then specific regions were illuminated using a transilluminator, 
allowing white light (light-fluence 1 J/cm2) to pass through slits made by masking 
surrounding areas with black electrical tape (Figure 2.4B). In this way, neurites 
could be illuminated while their cell bodies remained shielded from the light. 
Cultures were incubated for 24 h post PDT and cell death was assessed as before 
with the use of PI exclusion and immunostaining for ~1I1-tubulin/FITC. 
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2.2.11.2 Aligned three dimensional neuronal growth models 
The monolayer system in which neurones extended neurites over the surface of a 
confluent monolayer of glial cells (Figure 2.4) enabled focal PDT wounding, but it 
was not optimal for these studies due to detachment of dead cells as previously 
described. Therefore, a 3D culture system in which neurites extended away from 
the neuronal cell bodies was developed (Figures 2.5 and 2.6). 
Collagen gels seeded with satellite cell cultures or a combination of these cultures 
with nerve fibroblasts were prepared (as described in Sections 2.2.1.2; 2.2.1.4 and 
2.2.3.3). These cultures were set within rectangular moulds, with the collagen gel 
integrated within fixed mesh bars at each end of the moulds effectively tethering 
the gel in place (Eastwood et al., 1994; Eastwood et al., 1998; Phillips et al., 
2005). Rectangular culture moulds were constructed from nylon or stainless steel, 
and tethering bars were cut from sheets of nylon cross-stitch mesh. Nylon 
tethering bars were inserted into culture moulds before gelation. This allowed the 
culture mixture to enter spaces of the nylon mesh where the collagen sets, 
moulded to the nylon mesh, forming two tethered ends. Nylon moulds (Figure 2.5 
A) were larger, and were seeded with 2.5 ml gel, whereas the smaller stainless 
steel moulds (Figure 2.58) were seeded with 750 1-11 gel. Previous work using this 
arrangement of tethered cell-seeded rectangular collagen gels has shown that 
contraction of cells results in their alignment along the axis of principal strain and 
the formation of unaligned regions at each end, due to stress shielding (Figure 2.6) 
(Eastwood et al., 1998; Porter et al., 1998; Phillips et a/., 2005). In effect, the 
tethered collagen gel narrows along the un-tethered edges, while being prevented 
from narrowing at the tethered ends. 
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(A) 
Dissociated DRG Glia-substrate 
seediJ1g site layer Glass 
.. + surface 
~~~~~G?~~~~~~~~~~~~~~~~~::Jl +- pre-coated C 0 with PLL 
III 
50mm 
Figure 2.4 
Black tape 
and Petri 
dish 
.. --....... -p.----- Slit of light 
Cover glass 
Focal PDT application to glial substrate culture system. 
(A) Glial cells were allowed to form a confluent monolayer (blue) , and then dissociated 
DRGs were seeded at one end (green). Neuronal cell bodies remained at the seeding site 
and neurites extended all over the surface of the glia. (8 ) Masking the underside of the 
culture plate enabled focal light administration via a narrow slit. 
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Initial experiments were conducted to establish the optimal seeding density and 
ratio of Schwann cells to fibroblasts which gave sufficient contraction and 
alignment to form a stable environment for the support of neurite growth. Round 1 
ml collagen gels were prepared in 12-well culture plates seeded with 0, 3 000, 30 
000 and 300 000 cells! ml. After gels were set, their edges were detached from the 
plastic and free-floating gels were monitored regularly over 192 h (images 
captured using Alphalmager approximately every 12 h). The diameter of the gels 
was measured from the digital images and used to calculate their circular area, 
which was subtracted from the area of the plastic well as a measure of contraction. 
Further experiments compared contraction within tethered rectangular gels (in 
nylon moulds) which was scored by eye as no contraction (non-tethered gel edges 
the same size as the mould), little contraction (non-tethered gel edges contracted 
to more than half original size), optimal contraction (non-tethered gel edges 
contracted to half or less of original size) or over contracted (non-tethered gel 
edges contracted to near breaking point and to breaking point). 
In each case the ratio of Schwann cells to fibroblasts was assessed by seeding 
100 1-11 of cell suspension on to cover glasses, and counting the proportion of S-
100 immunopositive cells in three random fields. 
As a result of these optimisation experiments, gels were routinely cast using 400 
000 cells! ml of gel, allowed to set for 5 to 10 min under standard cell culture 
conditions, then DRG explants were pushed into the gels or dissociated DRGs 
were injected (2 x 104 cells in 10 1-11 volume) as shown in Figure 2.6A (at the 
position marked XX). Gels were covered with 7 ml (nylon moulds) or 10 ml 
(stainless steel moulds) culture media and maintained in culture for a week. The 
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Figure 2.5 
Aligned 3D neuronal growth models. 
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Nylon mould 
Tethering bar 
Cell-seeded 
collagen gel 
Space for cell-seeded 
collagen gel 
(A) Nylon and (8) stainless steel moulds with tethering bars made from nylon mesh . 
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Non-aligned delta zones Aligned region 
(C) 
1.25 em 
Figure 2.6 
Aligned 3D neuronal growth. 
Micrographs are of fixed cells , immunostained for glial cells with S-100 (green), neurones 
with 13111-tubulin (red) and nuclei with Hoechst (blue) (A) unaligned glial cells in delta zones 
(orange triangles in (e)) , (8 ) aligned glial cells in contracted areas (* in (e)) , (C) 
representation of a contracted gel in a nylon gel mould, and (D) DRG with aligned neurites 
(red) after - 3 days in this culture system (XX marks DRG implantation site in (e)). (E) 
Shows stainless steel mould with contraction of gel over time (images were captured at 2, 
4, 8 and 12 h after setting. Gels adopt a characteristic shape as cells contract and align. 
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culture medium was then removed and gels fixed overnight with 4 % PFA at 4° C. 
Immunocytochemistry and cell death analysis was performed as described 
previously and neurite projection detected using ~11I-tubulin/FITC immunostaining. 
In addition to the assessment of collagen gel contraction and neurone growth 
assessment performed in these cell-seeded collagen gels, experiments were 
carried out in order to ascertain the ability to produce a focal region of PDT killed 
cells. Satellite cell-seeded tethered collagen gels were incubated with the 
photosensitiser m-THPC (as described in Section 2.2.4.3). A 633 nm laser beam 
was applied to one end of the gel. Collagen gels were then assayed after 24 h 
using PI exclusion to identify a localised region of cell death and with Hoechst 
33258 counterstaining. ~III-tubulin immunostaining was not performed on these 
satellite cell only-seeded collagen gels. 
2.2.12 Effect of PDT on dissected nerve tissue 
2.2.12.1 m-THPC-mediated PDT on dissected sciatic nerves 
To investigate the effects of PDT on nerve cells in a more natural tissue 
environment than that created in culture systems, sciatic nerves were harvested 
from Sprague Dawley rats complete with their ORGs. Nerve explants were 
maintained in culture for up to 2 days. Pilot studies were conducted to detect the 
ability of neurones to survive in explant culture. The presence of neurones within 
the nerve was assessed by staining cross-sections for NF immunopositive 
structures and the proportion of S-100 positive Schwann cell tubes, which 
contained NF positive axons, were determined. 
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The suitability of this approach for modelling focal PDT treatment was assessed by 
incubating the dissected nerves for 24 h in 4 \-Ig/ml m-TH PC and assessing 
photosensitiser fluorescence in sections. An alternative approach avoided this 
incubation stage by obtaining sciatic nerve explants from freshly culled Wistar rats 
that had been intravenously (Lv.) injected with 0.3 mglkg m-THPC 24 h previously 
as part of another study (gift from Dr Josephine Woodhams at the NMLC, 
London). 
Dissected nerves were either protected from light or exposed to a beam of light 
from a red laser diode. Nerves from the experiment in which m-THPC was applied 
in culture were exposed to a 1 mm diameter 633 nm light beam supplied by a 
diode laser in conjunction with an optical fibre for 20 s (1 J/cm2 light fluence) at the 
au, and nerves from rats injected with m-THPC were exposed to a 5 mm diameter 
652 nm light beam supplied from a Oiomed 652 PDT (clinical laser diode) in 
conjunction with an optical fibre and diffuser lens for 60s (10 J/cm3 light fluence) at 
the National Medical Laser Centre (NMLC), UCL. These light sources were used 
to produce a site of focal PDT treatment 1.5 cm from the end of the nerve explant, 
distal to the ORG. 
After treatment, dissected nerves were maintained in DMEM-complete culture 
medium for 24 h under standard cell culture conditions and protected from any 
further light exposure. Nerves were then fixed with 4 % (w/v) PFA at 4° C on a 
piece of card, to prevent tissue shrinkage. Regions of interests (midway along the 
nerve trunk or the focal damage site) were dissected out (Figure 2.7). 
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2.2.12.2 CryO- block preparation 
Tissue dissected from fixed nerve explants was incubated in 5 ml embedding 
reagent (20 % (w/v) sucrose in dH20) for up to 4 days at 4° C then embedded in 
warm supporting medium (7 % (w/v) gelatine and 20 % (w/v) sucrose in dH20) 
which was allowed to set at 4° C, removed from moulds and marked for orientation 
with a permanent marker. Blocks were then snap-frozen in cold iso-pentane on dry 
ice and samples loosely wrapped in aluminium foil and stored at _20° C for 
sectioning. 
2.2.12.3 Sectioning 
Cryo-blocks containing nerve tissue (Figure 2.8) were mounted onto cold chucks 
using Bright Cryo-M-Bed solution in a pre-cooled Leica Cryostat CM 1900 with 
chamber at -10° C and chuck head at -20° C. Samples were cut with sharp low-
profile cryostat blades, at an angle of 0° and thickness of 10 to 30 J..lm. Nerve 
tissue sections were collected and mounted onto warmed glass slides, pre-coated 
with 0.5 % (w/v) gelatine and 0.05 % (w/v) Chromium III potassium sulphate 12-
hydrate. Slides were stored at -20° C protected from light and dehydration. 
2.2.13 Immunohistochemistry of nerve tissue sections 
4 % (w/v) PFA nerve tissue sections were immunostained for NF, S-100 and 
laminin immunopositive structures as a means of assessing tissue architecture 
with and without focal PDT damage. Longitudinal and transverse frozen tissue 
sections mounted on glass slides were incubated with Triton® X-100, followed by 
swine serum incubation. Tissue sections were incubated with mouse anti-NF and, 
- 98 -
Chapter 2-Materials & Methods 
rabbit anti-S-100 and/or anti-Iaminin primary antibody. All reagents were prepared 
in PBS, and there were PBS washes between each incubation step. Tissue 
sections were further incubated at room temperature with FITC or TRITC 
conjugated secondary antibodies in combination with 10 lJM Hoechst 33258 (as 
described in Table 2.3). 
Stained tissue sections were mounted with aqueous Citifluor AF2 mountant under 
cover-glasses and edges were sealed with nail varnish. Sections were stored at 4° 
C and protected from light. Samples were viewed and images collected as 
described previously. 
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'----------------- ----------------~ --...y
Sciatic nerve trunk 
Figure 2.7 
Diagram of dissected sciatic nerve showing site of focal PDT application. 
DRGs contain neuronal cell bodies and the nerve trunk contains bundles of axonal fibres. 
Nerve explant was - 4 cm in length. Rectangle indicates region of nerve tissue dissected 
out 24 h post PDT. 
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Nerve tissue within cryo-block showing planes of sectioning. 
Illustration shows an example of an excised piece of nerve trunk embedded in snap-
frozen gelatine block. Broken lines represent planes of sectioning. 
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Chemical Concentration Incubation time 
or dilution (min) 
Triton X-100 0.5 % (v/v) 10 
Swine Serum 5 % (v/v) 10 
Primary Ab mouse anti-NF 1 :1000 60 
Primary Ab rabbit anti-S-1 00 or anti-Iaminin 1:200 60 
FITe or TRITe conjugated secondary Ab 1 :100 45 
Hoechst 33258 1 :1000 45 
Table 2.3 
Summary of conditions for immunohistochemistry of frozen sections of dissected 
nerves 
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Chapter 3: Effect of m·THPC·Mediated PDT on Neural and Tumour 
Cells in 20 and 3D Culture Models 
3.1 Introduction 
To date, a number of photosensitisers have been used clinically to treat areas of 
the body rich in nerve structures, e.g. the prostate (Chang et al., 1996; Chang et 
al., 1999; Huang et al., 2005; Moore et al., 2006) and regions of the head/neck 
(Lou et al., 2004; Betz et al., 2007; Nyst et al., 2009). Research on the effects of 
m-THPC-mediated PDT in experimental models (Kubler et a/., 2003), and in 
clinical trials and practice (Betz et a/., 2007; Moore et a/., 2006, Lou et a/., 2004 
and Ris et a/., 1996), have reported that no major peripheral nerve damage is 
associated with the use of this treatment. This nerve sparing was observed 
alongside effective destruction of tumour cells, suggesting that this treatment may 
be a useful tool for destroying cancers situated within close proximity to important 
nerve structures where alternative surgical treatments would carry a greater risk of 
nerve damage. 
Despite the potential usefulness of a treatment that could selectively spare nerve 
tissue, little has been published about the effects of m-THPC-mediated PDT on 
the non-cancerous cells of the nervous system, although there have been reports 
on the use of this treatment for destroying cancers of the nervous system, (e.g. 
glioma, schwan noma, ependymoma, etc (Obwegeser et a/., 1998; Lilge et a/., 
2000; Rousset et a/., 2000; Molinari et a/., 2007; Mannino et a/., 2008)). In this 
chapter, the sensitivity of primary neural cells and MCF-7 breast cancer cells to m-
THPC-mediated PDT was established using conventional 20 cultures and also an 
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innovative 3D collagen hydrogel cell culture system. These were also used to 
characterise the sensitivity of neural cells and MCF-7 cells to an alternative 
photosensitiser, hypericin, for which there have not been any reports of nerve 
sparing. 
3.1.1 Cell uptake of photosensitisers 
It is generally accepted that non-ionised species can cross the plasma membrane 
more easily than charged compounds. Hence it is expected that neutral or 
lipophilic (hydrophobic) photosensitisers would be more readily taken up into 
membranes than charged or water-soluble (hydrophilic) photosensitisers (Ball et 
al., 1999). There are three mechanisms by which photosensitiser uptake into cells 
has been proposed to occur: 1) Simple diffusion of lipophilic photosensitisers, 2) 
Fluid phase endocytosis (pinocytosis) of water-soluble photosensitisers, and 3) 
Receptor-mediated endocytosis of low density lipoprotein (LDL)-associated dyes 
(Ball et al., 1999). It was suggested that the lipophilic photosensitiser m-THPC was 
taken up into cells by multiple mechanisms and was shown to have greater ability 
than Photofrin® to be sequestered into lipid bilayers where it remains tightly bound 
(Ball et al., 1999). An HDL-mediated endocytosis mechanism was also proposed 
as a central mode of m-THPC transport into cells (Sasnouski et al., 2006), while 
Laville et al. (2003) reported a mainly passive m-THPC uptake with less active 
transport via LDL. 
3.1.2 Cell death after exposure to PDT 
PDT can trigger the main modes of cell death in target cells both in vitro and in 
vivo (BanaSiak et al., 2000; Fabris et al., 2001; Plaetzer et al., 2003). PDT can 
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cause death via either necrotic, apoptotic or autophagic mechanisms. The cell 
death mode is dependent on the photosensitiser used, its concentration and 
subcellular localisation, the cell type and the light dose administered (BourrE3 et a/., 
2002; Leung et a/., 2002; Almeida et a/. 2004; Valencia and Moran et a/., 2004; 
Kiesslich et a/., 2007). For certain photosensitiser-cell combinations, the mode of 
cell death can shift from apoptosis to necrosis (Leung et al., 2002; Plaetzer et a/., 
2003). In the literature apoptosis has been found to be the predominant form of 
cell death in response to PDT for many cell types in culture, this has been based 
on observed DNA fragmentation and chromatin condensation (Oleinick et al., 
2002). However, necrosis rather than apoptosis seems to be the major cause of 
short-term cytotoxicity by m-THPC-mediated PDT (Heinzelmann-Schwarz et al., 
2003). A key event in PDT is the cut off of cellular energy supply by inhibition of 
mitochondrial enzymes; this is severe enough to cause necrotic cell death 
(Plaetzer et al., 2003). 
In this study the PI exclusion assay was used to determine cell death after PDT. 
This method was chosen because not only is it able to detect total cell death 
regardless of the mechanism, but it is also compatible with the 
immunofluorescence techniques used here for microscopic analysis of specific cell 
types. In addition, dying cells often do not display characteristics of only 1 of the 2 
main modes of cell death; they instead show morphologies that include traits of 
both necrosis and apoptosis (Banasiak et al., 2000). Permeability of apoptotic cells 
to PI increases 24 h after PDT; this is due to eventual loss of membrane integrity 
in the later phases of the apoptotic process (secondary necrosis) (Noodt et al., 
1999) (Figure 3.1 ). 
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3.1.3 Mammalian nerve culture system for assessing PDT 
Relatively few studies have examined the effects of PDT on isolated peripheral 
nerve cells. The majority of this research has been done using non-mammalian 
nerve culture systems such as crayfish stretch receptors (Uzdensky et a/., 2004; 
see Introduction, Section 1.5). These nerve culture systems have been useful in 
comparing photosensitisers and in monitoring their effects on neuronal function, 
but they are limited in terms of their relevance to the mammalian nervous system. 
This study therefore developed and used cell culture models to specifically 
evaluate the response of primary mammalian neural cells and tumour cells to PDT 
challenges. Various cell culture systems have been used to study nerve cell 
responses to different treatments, and to study the intricate interactions between 
neurones and glial cells (reviewed by East and Phillips, 2008). Recent neuronal 
culture systems include monolayer cell cultures (Turcu et al., 2003; Tucker et a/., 
2005; Thompson and Buettner, 2006); and dissected tissue from the nervous 
system such as nerve trunks and ganglia (Svensson et a/., 1995; Tonge et a/., 
1997; Shi et a/., 1998; G61z et a/., 2006) and slices of the spinal cord (Rothstein et 
a/., 1994; Funk et a/., 2007). In the present study, both conventional 20 cultures, 
as well as an innovative thin 3D nerve cell-seeded collagen (Type-I) hydrogel 
culture system, were used. The advantages of the 3D thin collagen gel culture 
system over conventional culture systems for this purpose included: allowing cells 
to grow in a 3D environment, which would mimic some spatial aspects of the 
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Figure 3.1 
PI exclusion assay for staining dead cells . 
Micrographs show Annexin-V (green)/PI (red) staining of apoptotic and necrotic cells. 
These images of peripheral blood mononuclear cells (PBMC) show: (A) Early (Annexin-V 
positive/PI negative) and (8) Late (Annexin-V positive/PI positive) apoptotic and (C) 
necrotic (Annexin-V negative/PI positive) cells. These images were taken from (Baskic et 
al. , 2006). 
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endogenous nerve architecture; and trapping cells in a collagen lattice, to prevent 
loss of cells during multiple cycles of treatment and washing. For over 30 years 3D 
tissue engineered culture systems have been used in the field of cancer research 
(reviewed by Brown and Phillips, 2007). More recently, 3D cell-seeded collagen 
hydrogels were used to model peripheral nerves, and for implantation into 
damaged peripheral nerves (Phillips et a/., 2005). This technology was modified 
here to suit the specific requirements of an investigation into PDT, adopting a 
relatively thin gel profile to facilitate PDT treatment and subsequent cell death 
analysis. 
The uptake mechanism of hypericin, a comparator lipophilic photosensitiser used 
in this study, has been hypothesised to be similar in nature to m-THPC (Saw et a/., 
2005; van de Putte et a/., 2006). HyperiCin is known to have a high affinity for cell 
membrane and cytoplasm, and in culture hypericin was found in small amounts in 
the nucleus of human cancer cells (T47D, mammary tumour cells) (Miskovsky et 
a/., 1995) and in rat hippocampus neurones (English et a/., 1999). 
To our knowledge the cellular responses of primary mammalian peripheral neural 
cells in vitro to PDT had not been investigated prior to this study. Therefore, in this 
study the effects of m-THPC- and hypericin-mediated PDT on specific neural cell 
types and MCF-7 breast cancer cells were investigated. 
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3.2 Aims and objectives 
The aim of this chapter was to assess the sensitivity of key neural cells to m-
THPC-mediated PDT. As such, the primary objectives were: 
i) To assess whether or not m-THPC is taken up by the different cell types 
studied (DRG neurones, satellite cells, astrocytes and MCF-7 tumour 
cells). 
ii) To characterise the level of cell death in specific cell types treated with 
various doses of m-THPC-mediated PDT to reveal any differences in 
sensitivity to this treatment in neural cells compared to cancer cells. 
iii) To validate the culture system by also investigating the response of the 
various cell types to an alternative photosensitiser, hypericin. 
3.3 Results 
3.3.1 Cellular uptake and intracellular distribution of photosensitisers 
The responsiveness of specific cell types to PDT challenges is dependent on the 
rate and! or level of photosensitiser uptake and the subsequent intracellular 
distribution of photosensitiser. These parameters were therefore investigated in 
this study. 
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3.3.1.1 m-THPC uptake 
Using fluorescence microscopy of monolayer cultures, intense red m-THPC 
fluorescence was detected in the cytoplasm of all cell types, but not in their nuclei 
in monolayer cultures of dissociated DRGs (set up as described in Chapter 2, 
section 2.2.3.2), treated for 4 h with 4 ~g/m m-THPC at 3-4 days in vitro, m-THPC 
fluorescence was present in both neurones (Figure 3.2) and satellite cells (Figure 
3.3). Satellite cells showed lower fluorescence intensity than neurones, with a 
more punctuate distribution pattern. The overlay micrograph in Figure 3.2C shows 
m-THPC fluorescence (red) and ~III-tubulin immunostaining (green) co-localised 
(yellow), confirming the uptake of m-THPC into neuronal cell bodies. 
The presence of m-THPC did not interfere with the ability to detect neurones using 
~III-tubulin immunostaining in conjunction with a FITC secondary antibody. FITC 
fluorescence was restricted to the green channel and was not detected using the 
red channel used for detecting photosensitiser. Also, m-THPC fluorescence was 
restricted to the red channel and was not detected using the green channel 
(shown in Chapter 4). In contrast to the presence of m-THPC fluorescence in 
neuronal cell bodies, the overlay micrograph in Figure 3.3C shows neurites 
labelled with ~1I1-tubulin/FITC, but without m-THPC fluorescence. This suggested 
that m-THPC did not localise within neurites, or alternatively that m-THPC 
fluorescence in neurites could not be detected with the fluorescence microscopy 
used in this study. Control samples incubated without photosensitiser (no drug) 
showed no fluorescence attributed to m-THPC (Figure 3.2 D, E and F; and 3.3 D, 
E and F). 
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Further to this fluorescence study, confocal microscopy was also performed in 
order to try to detect any low level m-THPC fluorescence signal which might be 
present in DRG neurites but below the limit of detection of the fluorescence 
microscope or to confirm the results of the fluorescence microscopy. Figure 3.4 
shows a single neurone with a neurite bridging two areas of satellite cells. 
Although m-THPC fluorescence was detected in the cell bodies of the neurone 
and supporting satellite cells (Figure 3.4A), none was detectable along neurites 
(Figure 3.4A, B and C). These confocal micrographs therefore support the 
fluorescence results shown in Figure 3.3 that there was no detectable m-THPC 
fluorescence in neurites. 
A time course study was performed in order to determine whether an m-THPC 
incubation time of 4 h, as indicated in the literature (Bourre~ et al., 2002; Kiesslich 
et al., 2007), enabled a similar amount of m-THPC to accumulate in neurones as 
longer incubations. Figure 3.5 shows a graphical representation of m-THPC 
fluorescence intensity over time as an approximate measure of the levels of m-
THPC taken up into neurones. A slight increase in m-THPC levels in neuronal cell 
bodies was detected on increasing incubation time from 4 to 7 h. No further 
increase in m-THPC levels was observed up to 24 h incubation. Therefore 4 h was 
considered to be an adequate incubation time in monolayer cultures to achieve 
uptake of m-THPC into neurones. 
In addition to detection of m-THPC fluorescence in DRG neurones and satellite 
cells, m-THPC fluorescence was also detected in the cytoplasmic regions of MCF-
7 cells (Figure 3.6A) and astrocytes (Figure 3.68). Uptake into DRG satellite cells 
is shown for comparison (Figure 3.6C). 
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m-THPC No drug 
Figure 3.2. 
Micrographs of In-THPC fluorescence detected in ORG neuronal cell bodies in 
monolayer cultures. 
Micrographs show Hoechst stained nuclei (blue) , m-THPC fluorescence in neuronal cell 
body cytoplasm (red) , and PII I-tubulin immunolabelled neuronal cell body cytoplasm 
(green). These cells were fixed and immunostained in monolayer cultures. (A, B and C) 
incubated 4 Ilg/ml m-THPC for 4 h, this shows intense diffuse m-THPC fluorescence in 
the cytoplasm (red) of neuronal cell bodies (This fluorescence was not localised in 
neuronal nuclei , which were not visible in these neurones due to a layer of m-THPC on 
top of nuclei) and (0 , E and F) incubated no drug control for 4 h, this shows no m-THPC 
fluorescence in neuronal cell body cytoplasm (red) . (Arrows indicate position of neuronal 
cell bodies) 
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m-THPC No drug 
Figure 3.3 
Micrographs of m-THPC fluorescence detected in DRG satellite cells but not in 
neurites in monolayer cultures. 
Micrographs show Hoechst stained nuclei (blue) , m-THPC fluorescence in satellite cell 
cytoplasm (red) , and ~III-tubulin immunolabelled neurite cytoplasm (green). These cells 
were fixed and immunostained in monolayer cultures. (A, B and C) incubated 4 Ilg/ml m-
THPC for 4 h, this shows punctuate m-THPC fluorescence in cytoplasm of satellite cells 
(red), no detectable m-THPC fluorescence in ~ III -tubulin immunolabelled neuite (green) 
and no m-THPC fluorescence shown in cell nuclei. (D, E and F) incubated no drug control 
for 4 h; this shows no m-THPC fluorescence in satellite cell cytoplasm (red) or in ~ 1I1 -
tubul in immunolabelled neuite (green). (Arrows indicate positions of neurites) 
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Figure 3.4 
Confocal micrographs showing no detectable ~ THPC fluorescence in neurites of 
DRG neurones in monolayer cultures. 
Micrographs show m-THPC fluorescence in satellite cell and neuronal cell body 
cytoplasms (red) and ~III -tubulin immunolabelled neurone cytoplasm (green). These cells 
were fixed and immunostained in monolayer cultures. (A, 8 and C) incubated 4 \lg/ml m-
THPC for 4 h, this shows (A) punctate m-THPC fluorescence in satellite cell cytoplasm 
(red) , (8) no detectable m-THPC fluorescence (red) in ~III-tubulin immunolabelling neurite 
cytoplasm (green) , and (C) composite micrograph shows no colcalisation of m-THPC 
fluorescence (red) with ~III -tubulin immunolabelled neurite cytoplasm (green). Confocal 
images are maximum intensity projections from 40 optical sections in a 14 IJm z-series. 
(Rectangular box indicates segment of neurite bridging between areas of satellite cells) . 
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m-THPC 
24 
Time course of m-THPC uptake into DRG neuronal cell bodies in monolayer 
cultures. Comparison of m-THPC uptake over time was determined by measuring m-
THPC fluorescence (red) intensity, localised in neuronal cell bodies. Fixed neuronal cell 
bodies were first identified morphologically using phase contrast microscopy. m-THPC 
fluorescence was then captured. Data were obtained from 3 randomly selected points (not 
the nuclei) within each of a total of 5 neuronal cell bodies per cover glass, fluorescence 
intensity values were presented as means ± SEM of 5 neurones from 2 separate cover 
glasses and were analysed at each time point. 
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3.3.1.2 Hypericin 
Hypericin fluorescence was detected in all cell types, but not as strongly as m-
THPC. Hypericin was present in ORG neuronal cell bodies (Figures 3.7A, Band 
C) and satellite cells (Figure 3.8A, B and C), like m· THPC, hypericin was not 
detected in neurites (Figure 3.8A, B and C). No hypericin fluorescence was 
detected in control samples without the drug (Figures 3.70, E and F, and Figure 
3.80, E and F). Incubation with hypericin did not inhibit the ability to detect 
neurones using I3I11-tubulin immunostaining. There was no crossover of hypericin 
red fluorescence in the green channel used for detecting I3I11-tubulin/FITC (green) 
fluorescence (shown in Chapter 4). 
It was found that after immunostaining, cells did not retain the same level of 
hypericin fluorescence in comparison to before immunostaining and the 
distribution of hypericin in cells was different before (Figure 3.9C, 0, E and F) and 
after (Figure 3.9A and B) the immunostaining incubation and wash steps. The 
level of hypericin present in cells at the time of illumination therefore was likely to 
be greater than that displayed after immunostaining. No such effect was observed 
with m-THPC (data not shown). 
Hypericin fluorescence was also detected in the cytoplasmic regions of MCF-7 
cells (Figure 3.10). 
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Figure 3.6 
m-THPC uptake in MCF-7 cells, astrocytes and satellite cells. 
Micrographs show Hoechst stained nuclei (blue) and m-THPC fluorescence. in cytoplasm 
of cell types (red). These cells were fixed , and incubated with 4 Ilg/ml m-THPC for 4 h in 
monolayer cultures and were not immunostained. (A) MCF-7 cells, (8) Astrocytes and (C) 
Satellite cells, these micrographs show diffuse and punctate m-THPC fluorescence in 
different cell type cytoplasm (red) . No m-THPC fluorescence shown in cell nuclei. 
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Hypericin No drug 
Figure 3.7 
Hypericin fluorescence detected in DRG neuronal cell bodies in monolayer 
cultures. Micrographs show Hoechst stained nuclei (blue) , hypericin fluorescence in 
neuronal cell body cytoplasm (red) , and ~III -tubulin immunolabelled neuronal cell body 
cytoplasm (green) . These cells were fixed and immunostained in monolayer cultures. (A, 
B and C) incubated 1.6 1l9/ml hypericin for 7 h, this shows diffuse hypericin fluorescence 
in neuronal cell body cytoplasm (red) (This fluorescence was not localised in neuronal 
nuclei , which were not visible in these neurones) and (0 , E and F) incubated no drug 
control for 7 h, this shows no hypericin fluorescence in neuronal cell bodies cytoplasm 
(red). (Arrows indicate position of neuronal cell bodies) 
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Hypericin No drug 
Figure 3.8 
Hypericin fluorescence detected in DRG satellite cells but not in neurites in 
monolayer cultures. 
Micrographs show Hoechst stained nuclei (blue) , hyperisin fluorescence in satellite cell 
cytoplasm (red), and ~ III -tubulin immunolabelled neurite cytoplasm (green) . These cells 
were fixed and immunostained in monolayer cultures. (A, 8 and C) incubated 1.6 Ilg/ml 
hyperisin for 7 h, this shows some punctuate hypericin fluorescence in cytoplasm of 
satellite cells (red) , no detectable hypericin fluorescence in BIII-tubulin immunolabelled 
neuite (green) and no hypericin fluorescence shown in cell nuclei. (0 , E and F) incubated 
no drug control for 7 h, this shows no hypericin fluorescence in satellite cell cytoplasm 
(red) or in ~ I II-tubulin immunolabelled neuite (green). (Arrows indicate positions of 
neurites) 
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After Immunostaining 
Figure 3.9 
Hypericin uptake in ORG culture. 
Micrograph shows Hoechst stained nuclei (blue), hypericin florescence in cell cytoplasm 
(red) and ~1I1 -tubulin immunolabelled neurone cytoplasm (green) .These cells were fixed 
and incubated with 1.6 Ilg/ml for 7 h in monolayer cultures. (A and B, after 
Immunostaing) shows greatly reduced hypericin fluorescence in cell cytoplasm (red) in 
comparison to (C, 0 , E and F, non-immunostained). Hypericin is shown to localise in 
neuronal cell body and satellite cell cytoplasm, but not in nuclei. 
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Figure 3.10 
Hypericin uptake into MCF-7 cells. 
Micrograph shows Hoechst stained nuclei (blue) and hypericin florescence in cell 
cytoplasm (red) . These cells were fixed, and incubated with 1.6 Ilg/ml for 7 h in monolayer 
cultures, and were not immunostained. These cells show diffuse hypericin fluorescence in 
MCF-7 cell cytoplasm (red) . 
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3.3.2 Evaluation of PI exclusion assay for detecting cell death 
Several methods of microscopically assessing cell death and cell viability were 
tested including acridine orange inclusion and trypan blue exclusion (data not 
shown) as well as PI exclusion. However, of these assays tested in monolayer 
DRG cultures, PI exclusion by live cells in combination with Hoechst 33258 
nuclear DNA staining produced the best live/dead visual distinction system to 
distinguish between dead cells (cells with compromised membranes: bright red 
stained nuclei) and live cells (cells with intact membranes: only blue stained 
nuclei). Furthermore, this PI exclusion method could be combined with neuronal 
identification with ~III-tubulin immunostaining, providing an approach that enabled 
the cell death response of distinct cell types to be analysed separately within a co-
culture system. 
Figure 3.11 shows no drug control versus m-THPC-mediated PDT treated ORG 
satellite cells in collagen gels. These micrographs show clearly the ability to detect 
and distinguish between live and dead satellite cells in this 3D collagen culture 
system. 
Representative micrographs are shown in Figure 3.12 to illustrate how, in each of 
the cell populations under investigation, dead cells (PI-stained red nuclei) could be 
distinguished from live cells (no red staining, Hoechst 33258 blue nuclei). These 
cultures were within collagen gels and Figure 3.128 also illustrates how PI 
live/dead analysis could be used in conjunction with ~1I1-tubulin immunostaining to 
identify live and dead neurones. 
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1 J/cm2 light m-THPC-mediated PDT 
Figure 3.11 
PI-stained DRG satellite cell cultures within thin collagen gels after 4 IJglml m-
THPC-mediated PDT and 1 J/cm2 light only (no drug) control . 
No dead cells were detected with no drug control (A and B), but a number of PI-stained 
dead cells were detected after m-THPC-mediated PDT (C and D). 
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Figure 3.12 
PI-stained cell cultures within thin collagen gels after 4 ~g/ml m-THPC-mediated 
PDT. 
Various cell types (A) DRG satellite cells; (8) DRG neurones; (C) MCF-7 cells; and (0) 
astrocytes were analysed for death after m-THPC-mediated PDT using PI staining. 
Examples of dead cell nuclei are indicated by arrows, (3111 -tubulin labelled neurones and 
Hoechst 33258 labelled all nuclei. 
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3.3.3 Assessment of monolayer versus cell-seeded collagen cultures post-
experimental processing 
This collagen model system supported the growth of neural and tumour cells and 
enabled PDT treatments to be applied in a consistent controllable manner. The 
collagen scaffold trapped live and dead cells throughout the staining procedures 
enabling microscopic analyses of treated samples. Figure 3.13 shows an example 
of DRG neurones and satellite cells grown in co-culture within a thin collagen ge\. 
Figure 3.14 shows neurite growth was supported within the 3D collagen gel lattice. 
The reason for developing this thin 3D collagen culture system was to overcome 
the main limitation of monolayer cultures for these experiments, which was loss of 
cells from the cultures during the incubation and washing stages. Figure 3.15A 
shows DRG cells seeded within collagen cultures (3D) exhibited an increase in 
percentage of dead cells following PDT with increasing m-THPC concentrations. 
The equivalent use of monolayer (20) cultures is also shown, which indicated a 
larger increase in percentage dead cells 24 h post-PDT incubation. 
However, the apparent increase in percentage cell death in monolayer cultures 
(white bars) was accompanied by a decrease in overall cell numbers as cells were 
lost from the monolayer culture system. This resulted in the reduction of mean cell 
numbers calculated per cover glass in comparison to stable mean cell numbers 
per gel in the 3D cultures (Figure 3.158). Treating satellite cell cultures with light 
only (no drug) did not induce cell loss or death from either monolayer or 3D 
cultures (Figure 3.15A and B). However, results in Figure 3.15B indicated that the 
use of monolayer cultures (white bars) was inadequate for the study of accurate 
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Figure 3.13 
Confocal micrograph showing neurones and satellite cells in thin collagen cultures 
after 4 IJglml ~ THPC-mediated PDT. 
Micrograph shows PI (dead cells ; red nuclei) and 13111-tubulin immunofluorescence 
(neurone; green) . Fixed gels were prepared for microscopy by compressing under cover 
glasses. Side views of z-stack show cells are within the collagen lattice limits (double 
headed arrows). (A) Confocal image is a maximum intensity projection for 400 optical 
sections through the flattened gel. Scale bar is 49 J..lm. (8) 3D projection using Volocity 
imaging software. 
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Figure 3.14 
Micrograph of neurites grown from DRG neurones within collagen matrix. 
Micrograph of fixed and immunostained 3D collagen culture shows Hoechst staining (total 
cell nuclei, blue), PI (dead cell nuclei, pink) indicated by a circle and (3111-tubulin (DRG 
neurone with neurites; green) indicated with arrows). 
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cell death responses following PDT; and supported the use of a 3D culture system 
(blue bars). The increase in dead cell detection accompanied with reduced cell 
numbers in monolayer cultures are possible indicators of more live cells than dead 
cells being lost from the monolayer culture system (Figure 3.15A and B white 
bars). Thus the 3D culture system gave a more accurate depiction of mean 
percentage dead cells, was able to withstand PDT and processing by retaining cell 
content and integrity after immunocytochemistry, and permitted the use of 
microscopic analysis. 
3.3.4 Compatibility of PI exclusion assay with immunocytochemistry fixation 
procedure 
In addition to reducing any cell losses during processing, if neurones were to be 
successfully identified within co-cultures it was necessary to ensure that the 
fixation required would not interfere with the PI exclusion assay (live/dead) results. 
It was important to assess whether PFA fixation might result in additional uptake of 
residual PI from the collagen gel surroundings into cells which had previously 
excluded it. Pilot experiments in which cells were fixed with 4 % (w/v) PFA before 
or after PI staining showed that fixation did not alter the plasma membrane in such 
a way as to result in an increase in the number of cells stained with PI (Figure 
3.15). 
This collagen gel culture system in combination with the PI exclusion assay use 
was also tested for the ability to display 100 % cell death. There were increases in 
the mean % of PI staining after 10 min incubation with 0.5 % (v/v) tritonX-100, 
which permeabilised cell plasma membranes allowing entry of PI into cells. Here 
near maximum cell death was detected for all cell types including neurones 
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following TritonX-100 treatment (Figure 3.16), confirming that detection of maximal 
cell death was achievable in this system. 
These initial experiments confirmed that the combined use of the thin cell-seeded 
collagen gels with the PI exclusion assay, followed by fixation with PFA and 
immunostaining was feasible; therefore these collagen gel culture systems were 
suited for further use in this investigation. 
3.3.5. Comparison of the relative sensitivity of specific cell types to PDT 
Having established the effectiveness of the thin 3D culture system for assessing 
cell death following PDT, studies were undertaken to characterise the sensitivity of 
a range of cell types to m-THPC-mediated PDT. This approach allowed the 
differential responses of neurones and satellite cells growing in co-culture to be 
studied and compared to MCF-7 cells and to astrocytes. Studies were also 
undertaken using hypericin as an alternative photosensitiser, partly to gain an 
insight into this drug, but mainly to use it as a comparator to m-THPC to help 
validate the culture system. As for m-THPC, hypericin fluorescence was detected 
throughout the cytoplasm in each cell type as previously shown, but was not 
present in the nuclei or in the neurites. 
Comparisons of the sensitivity of neurones, satellite cells and MCF-7 cells to m-
THPC- and hypericin-mediated PDT are shown in Figure 3.17 and Figure 3.19 in 
addition to astrocytes in Figure 3.17. It is possible that increasing incubation time, 
- 129 -
Chapter 3-Results 
m-THPC-mediated PDT on 20 and 3D DRG cultures 
(A) 1 
m-THPC (J.1g/ml) 
c:::J 2D 
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m-THPC-mediated PDT on 20 and 3D ORG cultures 
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The analysis of cell death in monolayer and 3D DRG cultures following PDT. 
Graphs show data from fixed and immunostained culture systems (A) A comparison of the 
% of ORG cell death in 20 and 3D culture systems post-PDT and immunostaining and (8 ) 
A comparison of the mean DRG cell numbers detected per cover glass or gel , in the same 
experiment. Data were collected from 3 random fields and presented as mean ± SEM of 9 
separate cover glasses (20 cultures) and 6 separate gels (3~ cultures) . 
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(A) Effect of PFA fixation on PI exclusion assay 
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Figure 3.16 
TritonX-100 + PI + PFA 
Treatments 
Assessment of 100 % cell death detection. 
• Satellite Cells 
• DRG neurones 
MCF-7 Cells 
(A) PFA fixation did not affect PI exclusion assay results (addition of PI and then PFA) ; 
and 100 % cell death detection was possible in this culture system using PI exclusion 
assay (addition of TritonX-100, then PI and PFA). (8) Cell numbers remained constant. 
Data were collected from 3 representative fields (satellite cells and MCF-7 cells) and all 
detectable neurones in each gel. Data are presented as mean ± SEM of at least 3 
separate gels. (DRG neurones and satellite cells were co-cultured in 3D collagen culture 
systems) 
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photosensitiser concentration or light dose may result in an increase in the killing 
efficiency of PDT on cell types used in this study, including neurones. 
3.3.5.1 Relative sensitivity of different cell types to m-THPC-mediated PDT 
The dose-response profiles obtained showed a difference in sensitivity between 
the cell types, with neurones showing less sensitivity to m-THPC-mediated PDT 
than the other cell types (Figure 3.17 A). Overall, sensitivity was in the order: 
astrocytes > MCF-7 cells > satellite cells > neurones across the range of 
concentrations. Interestingly, at 4 ~g/ml m-THPC-mediated PDT, neurones 
showed significantly lower sensitivity than the other cell types, with only 11.9 ± 1.4 
% neurone death in comparison to 48 ± 5.4 % in MCF-7 cells, 39 ± 4.0 % in 
satellite cells and 89 ± 3.1 % in astrocytes (p < 0.001 using one-way ANOVA with 
Tukey's post test). Furthermore treated neurones showed no more death than light 
only (no drug, Table 3.1) and drug only (no light, Figure 3.178) controls at all 
concentrations up to and including 10 ~g/ml m-THPC. PDT-induced EC50 values 
were estimated from the dose response data to be approximately 1 0 ~g/ml for 
satellite cells, 4 ~g/ml for MCF-7 cells and 1.5 ~g/ml for astrocytes (Figure 3.178). 
Table 3.1 lists specific no light or drug control cell death values for all cell types 
used, which were similar in value to their respective light only (no drug) controls. 
Figure 3.18 shows a series of representative micrographs of cell death after m-
THPC-mediated PDT in each cell type. 
3.3.5.2 Relative sensitivity of different cell types to hypericin-mediated PDT 
To investigate the sensitivity of these cells to another PDT agent and confirm that 
neuronal death by PDT could be detected using this culture system, the 
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experiment was repeated using hypericin. Unlike m-THPC-mediated PDT, Figure 
3.19A shows neurones, MCF-7 cells and satellite cells were all sensitive to 
hypericin-mediated PDT in a similar dose-dependent response pattern. At 
concentrations of 2.2 Ilg/ml and above, there was a significant difference in cell 
death between hypericin-POT-treated neurones and untreated controls (Figure 
3.19) (P<0.001 using one-way ANOVA with Tukey's post test). Table 3.2 lists the 
no light or drug control values of cell death for all cell types used, which were 
similar in value to their respective light only (no drug) controls and Figure 3.20 
shows a series of representative micrographs of cell death after hypericin-
mediated PDT. 
3.3.6 Morphological effect of PDT on neurites 
The effect of PDT on neurites of DRG neurones was also of importance in this 
study. This was because it is the neurites (or axonal projections, in vivo), which 
are commonly at risk of exposure to PDT while treating tumours in areas of the 
body rich in peripheral nerves. Both m-THPC and hypericin fluorescence were 
shown not to be detected in neurites of these neurones. 
Figure 3.21 shows m-THPC mediated PDT reduced the neurite length of DRG 
neurones in monolayer after a 24 latency period. There was no statistically 
significant effect on the neurite length when drug or light were applied separately, 
or when PDT was performed using 0.1 Ilg/ml m-THPC, whereas PDT using higher 
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--- DRG neurones 
--.- Satellite cells 
-.- MCF-7 cells 
-+- Astrocytes 
DRG neurones 
--.- Satellite cells 
-.- MCF-7 cells 
-+- Astrocytes 
Comparison of specific cell type sensitivity to m-THPC-mediated PDT treatments. 
Graphs show comparisons of various cell types (co-cultured DRG neurones and satellite 
cells, astrocytes and MCF-7 cells). Cells were cultured in 3D collagen culture systems and 
were fixed and immunostained after PI-exclusion assay was applied (A) 24 h after m-
THPC-mediated PDT and (8 ) their respective no light controls. Data were collected from 3 
representative fields of each gel , and presented as mean ±SEM of at least 3 separate gels 
(no light controls) and 9 separate gels (m-THPC-mediated PDT) . MCF-7 cells were 
assessed separately from astrocytes, and DRG cultures (co-cultures of neurones and 
satellite cells) were also assessed separately. 
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Further assay controls Neurones Satellite cells Astrocytes MCF-7 cells 
1 J/cm2 light only 3.52±O.7 4.78±1.1 3.17±O.5 7.6±1 .0 
No m-THPC or light 3.1±1.0 4.22±1.2 8.81±3.1 1.89±O.7 
Table 3.1 
Comparison of no drug or light and 1 J/cm2 light only (no drug) controls. 
Values are of mean percentage dead cells for each cell type after 4 h incubation of phenol 
red free DMEM. Data were collected from 3 representative fields of each gel , and 
presented as mean ±SEM of at least 3 separate gels. MCF-7 cells were assessed 
separately from astrocytes, and DRG cultures (co-cultures of neurones and satellite cells) 
were also assessed separately. 
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Figure 3.18 
Representative micrographs of cell death after TTl-THPC-mediated PDT. 
Micrographs are representative images of fields of the fixed 3D collagen culture system 
after treatment with m-THPC-mediated PDT and fluorescence staining. (A) Neurones, (8) 
Satellite cells, (C) MCF-7 cells and (D) Astrocytes. Cells were PI stained 24 h after 
exposure to light. (Note these images were not used to collect data, and that there is 
some red cytoplasmic staining which is the m-THPC localised in these cells). 
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----.- Satellite cells 
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Comparison of specific cell type sensitivity to hypericin-mediated PDT. 
Graphs show (co-cultured DRG neurones and satellite cells, astrocytes and MCF-7 cells). 
Cells were cultured in 3D collagen culture systems and were fixed and immunostained 
after PI-exclusion assay was applied (A) 24 h after hypericin-mediated PDT and (8 ) no 
light controls. Data were collected from 3 representative fields of each gel, and presented 
as mean ± SEM of at least 5 (no light controls) or 6 (hypericin-mediated PDT) 
independent gels. MCF-7 cells were assessed separately from DRG cultures (co-cultures 
of neurones and satellite cells) 
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Further assay controls Neurones Satellite cells MCF-7 cells 
1 J/cm2 light only 7.9±1.1 4.0±O.9 1.0±O.2 
No hypericin or light 5.4±1.27 B.O±2.7B 1.61±O.65 
Table 3.2 
Comparison of no drug or light and 1 J/cm2 light only (no drug) controls. 
Values are of mean percentage dead cells for each cell type after 7 h incubation of phenol 
red free DMEM. Data were collected from 3 representative fields of each gel, and 
presented as mean ±SEM of at least 5 separate gels. MCF-7 cells were assessed 
separately from DRG cultures (co-cultures of neurones and satellite cells) 
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Figure 3.20 
Cell death after hypericin-mediated PDT. 
Micrographs are representative images of fields of the fixed 3D collagen culture system 
after treatment with hypericin-mediated PDT and fluorescence staining. (A) Neurone, (8) 
Satellite cells and (C) MCF-7 cells. Cells were PI stained 24 h after exposure to treatment 
conditions. (Note these images were not used to collect data, and that there is some red 
cytoplasmic staining which is the hypericin localised in these celis.) 
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** 
** ** 
m-THPC treatment 
Reduction in neurite length due to m-THPC-mediated PDT treatments. 
DRG neurones were cultured on cover-glass for three days then treated with various 
concentrations of m-THPC and blue light of 4.2 J/cm2 . Samples were then maintained in 
culture for a further 24 h prior to fixation and quantification of the mean neurite length in 
millimetres, of all ~1I1-tubulin immunostained neurites. Data were presented as means ± 
SEM of 4 separate cover glasses. One-way ANOVA with Dunnett's multiple comparison 
post test were used to assess neurite lengths. Significant decreases in lengths are 
marked as (**) P<0.001 for treatments compared to no drug or light control. Figure 
prepared by Elizabeth Liniker, in Wright et al. (2009). 
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concentrations of m-THPC (0.3 \-Ig/ml and above) caused a significant reduction in 
neurite length compared with untreated controls (P<0.001, one-way ANOVA with 
Dunnett's post test). 
Further to this, in the present study, most DRG neurones assessed for viability in 
the thin 3D collagen culture system were microscopically observed to be lacking in 
detectable neurites after exposure to PDT in comparison to non-PDT treated ORG 
neurones. 
3.3.7 Distinction between mitosis and DNA fragmentation post-hypericin-
mediated PDT 
After treatment with hypericin-mediated PDT, satellite cells and MCF-7 cells 
displayed some fragmented nuclei, a feature which was not detected in m-THPC-
mediated PDT and which may have indicated a difference in the type of cell death 
mediated by the 2 photosensitisers. Nucleus fragmentation can be an indication of 
apoptosis, but could also be a feature of cells undergoing mitosis at the time of cell 
death. Hypericin is known to cause cells to arrest in mitosis, so it was useful to 
investigate this further using a marker of mitosis. Figure 3.22A, Band C shows 
DNA fragmentation in satellite cells stained with Hoechst 33258 and PI. Mitotic 
satellite cells were detected using P-MPM2 (green). As a positive control for P-
MPM2 staining, cells were poisoned during mitosis using colchicine and Figure 
3.220 shows a number of mitotic satellite cells. When the presence of mitosis was 
investigated in cells after hypericin-mediated PDT (Figure 3.22E) it was clear that 
the fragmented DNA was not necessarily associated with P-MPM2 positive cells 
and was therefore likely to indicate apoptosis. 
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Figure 3.22 
Nuclear morphology change and mitosis detection after hypericin-mediated PDT in 
DRG satellite cells. 
Micrographs show fixed and immunostained satellite cells co-cultured with neurones in 3D 
collagen culture systems (A) Hoechst stain (blue) indicating nuclear material, (8 ) PI stain 
(red) indicating nuclear material of cells with compromised membrane and (C) Overlay of 
Hoechst and PI images to demonstrate the fragmentation observed 24 h after 1.6 ~g/ml 
hypericin-mediated PDT in satellite cells. 50 ng/ml colchicine treatment arrested ORG 
satellite cells during mitosis showing that they were detectable using (D) P-MPM2/FITC 
immunostaining (green) and (E) After 1.6 ~g/ml hypericin-mediated PDT, some satellite 
cells were positive for P-MPM2/FITC staining, but other cells which were not undergoing 
mitosis exhibited the nuclear fragmentation . (Arrows indicate fragmented nuclei) 
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3.4 Discussion 
The key finding from this study is that ORG neurones were less sensitive to m-
THPC-mediated PDT than their associated satellite cells and the tumour cell line, 
MCF-7, both of which exhibited dose-dependent cell death over the range of 
treatment concentrations used. This is an important observation as it indicates that 
ORG neurones are able to survive m-THPC-mediated PDT treatments that kill 
tumour cells, offering the possibility that therapeutic regimens could be developed 
to treat tumours in close proximity to neurones. In addition photosensitiser 
fluorescence was not detected in neurites, but these neuronal compartments were 
adversely affected by PDT treatment both in monolayer and in 3D culture systems. 
3.4.1 Cellular photosensitiser uptake and compartmental distribution 
In this study all cells showed uptake of m-THPC and hypericin photosensitisers 
into the cytoplasm. DRG neurones appeared to accumulate more m-THPC in 4 h 
incubation periods than co-cultured satellite cells on the basis of detected 
fluorescence intensity; however this may have been to do with their size and 
shape rather than an actual difference in uptake. m-THPC uptake rate has been 
reported to vary between different cell types, for example Triesscheijn et al. (2004) 
showed that in hMVEC (human dermal microvascular endothelial) cells m-THPC 
content increased linearly for at least 48 h, in comparison to HMESO-1 
(mesothelioma-derived cell line) cells, HNXOE (head and neck squamous cell 
carcinoma cell line) cells and BCT-27 (human fibroblast of normal breast skin) 
cells which reached maximum fluorescence at 24 h. In this study DRG neurones 
displayed maximum m-THPC fluorescence in neuronal cell bodies by 7 h after 
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incubation of 4 ~g/ml m-THPC with no further increase at 24 h. However, since 
uptake was only slightly greater at 7 h than that at 4 h, the shorter time point was 
used for convenience. Furthermore, Sasnouski et a/. (2007) showed that a 
moderate incubation of 3 h for 7.5 ~M (5.1 ~g/ml) m-THPC resulted in a 1.8 times 
higher absorbed photons than 24 h incubation in MCF-7 cells, providing further 
support for the 4 h incubation time chosen here. This may be the result of m-THPC 
self-quenching after aggregation within cells due to high intracellular 
concentration. 
Subcellular localisation of photosensitisers within cells is an important parameter 
to consider in photodynamic activity, due to the short lifetime displayed by 102 
generated at photodamaged sites. Phototoxicity may be more accurately deduced 
from subcellular localisation studies rather than from the amount of photosensitiser 
taken up by specific cell types (Laville et a/., 2003). This is because oxidative 
damage of cellular components is known to occur within 10 nm of the activated 
photosensitiser molecule (Sadauskaite et a/., 2004). 
In previous studies, Sasnouski et a/. (2007) observed a change in m-THPC uptake 
pattern over time from a more diffuse to a more punctate pattern; this was shown 
to be accompanied by a reduction in photosensitisation efficiency at high m-THPC 
concentrations within MCF-7 cells, which may be due to photosensitiser 
aggregation and self-quenching. m-THPC uptake in HT29 cells was also reported 
to display a diffuse m-THPC fluorescence with some bright spots in the cytoplasm, 
but not in the nucleus (Laville et a/., 2003). This study showed satellite cells, 
astrocytes and MCF-7 cells as having a punctiform subcellular distribution pattern, 
after 4 ~g/ml m-THPC incubation for 4 h, whereupon illumination of these cells 
resulted in cell death. Neurones displayed more diffuse m-THPC fluorescence in 
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their cell bodies with no neurone death after illumination. The comparator 
photosensitiser, hypericin, used at a concentration of 1.6 \-Ig/ml, displayed a diffuse 
localisation pattern in satellite cells and MCF-7 cells and neurones after 7 h 
incubation, and resulted in cell death after illumination. 
Detailed investigation of the cellular localisation of m-THPC within neurones would 
be a useful future direction as differences in drug distribution between neurones 
and other cells might account for the differences in sensitivity reported here. This 
possibility is further investigated in the next chapter. 
Intense m-THPC and hypericin fluorescence was observed in DRG neuronal cell 
bodies, with the absence of photosensitiser fluorescence in neurite compartments. 
This absence of photosensitiser fluorescence detection may be due to a lack of 
photosensitiser uptake into neurites, or subsequent movement of photosensitiser 
out of neurites. However, it is also possible that photosensitisers were present 
within the neurites, but perhaps due to the very narrow dimensions of this cellular 
compartment the fluorescence was below the level of detection of the microscopy 
used here. 
3.4.2 Thin 3D cell-seeded collagen culture systems 
Collagen gels have been used as culture substrates for many years because they 
provide a 3D environment in which cells can grow in a more natural spatial and 
physical environment than they would on a stiff monolayer substrate (Kim et a/., 
2004; Brown and Phillips, 2007). The rate of diffusion of oxygen and other 
nutrients through collagen gels is relatively rapid, facilitating cell survival under 
normal conditions and ensuring that oxygen availability does not become a limiting 
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factor during PDT treatment. However, the main advantage of using a collagen gel 
system in this study was that cells remained trapped within the gels throughout 
treatment and in subsequent analysis stages. This meant that cell death could be 
determined more accurately than in many studies in which conventional cell 
monolayers were used. In those studies a proportion of cells we~e washed away 
during processing stages, and so the resulting analyses of cell death or cell 
viability do not account for all of the cells. Furthermore, trapping the cells in this 
manner enabled the multiple washes and incubations required for a PI exclusion 
assay to be used in conjunction with an immunostaining technique so that 
numbers of live or dead neurones and satellite cells could be analysed separately 
within a co-culture. 
As the interaction between neurones and their associated satellite cells is 
important for neuronal function and survival, co-culture systems such as this are 
often favoured over isolated neuronal cultures. This is the first study in which the 
differential effects of m-THPC- and hypericin-mediated PDT have been shown on 
mammalian DRG neurones and satellite cells in co-culture. A previous study using 
isolated crayfish stretch receptors (neurones and glial cells) and the 
photosensitiser Photosens (a mixture of sulphonated alumophthalocyanines) 
mentioned that glial cells seemed more sensitive than neurones to proteolytic and 
PDT treatments in that system (Lobanov and Uzdensky, 2005). It would be 
interesting to explore whether mammalian neurones and glial cells have different 
sensitivities to Photosens in our system. 
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3.4.3 Relative sensitivity of cells to PDT 
Primary mammalian ORG neurones in co-culture with satellite cells were shown to 
be less sensitive to m-THPC-mediated PDT than satellite cells, astrocytes and 
MCF-7 tumour cells. Satellite cells, astrocytes and MCF-7 cells all exhibited dose-
dependent cell death over the range of PDT treatments applied. ORG neurones 
were able to survive m-THPC-mediated PDT treatment at doses that killed the 
other cell types. This neurone sparing, however, was not seen when the 
comparator, hypericin-mediated PDT treatment was administered. 
3.4.3.1 m-THPC-mediated PDT 
It is important to note that the ECso value for MCF-7 cells (4 \.Ig/ml m-THPC-
mediated PDT) caused no dark toxic effect on cell types used in this study. Yet, 
when this concentration of m-THPC was activated using 1 JI cm2 light, it resulted 
in substantial glial cell and MCF-7 cell death as previously reported for MCF-7 
cells in other culture systems (Koechli et a/., 1995). This was with no neurone 
death (after exposure to 0-10 \.Ig/ml m-THPC-mediated PDT) above that seen in 
untreated controls. 
3.4.3.2 Hypericin-mediated PDT 
Hypericin was used as an alternative to m-THPC primarily to validate the thin 3D 
collagen culture system. The sensitivity of MCF-7 cells to hypericin-mediated PDT 
in this system was similar to that previously reported (Vandenbogaerde et a/., 
1997). The presence of DNA fragmentation after hypericin-mediated PDT 
suggests that the mechanism of cell death caused by hypericin included apoptosis 
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to a greater extent than observed with m-THPC in MCF-7 and satellite cells (a 
feature not seen after m-THPC-mediated PDT). Similar apoptotic DNA 
fragmentation was observed 24 h after hypericin-mediated PDT on HeLa cells 
(Assefa et a/., 1999). 
In contrast to m-THPC-mediated PDT, approximately 90 % neuronal death was 
detected after hypericin-mediated PDT. This confirmed that the lack of neuronal 
cell death detection after m-THPC-mediated PDT was not due to an inability to 
detect neuronal death in this culture system. 
Together, the m-THPC and the hypericin data showed that this thin 3D collagen 
culture system can be used to compare mixtures of cells, exposing them to PDT 
and then combining cell death analysis with immunofluorescence identification to 
dissect out any differences in sensitivity between cell populations. This is a 
valuable culture system which could facilitate research in which the response of 
two or more cell types to PDT needs to be evaluated and may be particularly 
useful for studies comparing responses in tumour cells and non-tumour cells 
during screening for selective photosensitisers. 
3.4.4 DRG neuronal cell body survival with neurite degeneration 
The light dose (f1uence rate) of 1 J/cm2 , showed no toxic effect to cells used in this 
study (without photosensitiser incubation). It has been suggested that in general 
an increase in light dose was less toxic than an increase in m-THPC concentration 
(Rousset et al., 2000). This is because, with increasing light dose, photobleaching 
would occur which would destroy photosensitiser molecules and therefore reduce 
the toxic effect of PDT. Increasing the concentration of the photosensitiser would 
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increase the toxic effect of PDT; however it is possible that quenching of 
photosensitiser molecules would occur at high concentrations. Therefore this study 
concentrated on varying the photosensitiser concentration, while maintaining other 
variables, such as light source and fluence rate. 
Previous studies showed that PDT using m-THPC was sufficient to inhibit 
conduction in crayfish stretch receptor neurones at concentrations much lower 
than those used in this study 10 nM or (0.0068 ~g/ml) (Uzdensky et al., 2004). 
These previous data, together with our neurite loss results, indicated that, in cell 
culture, neuronal function is compromised by m-THPC-mediated PDT, but that 
unlike other cell types they have the capacity to survive m-THPC-mediated PDT 
treatment, giving them the potential for regeneration and subsequent restoration of 
function. 
Neurones are thought to use a range of intracellular signalling pathways to 
maintain their survival, and their neurite integrity. Goldberg (2003) suggested that 
the response of trophic factors may diverge inside neurones (i.e. one response to 
maintain neurone survival and another to maintain neurite integrity). This may 
explain the observation of neuronal cell body survival accompanied by neurite loss 
in this study. However, a review by Conforti et al. (2007) reports that neuronal sub-
compartments (neuronal cell bodies and neurites) are known to depend on each 
other for survival. Therefore, impairment of one of these neuronal compartments 
could in theory result in the degeneration of the other. Survival of the neuronal cell 
body may therefore be dependent on neurites, while neurites are known to be 
protected by the slow Wallerian degeneration protein (WldS ) (reviewed by Conforti 
et a/., 2007) produced by the neuronal cell body. 
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Previous work from this group showed significant DRG neurite loss after m-THPC-
mediated PDT in monolayer cultures (Wright et aI., 2009) and similar loss of ORG 
neurites after ALA-mediated PDT. Loss of ORG neurites was also observed but 
not quantified in this study after using both m-THPC- and hypericin-mediated PDT 
in collagen gels. Interestingly, this phenomenon of neurite loss accompanied by 
neuronal cell body survival after m-THPC-mediated PDT is similar to that reported 
by Hahn et al. (2008) in primary human DRG neurones exposed to HIV. In that 
culture study, neuronal cell bodies survived oxidative stress imposed by HIV 
infected macrophage supernatant, while their neurites retracted. These human 
ORG neurones were also found to have suffered mitochondrial dysfunction in their 
neuronal cell bodies, but not in the retracted neurites. The damage to neurites was 
suggested by Hahn et al. (2008) to have occurred independently of the induced 
oxidative stress. It was shown previously by Sayan et al. (2004) in rat sciatic 
nerves injured by ROS, that antioxidants were able to rescue neuronal cell bodies, 
but not neurites from oxidative stress. These studies re-highlight the point that 
neurones may have responded to m-THPC-mediated PDT using different 
mechanisms for these 2 neuronal compartments (neuronal cell bodies and 
neurites). 
It is interesting that the decrease in neurite length in monolayer cultures occurred 
despite the lack of detection of any photosensitiser along the length of the 
neurites. If there was no photosensitiser present in the neurites, m-THPC-
mediated PDT in the neuronal cell body might have activated or inhibited 
pathways which resulted in neurite loss, but not DRG neurone death. 
The complex relationship between neurones and glial cells makes it difficult to 
speculate any further about a mechanism by which m-THPC-mediated PDT 
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reduced neurite length without killing neurones, as neurite outgrowth can be 
influenced by factors such as the level of activation of the supporting glial cells 
(Armstrong et a/., 2008), membrane proteins expressed on the surface of the glial 
cells (Castro and Kuffler, 2006) and diffusible factors released from them 
(Armstrong et a/., 2007). This means that the changes in neurite length measured 
in these co-cultures could be a result of the effect of the PDT on the 
accompanying satellite cells rather than a direct effect on the neurones. Further 
studies could address this pOint by investigating the effects of m-THPC on 
neuronal cultures in the absence of supporting glia; however for this study it was 
important to use co-cultures since they are more reminiscent of the neuronal 
environment in vivo. 
3.5 Conclusions 
In summary, the results in this Chapter demonstrated the uptake of 
photosensitisers (m-THPC and hypericin) by neural and MCF-7 tumour cells in 
vitro. Cellular distributions appeared to be cytosolic, with no detectable 
photosensitiser along the neurites or in nuclei. A useful thin collagen-based culture 
system was developed in which to investigate the sensitivity of specific cell types 
to PDT in mixed-cultures and in isolation. The ability to keep both dead and live 
cells trapped in the collagen gel allowed the accurate detection of cell death and 
the identification of neurones in mixed cultures. The key finding from these 
experiments was to identify that there are particular m-THPC-mediated PDT 
conditions in which ORG neurones survive treatment while tumour cells and glial 
cells are killed. Although the effects of m-THPC-mediated PDT on the PNS 
(satellite cells) and the CNS (astrocytes) glial cells were substantial these cells , 
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are able to proliferate and to re-innervate intact collagen structures of PDT treated 
areas. m-THPC-mediated PDT treatment may therefore offer the possibility of a 
therapeutic procedure, which could be refined to treat tumours in close proximity to 
DRGs (e.g. vertebral tumours (Burch et al./ 2005». 
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Chapter 4: Investigation of ORG neurone sparing after m-THPC-
mediated PDT in vitro 
4.1 Introduction 
In Chapter 3, ORG neurones were shown to survive m-THPC-mediated PDT 
doses that killed satellite cells, MCF-7 cells and astrocytes cultured in 3D collagen 
gels. This ORG neurone-sparing phenomenon is investigated in this chapter. 
Firstly, the survival of ORG neurones post-m-THPC-mediated PDT was assessed 
for signs of an early phase of apoptotic cell death, which may have been missed in 
the previous chapter due to the use of the PI exclusion assay (this does not detect 
early stages of apoptosis) at a single time point, 24 h post-PDT (latency period). 
The time course of cell death is known to vary between different cell types 
(Sundquist et a/., 2006); and apoptotic cell death rate in PDT killing can vary 
considerably according to the cell type, the photosensitiser and concentration 
used, the photosensitiser/light dose interval, and the photosensitiser subcellular 
localisation (Noodt et a/., 1999; Oleinick et a/., 2002; Bourre et a/., 2002). There is 
a therefore a possibility that DRG neurones may require a much longer latency 
period, than other cell types used in this study, before showing signs of a 
compromised membrane (cell death). 
A series of experiments are presented: 1} Shorter and longer latency periods were 
tested with the PI exclusion assay for DRG neurone and satellite cell death and 2} 
Assessment of the ability of DRG neurones to function post 4 IJg/ml m-THPC-
mediated PDT in terms of the regeneration of neurites following PDT. Having 
established that ORG neurones are indeed surviving m-THPC-mediated PDT, the 
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work described in this chapter then starts to investigate the mechanism that may 
be responsible. Selective inhibition of specific intracellular antioxidant pathways 
identified potential protective mechanisms within neurones, and detailed analyses 
of intracellular drug and 102/ROS localisation were undertaken to compare 
neurones to other cells in terms of PDT drug distribution and toxic product 
generation respectively. 
4.1.1 Brief overview of how nerves respond to oxidative stress 
The accumulation of ROS in rat sciatic nerves has been shown to cause lipid 
peroxidation, protein oxidation and DNA damage, which can result in nerve fibre 
degeneration and the breakdown of the PNS blood-nerve barrier (Sayan et a/., 
2004). In addition, after constriction injury to rat sciatic nerve the resultant 
oxidative stress has been shown to increase the enzymes SOD and GPx, and to 
reduce the activity of the antioxidant GSH and the enzyme catalase in the spinal 
cord, DRGs, dorsal root and ventral root (Varija et a/., 2009). Cells have 
endogenous intracellular antioxidant pathways, which provide a level of protection 
from oxidative stress. Interestingly, it has been suggested that in neurones, the 
neuronal cell bodies are protected from effects of oxidative stress, but not their 
neurites (Sayan et al., 2004), suggesting the presence of different mechanisms 
regulating the damage response within each neurone compartment. SOD and 
GSH are important ways in which neurones deal with oxidative stress, so 
investigations were made into whether they were involved in ORG neural cell 
survival after m-THPC-mediated PDT. 
In this study the intracellular antioxidant pathways investigated in terms of their 
contribution to protecting neurones during PDT were the SOO-1 and SOO-2 
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pathways, and the glutathione synthase pathway. These intracellular antioxidant 
pathways were chosen in preference to others such as catalase (Valencia and 
Moran, 2004), cytochrome C oxidase (Taylor and Moncada, 2009) or heme 
oxygenase (Gomer et al., 1991; Almeida et al., 2004; Frank et al., 2007) because 
they are the main pathways associated with neuronal survival in other systems 
(e.g. brain (Gonzalez-Zulueta et al., 1998; Gegg et al., 2005; Watts et al., 2005) 
and the spine (Rothstein et al., 1994; Iwasaki et al., 1997)}. 
4.1.1.1 SOD pathways 
The overexpression of SOO-2 and not SOO-1 or SOO-3 has been shown to 
protect tumour cells against free radical toxicity (Wong, 1995). However Antonyuk 
et al. (2009) have recently shown that SOO-1 may play important roles in 
protecting mitochondrial components from oxidative damage. In neural cells SOO-
1 is known to act as a scavenger enzyme that works by transforming 
physiologically generated O2' to H20 2 (as previously described in Chapter 1), 
which feeds into the glutathione peroxidase and/or the catalase reaction pathways, 
protecting neural cells from the harmful effects of oxidative stress (Raimondi et al., 
2006). 
4.1.1.2 Glutathione synthase pathway 
Investigations into the effects of Photosens-mediated PDT in a crayfish neural cell 
culture system showed that signalJing between neurones and glial cells involves 
the export of GSH from glial cells, which is subsequently cleaved to Cys-Gly 
dipeptide by the membrane-bound enzyme GGT, present on the other side of the 
glial cell (Uzdenskii et al., 2008). This is used to maintain optimal thiol status of 
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neurones, protecting them from oxidative stress (Mytilineou et al., 1999). The 
importance of this type of cell antioxidant protective system was reported by Maffi 
et al. (2007), who showed that rat cell populations with suppressed GSH levels 
resulted in elevated cell death response to ethanol-mediated oxidative stress. 
4.1.1.3 Inhibition of cell antioxidant pathways 
Oxidative stress occurs when there is an imbalance between the rate of ROS 
production and the antioxidant defence system that removes it. This may arise 
from a reduced level of antioxidant, or from an increased production of ROS. If the 
antioxidant pathways involving SOO-1, SOO-2 or GSH were involved in protecting 
neurones from death following PDT, a reasonable hypothesis would be that their 
inhibition would result in neurone death on exposure to m-THPC-mediated PDT. 
Such a result would therefore reveal a cellular mechanism by which ORG 
neurones were being protected from the effects of m-THPC-mediated PDT as 
observed in Chapter 3. 
The inhibitors used in this study were Oiethyldithiocarbamate (~OC) (Figure 4.1A), 
a copper chelator and an inhibitor of the SOO-1 enzyme (Ginsburg et al., 1997; 
Tanioka et al., 2005; Han et al., 2009). DOC has been shown to decrease levels of 
SOD activity, while increasing lipid peroxidation products in pancreatic stellate 
cells (Tanioka et al., 2005). A reduction in the levels of 500-1 activity with the use 
of DOC was also observed in rat ventral spinal cord neurones (Iwasaki et al., 
1997). 
2-Methoxy-estradiol (2-MeOE2) (Figure 4.1 B), is an oestrogen derivative that can 
not bind the oestrogen receptor (Huang et al. 2000). This compound was found to 
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be a chelating agent and a selective inhibitor of the SOO-2 enzyme (Gofqb et a/., 
2003). It has been used in PDT to potentiate the cytoplasmic effects of sub-lethal 
doses of PDT on the human breast cancer cell line T47-0 (Gofqb et a/., 2003). 
Also, the inhibitor OL-buthionine-(S, R)-sulfoximine (L-BSO) (Figure 4.1 C), was 
used in this study to inhibit the glutathione synthase pathway (Griffith 1999; 
Hamilton et al., 2007; Han et al., 2009), by inhibiting the first rate-limiting enzyme 
yGCS (Devesa et al., 1993; Nicole et al., 1998; Griffith, 1999; Avshalumov et al., 
2004; Gegg et al., 2005; Wang et al., 2006; Hamilton et al., 2007). L-BSO is 
known to cause a dose- and time- dependent accumulation of ROS in rat 
mesencephalic neurones, and to activate extracellular signal-regulated kinase 
(ERK-1/2), 4 and 6 h after treatment (de Bernardo et al., 2004). 
Concentrations and incubation times of inhibitors were chosen on the basis of 
reported use in the literature. 50 IJM DOC incubated for 1.5 h was used to inhibit 
800-1 in this study. Du et al. (2001) used 50 IJM DOC for 30 min on Jurkat cells, 
which resulted in enhancement of methylglyoxal-mediated ASK1 activation; and 
10 IJM DOC incubated for 4 h enhanced cytotoxicity of microglia to endogenous 
ROS (Miller et al., 2007). Gofqb et al. (2003) experimented with 1 IJM 2-MeOE2 
incubated for 24 h (as used in this study), resulting in a reduction of SOD activity in 
C-26 cells (murine colon-26 cells). This study also used L-BSO at similar 
parameters as Vasquez et al. (2001), who reported the use of 0.5 to 1.0 mM L-
SSO after 24 h incubation dramatically reduced GSH levels within glial cells by 80 
to 94 %. These 3 inhibitors were used individually to block the 3 specific 
antioxidant pathways identified as being potentially interesting in this study (Figure 
4.2). They were also tried in combination to see whether inhibiting multiple 
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antioxidant pathways would aid in deciphering the mechanism by which neurones 
are protected from m-THPC-mediated PDT. 
4.1.2 Photosensitiser and 102/ROS localisation 
4.1.2.1 Subcellular localisation of photosensitisers 
An objective of this chapter was to test whether the localisation of m-THPC in cells 
might help to explain the lack of sensitivity of DRG neurones to m-THPC-mediated 
PDT. Here the subcellular localisation of m-THPC was investigated using its ability 
to fluoresce red upon illumination. As a comparator, hypericin localisation was also 
investigated. This was in conjunction with green fluorescent cell organelle probes. 
Photosensitiser localisation patterns in cells have been shown to be an important 
determinant of the mode of cell death and a possible predictor of PDT efficiency 
(Ball et al., 1999). Therefore a thorough study of m-THPC and hypericin 
localisation was undertaken involving a range of cell types and various organelle 
probes: MitoTrk-green (mitochondria), Lyso-Trk-green (Iysosomes) and Hoechst 
33258 (nuclei). 
Chapter 3 showed a difference in sensitivity in neurones between m-THPC- and 
hypericin-mediated PDT and differences in sensitivity to m-THPC-mediated PDT 
between different cell types studied. Such differences in PDT effectiveness can be 
caused by the intracellular localisation of the photosensitiser. Some 
photosensitisers used in PDT, including m-THPC and hypericin, have been known 
to display some association with mitochondria, which may explain their efficiency 
in inducing apoptotic cell death in vitro and in vivo (Almeida et al., 2004). 
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Figure 4.1 
Molecular structures of commercially available inhibitors of intracellular antioxidant 
pathway enzymes. 
(A) DOC, an inhibitor of the SOO-1 antioxidant enzyme; (8) 2-MeOE2 an inhibitor of SOO-
2 antioxidant enzyme; and (C) L-BSO inhibitor of the yGCS enzyme of the glutathione 
synthase pathway. (Structures taken from Sigma Aldrich) 
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1) Glutathione synthase pathway 
yGCS 
Glutamine + Cysteine --....:: 
T 
y-glutamylcysteirteJlycine 
SSO GSH reductase 
o 
2) SOD pathway (\ 
SODs 
DOC or 2MeOE2 o 
Catalase 
GSH peroxidase 
~+~0 
Figure 4.2 
A summary to show inhibition of intracellular antioxidant pathways. 
Use of enzyme inhibitors can block respective antioxidant pathways shown, which results 
in reduced endogenous protection of cells and increased oxidative stress sensitivity and 
may lead to cell death. DOC (SOO-1 enzyme inhibitor) , 2-MeOE2 (SOO-2 enzyme 
inhibitor), L-8S0 (yGCS enzyme inhibitor) , GSH (reduced glutathione), GSSH (oxidised 
form of GSH-glutathione disulfide glutathione) , GS (glutathione synthase) , yGCS (y-
glutamyl-cysteine synthetase or ligase) and SOD (superoxide dismutase) . 
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Therefore; the co-localisation of these photosensitisers with mitochondria, 
Iysosomes and nuclei were assessed in this study. The mitochondrial probe 
MitoTrk-green has been used previously to detect mitochondria in guinea pig 
enteric neurones (Berghe et al., 2004), and LysoTrk-green has been used 
previously to detect Iysosomes in human breast and bladder cancer cells (Adigbli 
et al., 2007). 
In a review by Ball et al. (1999), it was reported that cationic photosensitisers have 
selective affinity for membranes, Iysosomes and mitochondria; tetra substituted 
anionic photosensitisers primarily target Iysosomes; while lipophilic 
photosensitisers such as m-THPC and hyperiCin are known to target cellular 
membranes. This implies that the primary mechanism of cell death using m-THPC-
and hypericin-mediated PDT is to damage membranes. m-THPC has been 
reported to be localised in mitochondria and in Iysosomes and this multiple-
organelle localisation may occur as a result of different uptake mechanisms (e.g. 
simple diffusion through lipid bilayer into the cytoplasm and/or endocytosis into 
intracellular membrane bound transport vesicles). In addition to m-THPC, 
hypericin has also been shown to be localised throughout the cytoplasm of human 
breast and bladder cancer cells after 24 h incubation, with some degree of co-
localisation with Iysosomes (Adigbli et al., 2007). 
4.1.2.2 102/ROS localisation 
102 and ROS are produced at the site of excited 3S in the presence of 302. Cellular 
structures exposed to high concentrations of photosensitisers and oxygen are 
therefore potential targets for PDT damage. In the cellular environment 102 has a 
short lifetime and diffuses a distance of less than 0.1 I-Im, thus limiting oxidative 
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stress and damage to targets closest to the site of its generation (Peng et al., 
1995; 8all et a/., 1999). 
Malondialdehyde and advanced oxidation protein products have been used to 
assess oxidative stress under experimental conditions (Varija et a/., 2009), and a 
derivative 2', 7' Dichlorofluorescin diacetate (H2DCF-DA) (Figure 4.3A) was used 
by LeBel et a/. (1990) as an indicator of oxidative stress induced neurotoxic 
damage in a crude synaptosomal fraction of the brain. This oxidative stress 
detection agent was used in this study as a means of detecting the m-THPC-
mediated PDT generated oxidative stress in neural cells and in tumour cells in 
vitro. 2', 7' Dichlorofluorescin (H2DCF) and similar fluorescent compounds are 
popularly used in the detection and crude quantification of oxidative stress (Rota et 
a/., 1999; Witold and Grzegorz, 2000). It has been used with superior cervical 
ganglia cultures to indicate that oxidants were generated intracellularly following 
cell starvation (Saez et a/., 1987). H2DCF-DA used in this study, penetrates 
plasma membranes and is enzymatically converted into non-fluorescent H2DCF 
and then oxidised into a highly green fluorescent molecule 2'-7'-dichlorofluorescin 
(DCF) in the presence of ROS (Hempel et a/., 1999; Witold and Grzegorz, 2000; 
Mauzeroll et a/., 2004; Nevrelova et a/., 2005; Cao et a/., 2007). DCF green 
fluorescence was used as a marker of 102/ROS in monolayer cell cultures. 
In conjunction with H2DCF-DA, the compound 2-Methyl-1, 4-naphthoquinone 
(Vitamin K3, C11 Hs0 2 or Menadione) (Figure 4.38) was used in this study as a 
positive inducer of DCF fluorescence. Menadione worked by imposing oxidative 
stress, by generation of ROS (e.g. O2"-, H202 and HO") by 1 e- redox cycling at the 
mitochondrial outer membrane (Mauzeroll et a/., 2004; Nicholls and Budd, 2000). 
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Figure 4.3 
Molecular structures of H2DCF-DA and Menadione. 
(A) H2DCF-DA (C24H1SCI20 7) MW 487.29 (8 ) Menadione. (Structures taken from Sigma 
Aldrich) 
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H2DCF-DA was used in this study to determine the intracellular localisation of 102 
and ROS in cells, after exposure to 4 and 10 IJg/ml m-THPC-mediated PDT. In 
particular, H2DCF-DA was used for aid in the detection of m-THPC fluorescence 
within neurites of neurones, which were found in Chapter 3 not to exhibit 
photosensitiser fluorescence despite there being a progressive loss of neurites 
after PDT. 
4.2 Aims and objectives 
The aim of this chapter was to investigate the mechanism for the neurone sparing 
observed with m-THPC mediated PDT in the previous Chapter. The primary 
objectives were: 
i) To determine whether or not DRG neurones were truly surviving m-
THPC-mediated PDT by assessing their PI uptake after a 36 h period 
post PDT and their ability to regenerate neurites. 
ii) To use inhibitors of cellular antioxidant pathways (SOD-1, SOD-2 and 
yGCS) blockers, to elucidate the involvement of these pathways in 
neurone survival after m-THPC-mediated PDT. 
iii) To determine where 102/ROS could be detected in cells, in particular in 
association with neurites of DRG neurones using H2DCF-DA. 
iv) To assess the subcellular localisation of m-THPC and hypericin in 
different cell types (DRG neurones, satellite cells, astrocytes and MCF-7 
cells), using organelle markers and photosensitiser fluorescence. 
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4.3 Results 
4.3.1 Neuronal cell death assessment at different times after 4 J.lg/ml m-
THPC-mediated PDT 
It was important to establish whether the 24 h latency period, post-PDT treatment, 
was appropriate for this study. This was examined by extending incubation time 
post-PDT. 
Co-cultured neurones and satellite cells in thin collagen gels were treated using 4 
jJg/ml m-THPC-mediated PDT or no light control. Treated and control neurones 
and satellite cells were maintained in culture up to 36 h and no change in neuronal 
cell death were observed at different times after PDT. Figure 4.4A and B show the 
time courses of neurone and satellite cell death detection in thin collagen culture 
systems after m-THPC-mediated PDT using the PI exclusion assay. Data were 
compared to the 24 h time point for both 4 !-Ig/ml m-THPC-mediated PDT and the 
no light control. There was no apparent difference in the extent of cell death in 
cultures analysed after these different lengths of time. 36 h post-PDT should have 
been sufficient time for cell death (Le. neuronal cell death) in culture to become 
detectable (Sattler et al., 1997; Leung et al., 2002; Sundquist et al., 2006). 
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Time course of DRG neurone and satellite cell death following 4 IJg/ml m-THPC-
mediated PDT (A) or no light control (8 ). 
Varying latency periods after m-THPC-mediated PDT did not affect levels of neurone or 
satellite cell death. Co-cultured cells in thin collagen gels were exposed to treatment or 
control conditions then left for increasing latency periods before using PI to detect cell 
death, fixing and PIlI-tubulin immunostaining to detect neurones. Data were collected from 
all DRG neurones in each gel , typically up to 50 neurones, and satellite cell data were 
collected from 3 random fields of each of the same gels. Data are presented as means ± 
SEM of 6 separate gels. A one-way AN OVA was used to compare the different time 
pOints, followed by Dunnett's post-test to compare each point to the 24 h time point 
(p>0.05) . 
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In addition to this time course assay, a FragEL ™ assay kit (DAB) was used to 
detect whether any neurones were in an early stage of apoptosis, which is not 
detectable by the PI exclusion assay (Sattler et al., 1997; Leung et al., 2002; 
Sundquist et al., 2006). A gel from the 8 h PDT treated sample from the time 
course assay was counterstained with FragEL ™ and no r3111-tubulin labelled DRG 
neurones were detected as being DAB positive (which would indicate apoptosis). 
This was a limited experiment conducted in a preliminary manner on a single gel 
so no data are shown here, but it provided more evidence that DRG neurones 
were not dying of apoptosis, but rather they were surviving 4 IJg/ml m-THPC-
mediated PDT. Only two satellite cells were detected as positively stained for DAB 
in the whole gel, providing further indication that satellite cells were dying by 
necrosis rather than by apoptosis after 4 I-lg/ml m-THPC-mediated PDT. 
4.3.2 Regenerative capacity of DRG neurones after m-THPC-mediated PDT 
Having established that PDT with 3,4 and 10 I-lg/ml m-THPC resulted in low levels 
of neuronal death in 3D collagen gel culture systems in Chapter 3, the ability of 
'spared' neurones to sprout neurites was investigated. After PDT in collagen gels, 
neurones (along with remaining satellite cells and dead cells) were harvested from 
collagen gels using enzymatic digestion. These cells were mixed with untreated 
satellite cells, and then seeded in monolayer culture systems and maintained in 
culture for 2 days. Figure 4.5 shows new neurite growth from neurones, in fixed 
monolayer cultures, assessed after 2 days. Here, the ability of neurones to adhere 
and regenerate neurites is used as a marker for neurone function. It is clear that 
DRG neurones which had been treated previously with m-THPC-mediated PDT 
were able to adhere and regenerate neurites in monolayer co-culture with these 
non-PDT treated satellite cells. 
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Figure 4.5 
Micrographs of PDT-treated DRG neurones following subsequent co-culture with 
untreated satellite cells. 
Representative micrographs show 13111-tubulin neurite growth from neurones (green) and 
Hoechst 33258 stained nuclei (blue) , in fixed monolayer cultures, post exposure to m-
THPC-mediated PDT. This was following extraction from thin collagen gels and 2 days 
culture with non-PDT treated satellite cells . Images show (A) No light or drug control ; (8 ) 
1 J/cm2 light only control ; (C) 3 ~glml m-THPC-mediated PDT; (0) 4 ~g/ml m-THPC-
mediated PDT; and (E) 1 0 ~g/ml m-THPC-mediated PDT. 
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Figure 4.6 shows the ability of DRG neurones to regenerate neurites following m-
THPC-mediated PDT in collagen gels. These graphs show mean numbers of ~1I1-
tubulin immunoreactive neuronal cell bodies in monolayer cultures per cover-glass 
that showed neurite growth at 2 days after transfer to monolayer co-culture system 
with untreated satellites cells. Similar mean numbers of neurones were detected in 
no light or drug control, light only control, and 3 and 4 !-Ig/ml m-THPC-mediated 
PDT samples. However, there was approximately one-third as many mean 
neurones detected in the 10 !-I9/ml m-THPC-mediated PDT treated samples, as 
there were in other treatment conditions. There were similar mean percentages of 
neurones per cover-glass without neurite growth in all groups (Figure 4.68). 
Overall, it is apparent that all treated DRG neurones, except for the use of 10 
jJ9/ml m-THPC, showed similar % mean neurite re-growth capability, with between 
70 to 78 % of detectable neurones having at least one neurite. Neurones treated 
with 3 and 4 !-Ig/ml m-THPC-mediated PDT showed no difference to untreated 
control or light-only control in their ability to produce neurites. In contrast the DRG 
neurones treated with 10 !-I9/ml m-THPC-mediated PDT showed far fewer 
neurones were present in the cultures. Of these detected neurones only 58 % 
were able to regenerate at least one neurite. 
Further to demonstrating that neurones were capable of regenerating neurites 
following no light or drug control, light only, and 3 and 4 !-Ig/ml m-THPC-mediated 
PDT-treated treatments, Figure 4.7 shows that mean lengths per cover-glass of 
these neurites, in monolayer cultures, were equivalent to those from untreated 
neurones, with only the 10 !-I9/ml m-THPC-mediated PDT-treated neurones 
showing significantly reduced mean neurite outgrowth compared with light only 
control (one-way ANOVA with Dunnett's post test). Mean neurite lengths were 
between 20±4.S to 26 ±6.0 mm. However, 10 !-Ig/ml m-THPC-mediated PDT 
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treated DRG neurones, showed a marked reduction, in detectable neurite length to 
a mean of 3.1±1.3 mm. 
4.3.3 The role of cellular antioxidant pathways in protecting ORG neurones 
from PDT-induced cell death 
In order to determine the mechanism by which co-cultured DRG neurones were 
protected from m-THPC-mediated PDT, inhibitors of yGCS (glutathione synthase 
pathway), SOD-1 and/or SOD-2 were incubated prior to 4 lJg/ml m-THPC 
mediated-PDT. 
4.3.3.1 DRG neurones 
Figure 4.8A shows that inhibiting the glutathione synthase pathway using L-8S0 
or the constitutive SOD-1 pathway using DOC, followed by PDT, both caused 
significant increases in neuronal cell death, in the collagen culture system, 
(p<0.01, one-way ANOVA with Dunnett's multiple comparison post test compared 
with PDT only). However, inhibition of the inducible SOO-2 pathway using 2-
MeOE2 did not show a significant increase in neuronal death at the concentration 
and incubation time used in this study. Control experiments which received 
inhibitors with either drug only (Figure 4.88) or light only (Figure 4.8C) treatments 
showed no significant increase in neuronal death. The use of no drug or light 
(Figure 4.80) treatments showed some significant increases in neuronal death. 
This was the case treating neurones with L-8S0 alone, and on combining L-8S0 
and DOC in controls with no light or drug, approximately 100 % ORG neurone 
death was observed Figure 4.80. 
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DAG neurones (Normalised) 
m-THPC 
_ with neurites 
_ without neurites 
PDT-treated DAG neurones regenerated neurites during subsequent co-culture with 
untreated satellite cells. 
Fixed and ~III -tubulin immunostained (neurones) in monolayer cultures (A) shows the 
number of neuronal cell bodies without or with at least one neurite following 2 days in co-
culture , after m-THPC-mediated PDT and control treatments , and (8) shows the same 
data, normalised to account for variations in the number of neurones analysed, expressed 
as a percentage. A similar number of neuronal cell bodies had neurites associated with 
them in the 3-4 Ilg/ml m-THPC-mediated PDT samples as in the controls. The use of a 
high PDT dose (10 Ilg/ml m-THPC-mediated PDT) shows marked reduction in the mean 
number of detectable OAG neurones. There was also a slight reduction in the ability of 
these ORG neurones to re-grow neurites. Data were collected from all detectable ORG 
neurones on 2 cover-glasses in each case, and presented as means ± SEM of 3 
replicates. 
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DRG neurones 
m-THPC 
Neurite lengths of PDT-treated DRG neurones after subsequent co-culture with 
untreated satellite cells. 
Fixed and ~III-tubulin immunostained (neurones) in monolayer cultures. Graph shows the 
mean neurite lengths per cover-glass from DRG neurones treated with m-THPC-mediated 
and control treatments. The level of neurite regeneration was not reduced post m-THPC-
mediated PDT in comparison to light only control treated DRG neurones. Use of 10 Ilg/ml 
m-THPC-mediated PDT showed a marked reduction in neurite lengths after 2 days post 
PDT. Data were of the mean length of detectable neurites in millimetres, of 2 separate 
cover glasses per treatment condition , and presented as means ± SEM of 3 replicates. 
Significant decrease in neurite length marked as (*) p<O.05 for treatments compared to 
the light only control (one-way ANOVA was used, followed by Dunnett's post-test). 
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DRG neurone death in 3D cultures after 4 tJ9/ml m-THPC mediated-PDT and a 24 h 
latency period following inhibition of antioxidant pathways. 
Fixed and co-cultured with satellite cells in collagen gels (A) neurones survived 4 I-lg/ml m-
THPC-mediated PDT without inhibitor treatment. After inhibition with the glutathione 
synthase pathway inhibitor (L-BSO) and the SOD-1 pathway inhibitor (DOC) , there were 
significant increases in neuronal death with no significant increase in neurone death with 
the SOO-2 inhibitor (2-MeOE2) in comparison to no inhibitor controls. (8 ) 4 I-lg/ml drug 
only (no light) control , (C) 1 J/cm2 light only (no drug) control and (D) no drug or light 
control. After inhibition with a combination of L-BSO and DOC but with no m-THPC or 
light, neurones showed near 100 % death. Data were collected from approximately 50 
neurones per gel and presented as means ± SEM of 6 separate gels. Significant 
increases in cell death are marked as (*) p<0.05, and (**) p<0.01 for treatments compared 
to respective controls without inhibitor (one-way ANOVA with Dunnett's multiple 
comparison post test). 
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4.3.3.2 DRG satellite cells 
Figure 4.9A shows that inhibiting the glutathione synthase pathway using L-BSO 
followed by PDT produced a significant increase in satellite cell death, in the 
collagen culture system, in comparison with PDT only (one-way ANOVA with 
Dunnett's multiple comparison post test, p<O.05). However, using DOC or 2-
MeOE2 followed by PDT did not significantly increase satellite cell death in 
comparison to PDT without inhibitors (Figure 4.9A). In control cultures which 
received inhibitors with either drug only (Figure 4.9B), light only (Figure 4.9C), or 
no drug or light (Figure 4.90) treatments, L-BSO yielded approximately 100 % 
death and DOC yielded approximately 50 % death, whereas 2-MeOE2 had little 
effect. Testing the inhibitors in the absence of drug and light treatments revealed 
that satellite cells exposed to L-BSO or DOC (but not 2-MeOE2) showed large 
increases in cell death in comparison to cells treated with no inhibitor, (Figure 
4.90). On combination of L-BSO and DOC a similar result as with L-BSO only of 
near 100 % cell death was achieved (Figure 4.90). On the use of L-BSO where 
satellite cells were scored as dead due to uptake of PI, a proportion of nuclei had a 
fragmented appearance, possibly indicating apoptosis. 
4.3.4 Detection of 102/ROS after m-THPC-mediated PDT 
m-THPC fluorescence was not detected in neurites in Chapter 3, however it may 
have been present at a level below the detection limit of our microscope. While 
localisation of drug may be useful in understanding the mechanism of subsequent 
PDT-induced cell damage, the location of 102 or ROS generation during PDT 
provides an additional level of information. Therefore, the detection of 102 and 
ROS using H2DCF-DA after m-THPC-mediated PDT was tested here. 
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After loading cells in a monolayer DRG culture system with H2DCF-DA there was 
no green fluorescence (Figure 4.10) in untreated DRG cultures, whereas exposure 
to menadione elicited green fluorescence of DCF which was produced in response 
to elevated ROS levels. 
Exposure of DRG cultures to 4 \-Ig/ml m-THPC-mediated PDT elicited an increase 
in green DCF fluorescence, in monolayer cultures, compared to light only controls 
(Figure 4.11 A and 8). Figure 4.11 C shows higher levels of green DCF 
fluorescence in a few neuronal cell bodies after 10 \-Ig/ml m-THPC-mediated PDT, 
with DCF positive neuronal cell bodies displaying less intense m-THPC red 
fluorescence than their non-DCF positive counterparts. At higher magnification 
DCF green fluorescence was detected within the neuronal cell body and 
accumulated near the plasma membrane (Figure 4.11 D). Figure 4.10E and F 
show no green fluorescence after light only or 4 \-Ig/ml m-THPC-mediated PDT 
without H2DCF-DA incubation. In this experiment, neuronal cell bodies were 
identified morphologically using phase contrast microscopy. In Figure 4.12 the 
monolayer culture has been immunostained for ~III-tubulin to identify neurites and 
shows that after 4 \-Ig/ml m-THPC-mediated PDT, there was some DCF green 
fluorescence within neurites. Note that ~1I1-tubulin immunodetection shares the red 
fluorescence channel with m-THPC in this figure, but the red fluorescence of the 
neurites is morphologically distinguishable from the diffuse drug fluorescence. 
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DRG satellite cell death in 3D cultures after 4 J,.Ig/ml In-THPC mediated-PDT and a 24 
h latency period following inhibition of antioxidant pathways. 
Fixed satellite cells in co-culture with neurones in collagen gels (A) Without inhibitor 
treatment approximately 68 % satellite cells death was observed after 4 IJg/ml m-THPC-
mediated PDT. After inhibition with the glutathione synthase pathway inhibitor (L-BSO) 
there was a significant increase in death to near 100 %, with no significant increase with 
the SOO-1 pathway inhibitor (DOC) or SOD-2 inhibitor (2-MeOE2). (8) Drug only (no light) 
control , (C) 1 J/cm2 light only (no drug) control and (D) No drug or light control. Inhibition 
of intracellular antioxidant pathways in controls resulted in near 100 % satellite cell death 
after L-8S0 and 50 % after DOC treatment, but no cell death was observed in controls 
with MeOE2• Inhibition with a combination of L-BSO and DOC, showed no increase in 
satellite cell death in comparison to L-BSO only (near 100 % cell death). Data were 
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collected from 3 random fields per gel , and presented as means ± SEM of 6 separate 
gels. Significant increases in cell death are marked as (*) p<0.05, and (**) p<0.01 for 
treatments compared to respective controls without inhibitor (one-way ANOV A with 
Dunnett's multiple comparison post test). 
Figure 4.10. 
Micrographs of control samples of H2DCF-DA assay on monolayer DRG culture. 
Green fluorescence of DCF is generated when H2DCF-DA comes into contact with 10 2 or 
ROS. DRG cultures were fixed before Hoechst 33258 stained for nuclei (blue). (A) DCF 
negative control (25 ~M H2DCF-DA incubated for 60 min), and (8 ) DCF positive control 
(after increase in intracellular ROS using 100 IJM menadione incubated for 60 min, 
followed by 25 ~M H2DCF-DA, incubated for 60 min) . Menadione caused increased ROS 
in cells. DCF (green) fluorescence indicates 10 2 or ROS detection in cells. 
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Figure 4.11 
Micrographs of DCF detected in neuronal cell bodies of DRG cultures after In-
THPC-mediated PDT. 
Monolayer DRG cultures were treated with and without 100 !-1M H2DCF-DA for 60 min 
followed by test and control PDT treatments. DRG cultures were fixed before Hoechst 
33258 stained for nuclei (blue) . (A) 1 J/cm2 light only (no drug), (8 ) 4 !-Ig/ml Tn-THPC-
mediated PDT, (C) 10 !-Ig/ml Tn-THPC-mediated PDT, (0 ) Higher magnification of 10 
!-Ig/ml m-THPC-mediated PDT and (E) 1 J/cm2 light only (no drug) without H2DCF-DA and 
(F) 4 !-Ig/ml m-THPC-mediated PDT without H2DCF-DA. In some instances phase contrast 
(PH) images were shown because PH was used to identify neuronal cell bodies. Circles 
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indicate neuronal cell bodies). DCF (green) fluorescence indicates 10 2 or ROS detection 
in cells. 
Figure 4.12. 
Micrographs showing DCF detected in neurites. 
Monolayer DRG cultures were treated with 100 IJM H2DCF-DA for 60 min post m-THPC 
incubation or 4 Ilg/ml m-THPC-mediated PDT. DRG cultures were fixed, immunostained 
for neurone neurites (red) and Hoechst 33258 stained for nuclei (blue). Neurites were 
detected using ~1I1 -tubulinfTRITC , and very little DCF (green) fluorescence was detected 
in neurites (Arrows indicate neurites). (Note neurites are red in this figure due to the use of 
a TRITC conjugated 2° Ab. This change was because a green DCF fluorescence 
detection was being tested for in this experiment) 
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Monolayer cultures of satellite cells (co-cultured with neurones) also showed a 
clear increase in green OCF fluorescence following 4 and 10 ~g/ml m-THPC-
mediated PDT compared to light only controls (Figure 4.13A-C). At higher 
magnification, patchy OCF fluorescence was detected within satellite cells and 
near the cell plasma membrane (Figure 4.130 and E show 2 examples). 
Monolayer cultures of MCF-7 cells showed a clear increase in green OCF 
fluorescence following 4 ~g/ml m-THPC-mediated PDT compared to light only 
controls (Figure 4.14A-B). Figure 4.14C and 0 show no green fluorescence after 
light only or 4 ~g/ml m-THPC-mediated PDT without H2DCF-DA incubation. 
Monolayer cultures of astrocytes showed a clear increase in green OCF 
fluorescence following 4 and 1 0 ~g/ml m-THPC-mediated PDT compared to light 
only controls (Figure 4.1SA-C). Figure 4.1S0-F shows no green fluorescence after 
light only, 4 ~g/ml m-THPC-mediated PDT or 10 ~g/ml m-THPC-mediated PDT 
without H20CF-OA incubation. 
These images have shown that 102/ROS generated by m-THPC-mediated PDT 
could be detected within cells using the H20CF-OA assay. 
4.3.5 Subcellular localisation of LysoTrk or MitoTrk with m-THPC or 
hypericin 
LysoTrk-green probe was used as a marker for Iysosomes. This probe gave some 
signal when used on monolayer cultures of MCF-7 cells in combination with 4 
~g/ml m-THPC incubated for 4 h (Figure 4.16) and with 1.6 ~g/ml hypericin 
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Micrographs of DCF detected in DRG satellite cells after m-THPC-mediated PDT. 
Monolayer DRG cultures were treated with 100 IJM H2DCF-DA for 60 min post 4 h m-
THPC or no drug incubation. DCF fluorescence was detected in satellite cells after 4 and 
10 Ilg/ml m-THPC-mediated PDT. DRG cells were fixed before Hoechst 33258 stained for 
nuclei (blue). (A) 1 J/cm2 light only, (8 ) 4 \-lg/ml m-THPC-mediated PDT, (C) 10 \-lg/ml m-
THPC-mediated PDT, (0 and E) Higher magnification of 10 IJg/ml m-THPC-mediated 
PDT. DCF (green) fluorescence indicates 10 2 or ROS detection in cells. 
Figure 4.14 
Micrographs of DCF detected in MCF-7 cells after m-THPC-mediated PDT. 
Monolayer MCF-7 cells were treated with and without 100 11M H2DCF-DA incubated for 60 
min following 4 h m-THPC or no drug incubation. MCF-7 cells were fixed before Hoechst 
stained 33258 for nuclei (blue). (A) 1 J/cm2 light only (no drug) , (8) 4 I-lg/ml m-THPC-
mediated PDT, (C) light only without H2DCF-DA and (D) 4 I-lg/ml m-THPC-mediated PDT 
without H2DCF-DA. DCF (green) fluorescence was detected in MCF-7 cells. 
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Figure 4.15. 
Micrographs of OCF detected in astrocytes after m-THPC-mediated PDT. 
Monolayer astrocyte cultures were treated with 100 11M H2DCF-DA incubated for 60 min 
post 4 h m-THPC or no drug incubation. Astrocytes were fixed before Hoechst 33258 
stained for nuclei (blue) . (A) 1 J/cm2light only, (8 ) 4 I-Ig/ml m-THPC-mediated PDT, (C) 10 
Ilg/ml m-THPC-mediated PDT, (0 ) 1 J/cm2 (no drug) without H2DCF-DA (E) 4 I-Ig/ml m-
THPC-mediated PDT without H2DCF-DA and (F) 10 I-Ig/ml m-THPC-mediated PDT 
without H2DCF-DA. DCF (green) fluorescence was detected in astrocytes. 
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incubated for 7 h (Figure 4.17). 80th m-THPC and hypericin co-localised with 
LysoTrk-green fluorescence. However, this probe proved to be unreliable in other 
experiments and inconsistent when this experiment was repeated, so its use was 
discontinued for the purposes of this study. 
Composite fluorescence micrographs in Figure 4.18A and 8 show there was no 
green fluorescence emitted by photosensitisers (m-THPC or hypericin), which 
would interfere with organelle tracker green fluorescent signals in monolayer 
cultures of satellite cells (co-cultured with neurones). Composite fluorescence 
micrographs in Figure 4.18C, D, E and F show MitoTrk-green fluorescence 
(mitochondrial staining) on monolayer cultures of DRG neuronal cell bodies 
(identified with phase contrast by their large rounded morphology and their bright 
photosensitiser fluorescence), satellite cells, MCF-7 cells and astrocytes 
respectively. Micrographs also show no red fluorescence was emitted form 
MitoTrk-green, which would interfere with photosensitiser fluorescence signals. 
In DRG neuronal cell bodies (Figure 4.19) m-THPC and MitoTrk-green were 
diffusely distributed and occupied the same areas of the cell suggesting some 
degree of co-localisation, in monolayer culture, although higher magnification 
would be required in order to establish the true extent of this. In monolayer 
cultures of satellite cells (Figure 4.20), MCF-7 cells (Figure 4.21) and astrocytes 
(Figure 2.22), m-THPC was also observed to be generally localised in the 
cytoplasm in areas around the nucleus and away from the periphery of the cells. 
While m-THPC did co-localise to some extent with MitoTrk-green-labelled 
mitochondria, these organelles were not the predominant location of m-THPC 
within the cells (Figure 4.19C, 4.20C, 4.21 C and 4.22C). 
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Figure 4.16 
Micrographs of MCF-7 cells with m-THPC and LysoTrk-green. 
Monolayer cultures of MCF-7 cells were treated with 25 nM LysoTrk-green for 60 min 
following 4 h incubation with 4 !-Ig/ml m-THPC. MCF-7 cells were fixed before Hoechst 
33258 stained for nuclei (blue). (A) m-THPC uptake; (8) LysoTrk-green fluorescence and 
(C) overlay image showing that both m-THPC and LysoTrk occupied the same space 
within the cell. This assay was discontinued due to inconsistencies with LysoTrk-green 
probe. 
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Figure 4.17 
Micrographs of MCF-7cells with hypericin and LysoTrk-green. 
Monolayer cultures of MCF-7 cells were treated with 25 nM LysoTrk-green for 60 min 
following 7 h incubation with 1.6 !-Ig/ml hypericin. MCF-7 cells were fixed before Hoechst 
33258 stained for nuclei (blue). (A) hypericin uptake; (8) LysoTrk-green fluorescence and 
(C) Overlay image showing that both hypericin and LysoTrk occupied the same space 
within the cell. This assay was discontinued due to inconsistencies with LysoTrk-green 
probe. 
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Figure 4.18 
Micrographs of photosensitiser and MitoTrk-green controls. 
Composite micrographs of monolayer cultures of satellite cells treated with (A) 4 Ilg/ml m-
THPC (red) for 4 hand (8 ) with 1.6 IJg/ml hypericin (red) for 7 h, showed no green 
fluorescence. Composite micrographs of 300 nM MitoTrk-green (green) incubated for 30 
min, and Hoechst 33258 stained for nuclei (blue) after fixing (C) DRG neurones, (0) 
satellite cells, (E) MCF-7 cells and (F) astrocytes, showed no red fluorescence. 
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Figure 4.19 
m-THPC co-localisation with MitoTrk-green in DRG neuronal cell bodies. 
Monolayer DRG cultures were incubated with 100 nM MitoTrk-green for 60 min and 4 
Ilg/ml m-THPC for 4 h. Micrographs show (A) MitoTrk-green and (8 ) m-THPC 
fluorescence in combination with Hoechst stained nuclei (blue) after fixing. (C) Shows an 
enlarged overlay image of the red, blue and green channels. 
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Figure 4.20 
m-THPC co-localisation with MitoTrk-green in DRG satellite cells. 
Monolayer DRG cultures were incubated with 100 nM MitoTrk-green for 60 min and 4 
Ilg/ml m-THPC for 4 h. Micrographs show (A) MitoTrk-green and (8) m-THPC 
fluorescence in combination with Hoechst 33258 stained nuclei (blue) after fixing. (C) 
Shows an enlarged overlay image of the red, blue and green channels. 
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Figure 4.21 
m-THPC co-localisation with MitoTrk-green in MCF-7 cells. 
MCF-7 cells were incubated with 100 nM MitoTrk-green for 60 min and 4 Ilg/ml m-THPC 
for 4 h. Micrographs show (A) MitoTrk-green and (8 ) m-THPC fluorescence in 
combination with Hoechst 33258 stained nuclei (blue) after fixing . (C) Shows an enlarged 
overlay image of the red , blue and green channels 
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Figure 4.22 
m-THPC co-localisation with MitoTrk-green in astrocytes. 
Astrocytes were incubated with 300 nM MitoTrk-green for 30 min and 4 Ilg/ml m-THPC for 
4 h. Micrographs show (A) MitoTrk-green and (8) m-THPC fluorescence in combination 
with Hoechst 33258 stained nuclei (blue) after fixing. (C) Shows an enlarged overlay 
image of the red , blue and green channels. 
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In monolayer cultures of ORG neuronal cell bodies (Figure 4.23) hypericin and 
MitoTrk-green were diffusely distributed and occupied the same areas of the cell 
suggesting some degree of co-localisation as was the case for m-THPC, although 
higher magnification would be required in order to establish the true extent of this. 
In monolayer cultures of satellite cells (Figure 4.24) and MCF-7 cells (Figure 4.25), 
hypericin was also observed to be generally localised in the cytoplasm in areas 
around the nucleus and away from the periphery of the cells. Hypericin localised 
with MitoTrk-green-labelied mitochondria but these organelles were not the 
predominate location of hypericin within the cells (Figure 4.23, 4.24 and 4.25). 
4.4 Discussion 
4.4.1 DRG neurone survival after m·THPC·mediated PDT 
The effect of PDT on a cell is dependent on the cell genotype and phenotype (in 
particular prominent intracellular antioxidant pathways), the intracellular 
localisation of the photosensitiser being used, and the specific PDT protocol (Le. 
choice of photosensitiser, its concentration, incubation time, and light energy 
applied) (Almeida. et a/., 2004). In addition, interactions between cells can greatly 
influence their individual responses to PDT treatments (e.g. the interaction 
between ORG neurones and satellite cells). Uzdensky et a/. have studied 
interactions between neurones and satellite cells, and their respective sensitivity to 
PDT with a range of photosensitisers including m-THPC using crayfish nerve 
models (Lobanov and Uzdensky, 2005). However, little is known about the 
mechanisms by which mammalian neural cells respond to PDT treatment and the 
data in Chapter 3 of this thesis are the first demonstration that mammalian DRG 
- 192 -
Chapter 4-Results 
Figure 4.23 
Hypericin co-localisation with MitoTrk-green in DRG neurones. 
Monolayer DRG cultures were incubated with 1.6 I-lg/ml hypericin for 7 hand 100 nM 
MitoTrk-green for 60 min. Micrographs show (A) MitoTrk-green and (8 ) hypericin 
fluorescence in combination with Hoechst 33258 stained nuclei (blue) after fixing. (C) 
Shows an enlarged overlay image of the red, blue and green channels. 
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Figure 4.24 
Hypericin co-localisation with MitoTrk-green in DRG satellite cells. 
Monolayer DRG cultures were incubated with 1.6 j..Jg/ml hypericin for 7 hand 100 nM 
MitoTrk-green for 60 min. Micrographs show (A) MitoTrk-green and (8 ) hypericin 
fluorescence in combination with Hoechst 33258 stained nuclei (blue) after fixing. (C) 
Shows an enlarged overlay image of the red, blue and green channels. (Note that 
hypericin is not localised in the nucleus. There is a layer of hypericin on top of the nucleus 
in this cell .) 
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Figure 4.25 
Hypericin co-localisation with MitoTrk-green in MCF-7 cells. 
MCF-7 cells were incubated with 100 nM Mito Trk-green for 60 min and 1.6 I-lg/ml hypericin 
for 7 h. Micrographs show (A) MitoTrk-green and (8 ) hypericin fluorescence in 
combination with Hoechst stained 33258 nuclei (blue) after fixing. (C) Shows an enlarged 
overlay image of the red , blue and green channels. 
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neurones are relatively insensitive to m-THPC-mediated PDT (Wright et a/., 2009). 
The work described in this Chapter confirmed the survival and regenerative 
capacity of neurones following m-THPC-mediated PDT in culture and started to 
explore the biological mechanisms that might explain the phenomenon. 
It is known that in neurones the site of neuronal degeneration is not a reliable 
indicator of where in the neurone the initial lethal defect occurred (Conforti et a/., 
2007). For example, when peripheral nerves are damaged by severing or crush 
injury, it is the axons (neurites) which are initially damaged and this can result in 
neuronal cell bodies dying (McKay Hart et a/., 2002). 
One potential problem with an investigation of responses to toxic stress in a cell 
population such as that undertaken in Chapter 3, where cell death is assessed at a 
single time point, is that this gives only a 'snapshot' view. This study would be 
incomplete therefore without some understanding of the time course of cell death 
(or survival) in the neural cell populations. Assays using one specific time point 
may underestimate cell death for cells that die by slow non-apoptotic or delayed 
apoptotic processes (Xe et a/., 2001). With this in mind DRG cell survival assays 
were conducted using a range of latency periods. Furthermore, the ability of 
neurones to regenerate neurites after apparently surviving PDT was used as a 
way of confirming neuronal survival. 
Over the range of latency periods used (1 to 36 h post-4 !-Ig/ml m-THPC-mediated 
PDT) there were no significant changes in the levels of neuronal and satellite cell 
death detected by PI exclusion assay. These results supported the observations of 
a necrotic mode of satellite cell death and of DRG neurone survival after 4 !-Ig/ml 
m-THPC-mediated PDT. At an early time point of 8 h a test with FragEL ™ assay 
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(DAB) was performed to identify any cells exhibiting indicators of apoptosis. DRG 
neurones were not undergoing apoptosis, because no Frag EL and ~III-tubulin 
positive cells were detected. Overall, the time course experiments support the 
suggestion that neurones survived this PDT treatment, and their co-cultured 
satellite cells died rapidly (by necrosis) following PDT treatment, with no additional 
delayed cell death up to 36 h. The FragEL ™ assay also supported this suggestion 
with little apoptosis being detected 8 hours post-PDT. 
Neurones that had survived m-THPC-mediated PDT were assessed for functional 
viability with respect to their ability to regenerate neurites. Neurite length has been 
reported to be a useful indicator of the health of neurones (Funk et al., 2007). In 
this study the level of satellite cell death after m-THPC-mediated PDT ranged from 
24±6 to 46±5 % across treatment conditions of 3 to 10 jJg/ml m-THPC-mediated 
PDT (Chapter 3), and resulted in a neurone-enriched culture post PDT. Glial cells 
such as satellite cells are required for the continued survival and neurogenesis 
(neurite growth) of DRG neurones in culture without addition of growth factors 
(Fallon 1985; Delree et al., 1989). Therefore PDT-treated neurones were cultured 
with untreated satellite cell-enriched cultures in monolayer in order to provide an 
optimal environment for viable neurones to regenerate neurites. Under these 
conditions, neurones treated with 3 and 4 jJg/ml m-THPC-mediated PDT were 
shown to retain their ability to re-generate neurites with no Significant difference 
from that of non-PDT treated neurones. This was in contrast to the use of high 
doses of 10 jJg/ml m-THPC-mediated PDT, which caused significant reduction in 
neurone adhesion and neurite regeneration capacity. 
This is an important result, which goes beyond assessing the lack of neuronal cell 
death observed in Chapter 3 and demonstrates that, under the conditions used in 
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this study, DRG neurones are clearly able to survive m-THPC-mediated PDT 
treatments that are sufficient to kill other cell types, and retain their ability to 
regenerate neurites to the same extent as untreated neurones. 
Having confirmed that DRG neurones survived m-THPC-mediated PDT in this 
study, further experiments were undertaken to understand the mechanism by 
which this occurred. It was apparent that inhibiting intracellular antioxidant 
pathways in cells subjected to PDT treatment elicited neuronal cell death, 
suggesting that these antioxidant pathways were involved in protecting the 
neurones from PDT-induced oxidative stress. The antioxidant pathways 
investigated in this study were the glutathione synthase, 800-1 and 500-2 
pathways and the PDT treatment was the ECso dose for killing MCF-7 cells (Le. 4 
~g/ml m-THPC-mediated PDT). 
Results suggested that inhibition of either the SOD-1 pathway or the glutathione 
synthase pathway (specifically yGC8) in neurones was sufficient to render then 
susceptible to 4 ~g/ml m-THPC-mediated PDT. This then caused levels of cell 
death similar to those observed in Chapter 3 for other cell types. However, this 
was not the case with inhibition of 500-2 pathway, after which neurones remained 
resistant to PDT treatment. These results give some insight into the intracellular 
mechanisms that might be important for protecting neurones during m-THPC-
mediated PDT. Nevertheless, these results must be interpreted with some caution. 
While the data from the experiments were robust and appropriate controls were 
included, further work would need to be undertaken to delineate the preCise 
involvement of these pathways in neuronal protection. For example, alternative 
inhibitors could be used to target pathways, and inhibitor dose responses should 
be undertaken; particularly in the case of 500-2 pathway inhibition (2-MeOE2). 
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Without confirming that the inhibitor dose used would have been sufficient to block 
the SOO-2 pathway in these cells, it would be inappropriate to conclude that this 
pathway was not involved in neuronal protection from PDT. 
The glutathione synthase pathway has been previously shown to effectively 
protect neurones from oxidative stress due to both ethanol (Watts et al., 2005), 
and oxidised low-density lipoprotein (Wang et al., 2006). Moreover, SOD 1 and 2 
pathways have also been previously shown to be involved in human umbilical vein 
endothelial cell (HUV-EC), human lung carcinoma cell (A549) and MCF-7 cell 
death responses to Photofrin®-mediated PDT (Saczko et a/. 2008). 
The results in this Chapter are in line with those from other research on neural 
cells using L-BSO to inhibit the glutathione synthase pathway. Depletion of rat 
brain cell GSH levels with L-BSO itself was not toxic to CNS neurones, but 
increased dopaminergic toxicity (McNaught and Jenner, 1999). ORG neurones co-
cultured with satellite cells in this study remained viable in culture following the use 
of L-BSO for 24 h, as well as after incubation with the SOO-1 inhibitor DOC for 1.5 
h in all control conditions. This was in contrast with co-cultured satellite cells, 
which exhibited significant cell death determined by PI uptake in culture under 
control conditions. Microscopic examination revealed nucleus fragmentation in 
satellite cells treated with L-BSO and condensed nuclei in satellite cells treated 
with ~OC, indicating apoptotic cell death in many cells. These results suggested 
that glial cells are more sensitive than DRG neurones to these inhibitors under the 
conditions used in the culture model. Since satellite cells are important for 
neuronal survival, it is important to note that their sensitivity to these inhibitors 
might influence neuronal behaviour, so any effects attributed to the action of the 
inhibitors on neurones must be interpreted careful/y. 
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Mytilineou et al. (1999) and de Bernardo et al. (2004) suggested that neural cell 
death due to L-BSO inhibition of the glutathione synthase antioxidant pathway, in 
the presence of an oxidative stress challenge, is the consequence of events that 
are mediated by glial cells. Gegg et al. (2005) reported that levels of GSH were 
greater in rat neurones in co-culture with glial cells (astrocytes) than for neurones 
cultured alone. In addition, de Bernardo et al. (2004) reported no toxic effect of L-
SSO on rat mesencephalic neurone viability when cultured in isolation in contrast 
to neurones being more sensitive to L-SSO when cultured with glial cells. It was 
noted that glial cell GSH depletion did not cause neuronal death, but potentiated 
the toxicity of oxidative stress from glial cells (astrocytes) (McNaught and Jenner, 
1999). This was similar to the results presented in this chapter, in which L-SSO 
treatment in controls was not toxic to neurones while being highly toxic to glial 
cells (satellite cells). 
Inhibition of the SOD-2 pathway with 2-MeOE2 did not affect the viability of either 
DRG neurones or co-cultured satellite cells in culture under control conditions, or 
the level of cell death in response to 4 \Jg/ml m-THPC-mediated PDT. This implied 
that the SOD-2 cell antioxidant pathway may not be involved in the response of 
these cells to m-THPC-mediated PDT. Alternatively it may imply that the 
concentration of 1.0 \JM 2-MeOE2 incubated for 24 h on these cells was not 
sufficient to inhibit the SOD-2 antioxidant pathway in these cells. 
Previous studies have highlighted a link between the effectiveness of PDT and 
SOD levels with a major role played by inducible SOO-2, rather than SOO-1, in 
cancer cell lines in protecting them from PDT (Johnson and Pardini, 1998). There 
were observed reductions in the cell killing effects of Photofrin®-mediated PDT on 
a bladder cancer (T24) cell line that was transfected with SOD-2 isoenzyme and in 
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C-26 and T24 cell lines pre-treated with permeable SOD mimetics. However, this 
reduction in Photofrin®-mediated PDT killing efficiency was not observed with the 
transfection of SOO-1 isoenzyme in these cells (Gotqb et al., 2003). Oas et al. 
(2000) showed a marked difference between the long-term viability of two human 
cervical epithelial carcinoma cell lines after low levels of Photofrin II®-mediated 
PDT. CaSki cells (defective in induction of SOO-2 gene) were more sensitive to 
PDT treatment than were HeLa cells (where induction of the SOO-2 gene was 
observed). It would be interesting to extend the present study to explore the 
expression levels of the components of antioxidant pathways in neurones to see 
whether there is a link between the relative levels of the various antioxidant 
molecules and the response to inhibitors shown here. 
Combining the yGCS inhibitor and the SOO-1 inhibitor in this study caused 
approximately 100 % neurone death under control conditions. This prevented 
combinations of these inhibitors from being used to explore the relationship 
between the SOO-1 pathway and the glutathione synthase pathway in protecting 
neurones from PDT. Co-cultured satellite cells also died when exposed to this 
combination of VGCS inhibitor and the SOO-1 inhibitor. This study demonstrates 
for the first time the involvement of the glutathione synthase pathway and. the 
SOO-1 pathway in regulating the sensitivity of DRG neurones to m-THPC-
mediated PDT. It will be important to extend this study in the future to understand 
the conditions under which neurones might become sensitive to PDT treatment, 
particularly with a view to predicting how neurones might respond to PDT in vivo. 
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Degradation of neurites occurred after exposure of DRG neurones in 20 and 3D 
co-cultures with satellite cells to m-THPC- and hypericin-mediated PDT (Chapter 3 
and Wright et a/., 2009). Because neurites lacked detectable photosensitiser 
fluorescence, the generation of 102/ROS within these neurite structures was 
assessed. 
In monolayer cultures, small amounts of 102/ROS (DCF fluorescence) were 
detected within neurites after exposure to 4 \-Iglml m-THPC-mediated PDT. 
However, after a higher dose of 10 \-Ig/ml m-THPC-mediated PDT, no neurites 
were available for assessment. This means that the question of whether m-THPC 
localises within neurones to a sufficient level to generate damaging 102/ROS 
remains unanswered. Alternative ROS detection assays or more powerful 
microscopy could be a suitable way of exploring this further in the future. 
Very little 102/ROS was detected in DRG neuronal cell bodies, until the use of a 
high m-THPC-mediated PDT dose of 10 \-Ig/ml m-THPC was administered. At this 
concentration, only a few DRG neuronal cell bodies showed positive DCF 
fluorescence, which indicated 102/ROS accumulation in the cell. Interpreting these 
findings in the light of the antioxidant inhibition data reported above suggests that 
the lack of 102/ROS detection in many DRG neurones after exposure to m-THPC-
mediated PDT might be attributed to the action of intracellular antioxidant 
pathways within neurones. A higher level of antioxidant protection compared to the 
other cells under investigation would reduce 102/ROS and their oxidation products 
in neurones, thus reducing DCF levels. It was also observed that DRG neuronal 
cell bodies, which were positive for 102/ROS accumulation (DCF fluorescence), 
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exhibited reduced m-THPC fluorescence in comparison to DRG neuronal cell 
bodies that did not display DCF fluorescence. The generation of fluorescent OCF 
molecules within the cell, may playa role in quenching m-THPC fluorescence. It 
would be interesting to investigate the relative levels of m-THPC fluorescence and 
DCF fluorescence in neurones exposed to m-THPC-mediated PDT with the 
addition of the antioxidant pathway inhibitors, since this could give further insight 
into whether SOD-1 and GSH are involved in reducing the initial 102/ROS 
accumulation. 
102/ROS was shown to accumulate in the cytoplasm of astrocytes and MCF-7 
cells to a greater extent than in satellite cells and ORG neurones after m-THPC-
mediated PDT. This large amount of 102/ROS detected in astrocyte cultures after 
exposure to m-THPC-mediated PDT, was in line with their high level of sensitivity 
as demonstrated in Chapter 3. 
4.4.3 m-THPC and hypericin photosensitiser subcellular localisation 
Subcellular localisation of photosensitisers was of interest here as a possible 
mechanism by which DRG neurones responded differently to other cells to m-
THPC-mediated PDT. More broadly, little is known about the distribution of m-
THPC and hypericin in mammalian neurones, satellite cells and astrocytes; 
therefore any insight into this area would be of interest. The effects of PDT on 
specific targets may vary with photosensitiser subcellular localisation; therefore 
allowing organelle-dependent phototoxicity (Dabrowski et al., 2006). 
I n order to establish the subcellular localisation of photosensitisers, specific 
organelles need first to be identified. This is commonly done with the use of 
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organelle markers. Crosstalk is a problem that can occur when dealing with 
photosensitiser subcellular localisation in conjunction with fluorescent probes for 
organelle identification. For example, hypericin, when excited with 488 nm light 
emits fluorescence at both 590 nm and also at 660 nm and this dual emission can 
cause a spill-over problem when used with green fluorescence probes such as 
MitoTrk-green or LysoTrk green, possibly resulting in misleading observations 
(Adigbli et al., 2007). Keeping this in mind, this study first established that the 
green fluorescent probes were not detected in the red channel, while 
photosensitiser red fluorescence was not detected in the green channel. 
Several publications have reported m-THPC as having a diffuse cytoplasmic 
pattern of distribution within cells. m-THPC has been detected previously in many 
organelles including intracellular membranes of the ER and the Golgi apparatus 
(Melnikova et al., 1999a; Teiten et al., 2003b; Laville et al., 2003; Marchal et al., 
2007), mitochondrial membranes (Melnikova et al., 1999a; Yow et al., 2000; 
Laville et a/., 2003; Sadauskaite et al., 2004), in a diffuse cytoplasmic pattern 
attributed to lysosomal localisation (8all et al., 1999; Leung et al., 2002; Laville et 
al., 2003), peri-nuclear envelopes (Foster et al., 2005; Kiesslich et al., 2007; 
Lassalle et a/., 2008) and as homologously distributed bright fluorescent spots in 
the plasma membrane (Lassalle et al., 2008). Marchal et al. (2005) also proposed 
that the ER and the Golgi apparatus could be sites from which cell death signals 
originate during m-THPC-mediated PDT and then converge on mitochondria to 
trigger apoptotic processes in a less efficient manner than photosensitisers which 
directly target mitochondria. Hypericin has also been reported as being localised in 
the cell cytosol and to predominantly localise in the nuclear membrane, but like m-
THPC, it does not localise in the nucleus (Dabrowski et al., 2006). 
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From the literature it is difficult to find consensus for organelle-specific localisation 
of m-THPC. In this study m-THPC localisation in DRG neural cells and MCF-7 
cells was observed to be cytoplasmic in nature. However, in some cases a 
punctate distribution pattern, with intense accumulation in the peri-nuclear regions 
of satellite cells was observed. This was in comparison to hypericin, which was 
shown to be more diffusely distributed in the cytoplasm of satellite cells. In this 
study m-THPC and hypericin were found not to be localised within nuclei of neural 
cells or MCF-7 cells. From visual inspection of micrographs, m-THPC was found to 
be partially co-localised with mitochondria in MCF-7 cells, neuronal cell bodies and 
satellite cells. Greater co-localisation of m-THPC with mitochondria in astrocytes 
was observed. In comparison, hypericin showed greater mitochondrial co-
localisation than m-THPC in these cell types. An interesting future study would 
involve using high resolution fluorescence or confocal microscopy to provide 
images which could be quantified accurately, in order to establish whether there 
was any clear difference in the intracellular distribution of m-THPC in neurones 
compared to the other cells types. Also a reduction in the concentration of applied 
photosensitiser or a reduction in incubation time in localisation studies, could also 
aid in determining where in cells photosensitisers accumulated. But, results from 
these studies would have to be interpreted with caution. This is because the 
photosensitiser concentration or inCUbation time used would not be the same as 
during PDT-treatment. In addition, the photosensitiser can aggregate in solution or 
within cells, potentially influencing its localisation in cells. 
In regards to the use of LysoTrk-green for determining photosensitiser localisation 
in cells, this study's parameters were similar to those of Adigbli et a/., 2007. In their 
study they were able to show hypericin co-Iocalising with Iysosomes in MGHU1/R 
cells (50 nM LysoTrk-DND-26 incubated for 30 minutes). In the same study there 
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was also some report of re-Iocalisation of both hypericin and LysoTrk-green after 
illumination. 
As previously stated m-THPC is known to localise predominantly in the ER and 
Golgi apparatus, with some reports of mitochondrial and lysosomal localisation. 
Therefore m-THPC would be predicted to be present in mammalian neurites since 
they contain ER (Goldberg et al., 2003), and many mitochondria (8erghe et al., 
2004). However, this could not be demonstrated in this study, although further 
studies with higher magnification microscopy would be required before concluding 
that photosensitisers were indeed absent from neurites. A further complication 
may arise because only the primary localisation of m-THPC and hypericin were 
investigated here, and light-induced re-Iocalisation has been observed with some 
photosensitisers (Ball et al., 1999). This gives rise to the possibility that the initial 
localisation site of photosensitisers may not be as important as the secondary site 
with regard to cell damage and! or repair (Ball et al., 1999), so further stUdies 
would need to investigate photosensitiser localisation at various times after 
illumination. 
4.5 Conclusions 
In conclusion, this chapter has confirmed that DRG neurones survived m-THPC-
mediated PDT and remained capable of regenerating neurites in co-culture with 
satellite cells. This survival was prevented by inhibitors of the glutathione synthase 
and the SOO-1 antioxidant pathways. These findings suggest the involvement of 
these systems, but not the SOO-2 pathway, in neuronal protection during m-
THPC-mediated PDT. 
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Investigations into the localisation of 102/ROS production within neurones and 
other cells were undertaken, along with an investigation of the intracellular 
localisation of m-THPC. These studies revealed new information about the 
distribution of PDT photosensitisers (m-THPC and hypericin) and 102/ROS in 
cultured neural cells. While there were no conclusive data that would explain 
differences in sensitivity to PDT of neurones to other cells tested in this study, an 
insight was gained into techniques that would permit future studies in order to 
understand the effects of PDT on cells of the nervous system. 
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Chapter 5: Assessment of Neurone Sparing After Focal PDT 
Treatment-Peripheral Nerve Culture System Development 
5.1 Introduction 
Studies presented in previous Chapters revealed information about how adult 
DRG neurones may be spared damage during m-THPC-mediated PDT. These 
findings could potentially inform clinicians seeking to treat cancer within or 
adjacent to the nervous system, but for that to be achieved the phenomenon 
needs to be understood more thoroughly and its utility explored in animal models. 
With these aims in mind there are some key aspects of the DRG neurone sparing 
that could be investigated using more advanced cell culture models than those 
developed to date. 
In particular, the results presented in previous chapters involved exposing the 
entire DRG culture to PDT treatments. However, in the nervous system, neurites 
frequently extend long distances from their cell bodies. During PDT exposure of 
peripheral nerves, often only neurites are illuminated at the focal treatment site, 
because the neuronal cell bodies are situated quite some distance away. A 
fundamental question which will influence the future direction of this study, is how 
neuronal survival and function would be affected by focal application of PDT, to 
different parts of the neurone (Le. the neuronal cell body or at various distances 
away along the length of a neurite). Therefore, in this chapter the results of a 
series of pilot experiments are presented on the development of model peripheral 
nerve culture systems in which PDT could be directed towards specific parts of 
neurones. 
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5.1.1 Dissected peripheral nerve tissue culture systems 
One basic approach to exploring the effects of PDT on the different parts of a 
peripheral nerve in vitro is to explant a fresh nerve from an animal and maintain it 
in culture (ex. vivo), therefore preserving the architecture and arrangement of the 
tissue. In this way, it would be possible to direct PDT treatment towards the region 
of the dissected nerve containing neuronal cell bodies (in the ORG) or neurites (in 
the nerve trunk). Ex vivo models can be maintained in culture as free-floating 
tissues or embedded in substrates such as collagen hydrogels. Dissected sciatic 
nerves with attached DRGs are one potential nerve model that has been used 
previously (Svensson et al., 1995; Edstrom et al., 1996; Tonge et al., 1997). These 
dissected nerves can be removed from rats pre-injected with m-THPC or removed 
from non-injected rats and subsequently incubated in m-THPC solutions. 
Dissected DRGs have been used previously to assess neurone-glial cell 
interactions (Shi et a/., 1998), and have been maintained in semi-solid culture 
medium (with similar properties to hydrogels) which is known to preserve the 
internal organisation of the tissue so it resembles the in vivo situation (Mandys et 
al., 1998; Golz et a/., 2006). Even though the use of intact nerve tissue may seem 
the best model for evaluating the effect of m-THPC-mediated PDT on the nerve, 
the use of dissociated cells in tissue engineered models has the advantage of 
providing a more controlled environment to assess specific nerve cell responses. 
5.1.2 Cellular environment for 20 and 3D peripheral nerve culture systems 
The required parameters for a peripheral nerve culture system for use in PDT are 
that it reflects the cellular composition of the endogenous nerve tissue; it is 
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reproducible and controllable; and it is accessible to treatment with PDT (Le. 
photosensitiser and focal light exposures). The nerve trunk contains various cells 
including sensory and/or motor neurones, Schwann cells and nerve fibroblasts. 
The extracellular environment of the nerve trunk is a vascularised dense and 
aligned collagen-rich endoneurium surrounded by a perineurium, which is a barrier 
to fluid movement, and an outer collagenous epineurium. An overview of the 
cellular structure of the mammalian nervous system has been provided in Chapter 
1. 
5.1.2.1 Requirements for peripheral nerve culture systems 
A successful culture system would therefore require aligned extended growth of 
neurites many millimetres from neuronal cell bodies (to facilitate targeted PDT-
illumination towards distinct parts of neurones), and a clearly defined neuronal 
population, supported through interactions with the appropriate glial cells 
(Schwann cells andl or satellite cell). A 3D environment rich in collagen would also 
be beneficial, although such a system would need to be of much lower cell density 
than an in vivo nerve since it would lack the perfusion supplied by the vasculature. 
The ability to perform cell viability assays and relevant cell type identification using 
immunohistochemistry (dissected nerves) and immunocytochemistry (2D or 3D 
culture systems) would also be valuable properties. 
Neurones, glial cells and fibroblasts are significant cellular elements of nerve 
tissue. Inclusion of fibroblasts in nerve culture models is important because 
fibroblasts have been reported to contribute to glial cell (Schwann cell) alignment 
in culture (Dubuisson et al., 1999). As presented in Chapter 1, neurones are 
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dependent on supporting glial cells (e.g. Schwann cells and satellite cells) 
(Nascimento et al., 2008). 
Controlling cellular orientation and proliferation is useful in the modelling of cellular 
interactions. Schwann cells in the PNS are known to provide both trophic support 
and guidance for neurite growth; therefore by controlling glial cell orientation in 
monolayer cultures or in a 3D matrix, neurite elongation can be guided 
(Schmalenberg and Uhrich, 2005; Thompson and Buettner, 2006). In addition to 
extracellular signalling molecules from glial cells, extracellular matrix guidance 
molecules (slit2, and laminin and the related molecule netrin-1) can also induce 
neurite elongation (Goldberg, 2003). Goldberg (2003) also reported adult DRG 
neurite growth in vitro to be initially highly branched but then to revert to a rapid 
elongating and minimal branching mode. This change to an elongated mode both 
in vivo and in vitro resulted in a 2 fold increase in rate of neurite growth from -0.5 
t01.0 mm per day. This means that a good culture model system should be able to 
generate sufficient neurite length within a few days in culture in order to facilitate 
focal PDT application. In general ORG neurones are also known to form no more 
than 2 or 3 neurites in vitro, making it suitable for quantitative research (St~pien et 
al., 1999) and for the assessment of any change in neurite branching after PDT. 
It is important to note that in the peripheral nerve trunk, there are both sensory and 
motor neurones. In previous chapters of this study and for this chapter on 
peripheral nerve model development, motor neurones were excluded. This 
exclusion of motor neurones was because their neurites were severed from their 
neuronal cell bodies on explantation of ORGs. Therefore the response of motor 
neurone cell bodies and their neurites to the effects of PDT treatments were not 
assessed. 
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5.1.2.2 Existing peripheral nerve culture systems 
Nerve models that are presently being used, which could be adapted for use in 
this focal POT treatment assay include 20 and 3D nerve culture models. Several 
different 20 models have been used that facilitated aligned neurite growth, these 
included but are not limited to scratched glass surfaces (St~pien et al., 1999) or 
micropatterned grooves (Goldner et al., 2005), where lines were etched into 
culture surfaces before neurones were cultured and neurites then followed these 
etchings. The use of micropatterned substrates, where proteins are deposited on 
culture surfaces before neurones are plated has been shown to result in neurites 
being able to follow drawn patterns (Schmalenberg and Uhrich, 2005; Turcu et al., 
2003; Gustavsson et al., 2007). Cells have been used as neurone culture 
substrates (e.g. fibroblasts and glial cells), and when neurones are then seeded on 
top of cell substrates, neurites follow patterns of these cell substrates (Fallon, 
1985; St~pien et al., 1999; Thompson and Buettner, 2006). These techniques can 
also be used in combination to produce improved neurite alignment; for instance 
the use of a combination of micropatterned grooves and chemical substrates 
(Zhang et al., 2006). Further to this, the use of bioresorbable glass fibres 
(Bioglass®) in combination with glial cell substrates (with the ability to align in 
chains along glass fibres) have been used to promote aligned neurite growth 
(Bunting et a/., 2005). 
However, some patterned surfaces would not be suitable for use in PDT as these 
surfaces would cause refraction of light beams and thereby limit energy application 
to treatment sites. Alternative techniques to the production of etched surfaces and 
aligned substrates include the development of stretch-grown neurite models which 
consist of dissociated ORG neurones seeded at the junction of 2 adjoining plates 
- 212 -
Chapter 5-Results 
which are regularly pulled further apart over time, resulting in neuronal cell bodies 
localised at the end of the plates with aligned neurites growing across plates 
(Pfister et a/., 2006). A 2D culture system would be the simplest approach for use 
in these experiments, as long as it can be made so that neuronal cell bodies 
remain in one place while neurites grow out away from the neuronal cell bodies. 
3D culture systems are more complex to develop than 2D culture systems, but 
they may be more appropriate for some studies. The ability to organise cells in a 
3D environment is an important component of tissue engineering (Bellamkonda et 
a/., 1995), which requires the use of scaffolds (Bellamkonda, 2006). Hydrogels 
have been particularly attractive scaffolds for use in 3D cell culture because they 
are highly porous with a hydrated structure in which cells can assemble into tissue 
architectures (O'Connor et a/., 2000). 
3D tissue engineered peripheral nerve culture systems presently being used 
include but are not limited to the use of magnetically aligned collagen fibrils in 4 
mm diameter rods forming nerve culture systems, which incorporate collagen gel, 
glial cells and chick embryo DRG tissue such that neurites grow following aligned 
collagen fibrils (Dubey et a/., 1999). Also a 3D cell-seeded tethered collagen 
culture system exists, which incorporates collagen gels, glial cells, fibroblasts, and 
DRG tissue and contraction within the tethered collagen gel causes alignment of 
glial cells and neurite growth (Eastwood et a/., 1994; Eastwood et a/., 1998; 
Dubuisson et a/., 1999; Phillips et a/., 2005). In comparison to ex vivo nerve 
models, these types of tissue engineered culture systems would provide more 
controlled environments in which to perform focally applied m-THPC-mediated 
PDT experiments. 
- 213 -
Chapter 5-Results 
For this study, Type-I collagen was chosen as a suitable 3D substrate, because it 
is a natural polymer that is amenable to use in culture systems and is the major 
ECM component of peripheral nerves. Collagen hydrogels have relatively large 
pore sizes of S 2 ~m, they can support cell attachment, and the gelation process is 
simple; therefore it is extensively used in cell transplantation and tissue 
engineering applications (O'Connor et al., 2000). Collagen gels provide a 
reconstituted network of highly entangled collagen fibrils of 50-500 nm in diameter, 
which is 99-99.9 % interstitial liquid, dependent on collagen source and 
reconstitution method (Dubey et al., 1999). Type I collagen is found in the form of 
fibrils with diameters of about 30 to 300 nm, and is the major structural component 
of skin, tendon, bone and other connective tissues (Williams et a/., 1978). 
In this study 3D tethered cell-seeded collagen gels (Eastwood et a/., 1994; 
Eastwood et al., 1998; Phillips et al., 2005) were used in the development of a 
more advanced peripheral nerve culture system than the thin 3D cell-seeded 
culture system used in previous chapters. Cells within collagen gels are known to 
form stable integrin-mediated attachments with collagen fibrils. This is known to 
trigger cytoskeletal assembly, cell movement and subsequent force generation, 
which results in the contraction of collagen gels. When collagen gels are tethered 
at opposite ends of rectangular gels, forces generate a uniaxial strain on the gel 
along which cells and collagen fibrils become aligned (Eastwood et a/., 1994; 
Eastwood et al., 1998). However, Schwann cells entrapped in collagen gels will 
revert to their undifferentiated phenotype with features of spherical morphology, 
delayed spreading, long-axis alignment response and no NGF production (Rosner 
et al., 2005; East & Phillips 2008). 
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This study adapted and developed both a 20 glial cell substrate nerve culture 
system and a 3D cell-seeded tethered aligned collagen system for use in 
evaluating the effects of targeted m-THPC-mediated PDT to ORG neurones. 
5.2 Aims and desired properties 
The aim of the study presented in this final results chapter was to simulate nerve 
PDT wounding in ex vivo nerve tissue and advanced cell culture models to assess 
the effects of PDT directed towards distinct parts of neurones. The key properties 
desired for such a nerve model to be used in focally applied PDT are: 
i) To be reproducible and able to be kept under controlled environments. 
ii) To contain relevant nerve cells as found in endogenous nerve tissue 
iii) To support robust neurite growth, away from the neuronal cell body. 
iv) To maintain cell viability throughout the treatment period 
v) To enable specific application of focal PDT to different parts of the 
neurone (cell body and/or different distances along neurites) and 
subsequent detection of damage. 
5.3 Results 
5.3.1 Effects of focally applied m-THPC-mediated PDT on dissected nerves 
In this study m-THPC-mediated PDT was applied to dissected nerve tissues, 
which were then maintained in culture for 2 days before assessing for m-THPC 
uptake and signs of PDT damage. The dissected sciatic nerve tissue complete 
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with ORGs was similar to that used by Tonge et al. (1997). Rats were injected with 
0.3 mg/kg m-THPC, similar to Coutier et al. (2002) who had used this 
concentration to assess m-THPC-mediated PDT on HT29 xenografted nude mice; 
and Obwegeser et al. (1998) who used 14C_ labelled-m-THPC in C6 rat glioma 
brain tumour models for uptake and retention studies. 
Figure 5.1A shows an illustration of the application of focally applied m-THPC-
mediated PDT to the nerve trunk of a rat sciatic nerve dissected 24 h after pre-
injecting with m-THPC (m-THPC administered in vivo), to a concentration of 0.3 
mg/kg or vehicle injection. These nerves were collected as a by-product of another 
experiment and so the drug dose administered was based on the requirements of 
the intended study. Crucially, no detectable m-THPC red drug fluorescence was 
detected in nerve tissue under any of the treatment conditions used in this assay 
(Figure 5.2). There was no obvious tissue degradation in any of the assessed 
nerve tissue. Also, the 652 nm laser light treatment did not elicit morphological 
changes in the nerve tissue on its own, nor in combination with intravenous (Lv.) 
injection of m-THPC photosensitiser. These experiments were performed once for 
treatment parameter 10 J/cm2 of 652 nm focal laser light only, and 0.3 mg/kg m-
THPC Lv. injection only, while m-THPC-mediated PDT wounded region (-5.0 mm 
diameter spot), two sciatic nerves from different rats were tested. 
An alternative approach to using nerve explants from animals that had been 
injected with m-THPC, was to incubate isolated nerve preparations with m-THPC 
in culture. Figure 5.1 B shows focal m-THPC-mediated PDT being applied to a 
nerve explant in a sterile environment using light from a laser directed along an 
optical fibre light guide. m-THPC fluorescence was only detected up to 2.1 mm 
from the distal cut end of nerve explants, which had been removed from the rat 
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Oiomed clinical laser 
PDT treated area of sciatic nerve 
Figure 5.1 
Illustration and image of dissected sciatic nerve being exposed to focally applied 
m-THPC-mediated PDT. 
Light was delivered using a fibre optic lead under subdued lighting. (A) An -5 mm 
diameter PDT treatment area (red) was created -2.5 cm from the DRGs (green) using 652 
nm for in vivo administered nr THPC experiments, and (8 ) 633 nm beam applied to 
dissected nerve incubated in m-THPC for in vitro experiments. 
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Figure 5.2 
Sciatic nerve explants used to assess focal PDT wounding of nerve tissue 24 h after 
t reatment. 
Micrographs are of representative fixed cryosections from segments of sciatic nerves -2.5 
cm from the DRG and - 1 .5 cm from the distal cut end. (A) 10 J/cm2 of 652 nm focal laser 
light only, one nerve was tested; (8 ) 0.3 mg/kg m-THPC i.v. injection only, one nerve was 
tested; and (C) m-THPC-mediated PDT wounded region (-5.0 mm diameter spot made), 
two nerves were tested. No m-THPC fluorescence was detected in nerve tissue under 
these experimental conditions, and no obvious nerve tissue damage was detected. 
Neurofilament (NF) immunostained neurites (green), Hoechst 33258 stained nuclei (blue) 
and fluorescence of m-THPC photosensitiser (red). 
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then incubated for 24 h in 4 IJg/ml m-THPC (Figure 5.3). This 24 h incubation time 
was a longer incubation time in comparison to the 4 h used for dissociated cell 
culture experiments. No m-THPC red fluorescence was detected in the DRG or 
the proximal part of the incubated explants. m-THPC fluorescence co-localised 
(orange) with S-100 positive glial cells (Figure 5.3A), but not with NF positive 
neurones (Figure 5.3C). Also, no obvious tissue degradation was observed in 
relation to focal m-THPC-mediated PDT treatment. Figures 5.38 and Care 
composite images of the uptake of m-THPC and Hoechst 33258 staining. 8ecause 
of the lack of consistent m-THPC uptake into these nerve explants, this approach 
was deemed inappropriate for studying focal PDT 
This pilot study was conducted to assess whether damage in nerve explants could 
be quantified by immunolabelling for NF (to reveal neurite loss) or S100 (to reveal 
Schwann cell loss). This proved to be a promising approach; however it was not 
applied because the use of nerve explants was discontinued. 
5.3.2 20 glial cell substrate nerve culture system 
A number of monolayer culture approaches were tested in order to establish a 
nerve culture system in which neuronal cell bodies are retained at DRG seeding 
sites and neurites grow away from these neuronal cell bodies. Simply seeding 
dissociated DRG neurones and satellite cells onto PLL and lor laminin coated or 
patterned cover glasses, resulted in neuronal cell bodies migrating with satellite 
cells away from the site of seeding. Neurites were also found to grow mainly 
around the neuronal cell body itself as illustrated in Figure 5.4A. A solution to this 
problem is shown in Figure 5.48 which illustrates a glial cell substrate nerve 
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(A) (8) (C) (Proximal end) (D) 
Figure 5.3 
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Micrograph montage of m·THPC uptake into nerve explant after 24 h Incubation In 
solution. 
Micrographs are of representative fixed cryosections from a dissected DRG with attached 
distal nerve trunk. m-THPC was present in the distal parts of the nerve but no m-THPC 
fluorescence was detected in the DRG or proximal parts of the nerve. Composite 
micrographs showing (A) m-THPC fluorescence (red) and glial cells labelled with anti-S-
100 (green); (8, D) Hoechst 33258 stained (nuclei); (C) neurones labelled with anti-NF 
(green). Co-localisation (orange) between m-THPC fluorescence and 5-100 
immunostaining was observed, but not between m-THPC fluorescence and NF 
immunostaining. 
culture system, in which neurones were seeded on top of a confluent monolayer of 
glial cells. Neurites in this culture system grew away from neuronal cell bodies as 
shown in Figure 5.5 which shows dissociated DRG neurones growing on top of 
monolayers of Schwann cell/fibroblast cultures. Neuronal cell bodies were found to 
remain at the site of seeding and neurites extended away from the neuronal cell 
bodies. However, neurites were found to grow in an uneven manner. Figure 5.6 
shows dissociated DRG neurones growing on top of monolayer satellite cell-
enriched cultures. Here neuronal cell bodies also remained at the seeding sites, 
but neurites extended in a more even manner. 
Figure 5.7 shows attempts at creating focal PDT wounds (between 8 or C 
positions of figure 5.6), in these monolayer nerve culture systems. There is a 
possibility of detecting both 4 l-Ig/ml m-THPC- and 1.6 \-Ig/ml hypericin-mediated 
PDT wounds using the PI exclusion assay. Figure 5.78 shows the difference 
between PDT treated and non-PDT treated regions. 80th PDT treatments showed 
extensive cell loss at the treatment sites. 
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20 ~g/ml PLL coated 
glass surface 
CII;§~[:t: Satellite cells 
Illustration comparing two culture systems. 
(A) Without glial cell monolayer (substrate) and (8 ) with glial cell substrate. 
Figure 5.5 
Fluorescence micrograph of DRG neurones growing on Schwann cell If ibroblast 
culture monolayer. 
Shows uneven neurite growth on Schwann cell/fibroblast substrate in monolayer cultures 
after 7 days. Cells were PI stained then fixed and immunostained with 13111-tubulin. 13111-
tubulin labelled neurones (green), PI stained dead cell nuclei (red) and Hoechst 33258 
stained nuclei (blue). (Arrows indicate neurite growth and (*) indicate neuronal cell bodies) 
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D 
An Illustration and fluorescence micrographs of DRG neurones growing on satellite 
cell culture substrate in monolayer. 
Neurites grew evenly across satellite cells in monolayer cultures away from neuronal cell 
bodies after 7 days in culture . Cells were PI stained then fixed and immunostained with 
r3111-tubulin . Illustration indicates approximate positioning of micrograph images shown. 
r3111-tubulin labelled neurones (green), PI stained dead cell nuclei (red) and Hoechst 33258 
stained nuclei (blue) . 
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5.3.3 3D collagen tissue engineered peripheral nerve culture system 
Initial experiments showed that when DRG explants were cultured in the collagen 
gels, neurite outgrowth tended not to extend out of the tissue into the surrounding 
matrix, but rather stayed within the nerve tissue environment (Figure 5.8). 
In order to provide guidance cues to encourage neuronal growth out of the explant 
and into the surrounding collagen matrix, an approach was used in which collagen 
gels can be seeded with Schwann cells and fibroblasts which contract and align 
the collagen. Co-cultures of glial cells and nerve fibroblasts were seeded into 
collagen gels at various densities and assessed for their ability to cause collagen 
gel contraction. Figure 5.9A shows the ability to distinguish Schwann cells from 
fibroblasts in monolayer culture samples by their bright S-100 immunoreactivity. 
Figure 5.98 shows that the use of 300 000 cells/ml of collagen or above was 
required to cause gel contraction within 24 to 48 h of preparation. This was 
denoted by smaller gel sizes (cross-sectional areas calculated from the radius of 
each gel) at corresponding time pOints. This relatively quick contraction was 
required to reduce the time this culture system would take before being ready for 
use. 
Using 3D tethered collagen nerve culture systems (Figure 5.10), the extent of 
collagen gel contraction was assessed in relation to the ratio of Schwann cells to 
fibroblasts (Table 5.1). These results indicated that gel contraction was 
independent of percentage fibroblast content since Schwann cell to fibroblast ratio 
was found to vary greatly across culture preparations, and ranged from 14 % to 89 
% Schwann cell (S-100 positive) content. This large variation maybe attributed to 
cell cultures being preparation from different rat sciatic nerves. Table 5.1 also 
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Figure 5.7 
PDT wounding in monolayer nerve culture systems. 
(A) Wound made by focally applied m-THPC-mediated PDT and (8 ) wound made by 
focally applied hypericin-mediated PDT. f3111-tubulin labelled neurones (green), PI stained 
dead cell (red) and Hoechst 33258 stained nuclei (blue). 
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Figure 5.8 
No neurite growth from ORG explant into collagen gel matrix. 
Micrographs are of whole tissue pieces encased in collagen gel matrix, fixed and 
immunostained. (A) 13111-tubulin immunostained neirites (green), (8) S-100 immunostained 
Schwann cells (red), (C) Overlay micrograph of neurones and Schwann cells, with 
Hoechst 33258 stained nuclei (blue) (0 ). PH micrograph of nerve tissue (E). No 
immunostained structures were detected in the collagen gel matrix outside the nerve 
tissue. 
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Rate of contraction of Schwann celV fibroblast seeded untethered collagen gels. 
Graph shows the rate of collagen gel contraction as measured from a reduction in area of 
gels containing zero; 3 x 103 ; 2 x 104 and 3 x 105 Schwann cells/fibroblasts. (A) Shows 
sciatic nerve culture immunostained with anti-S-100 to distinguish Schwann cells from 
fibroblasts, and Hoechst nuclei. (8 ) Graph of gel contraction over time at various cell 
seeding densities and (C) Photographs of contracting gels at different time points. Data 
are presented as mean ± SEM of 3 separate gels per cell seeding density. Images show 
respective gel contraction over time. (Arrows indicate S-100 positive Schwann cells and 
broken line indicates diameter measurement taken per gel over time for use in calculating 
gel contraction rate) . 
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shows that a seeding density of approximately 1 million cells and above per 2.5 ml 
collagen gel mix (400 000 cells/ml) would result in gel contraction within 24 to 48 
h. This supports the previous finding that 300 000 cells/ml and above (Figure 5.98) 
will result in required gel contraction. 
In order to standardise the ratio of glial cells to fibroblasts, an alternative source of 
peripheral nerve glial cells, i.e. satellite cells (-100% 5-100 positive) from DRGs, 
were prepared and seeded into tethered collagen gels. However, these 3D 
tethered satellite cell seeded-collagen gels did not contract without the inclusion of 
-5 % nerve fibroblasts. The use of satellite cell-enriched cultures yielded glial cell 
and neurite outgrowth from DRG explants embedded within the contracted gels 
(Figure 5.11A). Subsequent to this, Figure 5.118 shows neurite growth from 
dissociated DRG neurones after implantation into satellite cell-seeded tethered 
collagen gels. The use of dissociated DRG neurones was preferred as it would 
reduce the effect of variability between explants, and enable neurone viability to be 
assessed in future studies, features not provided with the use of whole DRG 
tissue. 
In addition to neurites being extended in this nerve culture system, Figure 5.12 
shows that satellite cells were able to myelinate DRG neurites during extended 
periods in culture. 
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Figure 5.10 
Schwann cell/fibroblast-seeded tethered collagen nerve culture system. 
Schwann cell/fibroblast seeded collagen gels were allowed to set and contract as shown. 
(A) Tethered gel in mould shows site of DRG implantation and location of triangular stress 
shielded regions (delta zones) . (8) Schematic of gel contraction after 12 h and (C) after 24 
h are illustrated. Tethered rectangular 3D gel contractions are listed in table 5.1 with cell 
densities greater than 400 000 cells/ml required for gel contraction within 24 h. 
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Total cell count in 2.5 ml Cells per ml % Schwann cells Effect 
296,250 118,500 26 No contraction 
448,750 179,500 34 No contr etion 
1,016,250 406,500 19 Contraction 
1,103,125 441,250 14 Contr ction 
1,185,625 474,250 21 Contr ction 
1,564,375 625,750 49 Contraction 
1,783,750 713,500 89 Contraction 
Table 5.1 
Collagen gel contraction scored at 24 h using a range of seeding densities and 
proportions of Schwann cells. 
Cell seeding density rather than ratio of Schwann cell to fibroblast content is shown to 
determine collagen gel contraction in tethered collagen gels. Percentage Schwann cells 
were obtained for 3 random fields of n=3 cover-glasses form 7 different cultures. Total cell 
counts are expressed in 2.5 ml based on the volume of collagen gels used per nylon 
mould, and also in cells per ml of collagen gel mixture. 
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Figure 5.11 
3D tethered collagen gels seeded with satellite cell cultures support neurite 
outgrowth. 
Micrographs are of fixed and f3111-tubulin immunostained cells in collagen gels. A(iii) 
shows f3111-tubulin immunostained neurite growth (green) from implanted DRG tissue into 
gel ; and 8(iii) shows neurite growth from a neuronal cell body into gel. Cells were also 
stained with Hoechst 33258 nuclei stain (blue) . (Arrows indicate neurite growth after -10 
days in culture) . 
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Figure 5.13 shows a pilot study of m-THPC-mediated PDT wounding of a satellite 
cell-seeded collagen gel with the aid of a fibre optic lead. Fluorescence 
micrographs show a localised wound marked with dead cell (red nuclei PI 
staining). Non-nuclei red staining is as a result of m-THPC being localised in the 
cell cytoplasm. 
5.3.4 Live neurite growth tracking 
Having established appropriate conditions for neurite growth in the aligned 3D 
collagen gel culture system, the ability to track the growth of neurites was 
investigated. This would be a useful monitoring feature which would allow light for 
PDT to be targeted to specific segments of neurites as they extended through the 
gel. A number of fluorescent cell tracker (CeIlTrk) dyes are commercially available 
for use in labelling and fluorescently tracking live cells. One such CellTrk tested 
was CeIlTrk-red. 
Figure 5.14 shows a dissociated DRG culture in monolayer. DRG neurones were 
labelled with CellTrk-red while the neurones were alive. ~III-tubulin 
immunostaining and Hoechst 33258 staining were performed after fixation in order 
to assess co-localisation (orange) of markers. CellTrk-red fluorescence was 
detected in all cell types, but was not clearly detectable in neurites of DRG 
neurones. 
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Figure 5.13 
m-THPC-mediated PDT wounding of a satellite cell-seeded tethered 3D collagen gel. 
Fluorescent micrograph shows a section of a satellite cell seeded collagen gel culture 
stained for dead cells with PI nuclei stain (red), fixed and then Hoechst 33258 nuclei 
stained (blue) , 24 h after exposure to focally applied 4 ~g/ml m-THPC-mediated PDT 
using 1 J/cm2 of 633 nm red laser beam. (Note that non-nucleic red staining is associated 
with m-THPC being localised in the cell cytoplasm) 
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Figure 5.14 
CellTrk-red did not label neurites of unfixed neurones sufficiently for tracking. 
CellTrk-red labelled glial cells and neuronal cell bodies (red), but was not clearly detected 
in neurites after fixing and immunostaining with 13111-tubulin for neurones and their 
associated neurites (green) , and Hoechst 33258 nuclei stain (blue). (Arrows indicated 
position of neurite) 
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5.4 Discussion 
The work in this chapter was aimed at developing a suitable culture system to 
mimic the key physiological features of peripheral nerves in a controllable 
environment that would permit focal PDT treatments and subsequent monitoring of 
their effects on neurones. 
Nerve explants from rats after Lv. injection with m-THPC, or explants from 
untreated animals which were subsequently incubated in m-THPC solution were 
investigated. Explants were initially considered to be useful models for this 
investigation because they possessed the natural tissue architecture of the 
peripheral nerves along with the appropriate arrangement and proportions of 
neurones and glial cells which had not been subjected to disruptive enzymatic 
dissociation. 
5.4.1 Nerve tissue explant culture systems 
The dissected sciatic nerve tissue complete with ORGs was similar to that used by 
Tonge et al. (1997), and 0.3 mg/kg m-THPC tested was similar to Coutier et al. 
(2002) and Obwegeser et al. (1998). It is important to note that the m-THPC dose 
administered to rats was lower than the 4 IJg/ml dose used for the cell culture 
studies. This inconsistency was beyond our control, because these nerve tissues 
were sourced from animals in someone else's experiment. No detectable m-THPC 
fluorescence was observed in cryosections of sciatic nerve from these animals 
(Figure 5.2), however, tissue biopsies (blood, muscle, skin, lung, colon, kidney and 
liver) from the same group of rats (24 h post-injection of 0.3 mg/kg m-THPC) were 
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analysed for the presence of m-THPC using chemical extraction (Kascakova et al., 
2008). These experiments revealed the presence of m-THPC in these tissues 
(unpublished work by Dr Josephine Woodhams, National Medical Laser Centre, 
UCL). This method of chemical extraction is a more sensitive approach to 
assessing low levels of m-THPC in tissues and will be used with nerve tissue 
samples in the future to establish the amount of m-THPC localised within nerves 
which may have been below the limit of detection using fluorescence microscopy 
in this case (Peng et al., 1995). Commonly in human treatments, a photosensitiser 
dose of 0.15 mg/Kg m-THPC is Lv. injected with a drug-light interval of 4 days 
(Zimmermann et al., 2001; Lou et al., 2004; Lovat et al., 2005; Moore et al., 2006; 
8etz et al., 2007). Human studies have shown the presence of m-THPC in the 
brain under these conditions (Zimmermann et al., 2001), however, peripheral 
nerves have not been assessed for the presence of m-THPC. To our knowledge, 
the present study reports for the first time an investigation into the uptake of m-
THPC in peripheral nerve tissue after Lv. injection in rats and shows that either 
higher drug doses or a more sensitive detection method than fluorescence will be 
required to characterise it properly. 
Taking into consideration the low m-THPC concentration used, the time post 
injection before tissue acquisition, and the fast clearance of m-THPC; low 
concentrations of m-THPC were not unexpected in these nerve tissues. A low 
level of m-THPC would result in a reduced PDT effect on nerves and this study 
reports no obvious signs of nerve damage, (e.g. axon pruning and changes in 
nerve architecture) using NF and 5-100 fluorescent staining. Transverse sections 
of nerve tissue were also assessed here for their possible use in assessing nerve 
damage, using a quantitative approach developed previously which determines 
the proportion of Schwann cell 'tubes' which contain axons (Phillips et aI., 2005). 
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This method of nerve damage assessment is based on the assumption that 
damaged nerves will have a reduced proportion ofaxons in association with glial 
tubes, due to neurite degradation. Similar markers like Masson-Trichrome staining 
used in KObler et al. (2003) could also be used to assess these nerve sections. 
However, it is clear that the results of the initial experiments conducted here using 
explants have indicated that nerve tissue culture systems might not be suitable for 
use in assessing the effects of focally applied m-THPC-mediated PDT on nerve 
tissue, due to insufficient m-THPC levels in nerve tissue under these experimental 
conditions. A possible shortening in the time post m-THPC injection may be 
required as well as a possible increase in the m-THPC concentration administered 
to the animals in order to elicit a PDT effect. Altering these assay parameters may 
allow this explant tissue culture system to be used experimentally to determine if 
nerves are spared the effects of focal PDT application. More importantly, this 
nerve tissue culture system could indicate whether m-THPC is taken up at all by 
nerves in vivo, possibly aiding in determining whether nerve sparing in vivo is a 
result of lack of m-THPC uptake, without which there can be no direct PDT effect. 
Nerve explants from untreated animals were assessed for uptake of m-THPC from 
solution and focal PDT treatment was administered. Nerve explants were 
incubated in culture for 24 h in 4 J,Jg/ml m-THPC. This however, did not result in an 
effective uptake of m-THPC as determined by detection of drug fluorescence. This 
is in comparison to Chapter 3 which showed that m-THPC was taken up by 
neuronal cell bodies and glial cells in dissociated DRG cultures after 4 h incubation 
with 4 J,Jg/ml m-THPC to a level that was readily detectable using fluorescence 
microscopy. In this pilot study the pattern of m-THPC fluorescence suggested that 
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m-THPC may have penetrated the nerve explant via the distal cut end, with little or 
no m-THPC accumulating in the DRG itself. 
5.4.2 Nerve cell culture systems 
Monolayer cultures of glial cells have been shown to provide a surface on which 
neurites extend from the cell bodies of cultured neurones (Thompson and 
Buettner, 2006). In the present study, cultures of Schwann cells or satellite cells 
served as monolayer substrates to facilitate dissociated DRG neurone survival and 
growth. Neuronal cell bodies remained relatively stationary and neurites extended 
away, in particular with the use of satellite cells as the substrate. Without this glial 
cell substrate layer, neurites were observed to grow in circles around their 
neuronal cell bodies on top of colonies of migrating satellite cells (from the DRG 
culture). 
This glial cell substrate culture model was a promising system for studying the 
effect of focal PDT treatment on DRG neurones, however there were some 
limitations and considerable further optimisation would be necessary before the 
model could be considered robust. Limitations included the accurate sizing and 
positioning of the PDT wounding site which was attempted here by masking the 
base of the culture dishes to create a slit for illumination. The resulting focal PDT 
wounds were not clearly defined following PI staining, probably due to scattering of 
light resulting in a more complex pattern of illumination than predicted. In these 
initial studies neurite loss within the focal PDT wound was observed as in Chapter 
3, whereas, outside wounded regions DRG neurones retained their neurites. 
Therefore it would be possible to evaluate DRG neurone and glial cell responses 
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to focal PDT wounding using this culture system if a reproducible way of limiting 
illumination to discrete regions could be optimised. 
A range of 3D culture systems for neuroscience research have been developed in 
recent years (reviewed by Brown and Phillips, 2007; East and Phillips 2008). 
These model systems overcome some of the limitations of using monolayer 
cultures, in which nervous system cells often do not resemble their in vivo 
counterparts, but have the advantage of providing a controllable reproducible 
environment for studying cell behaviour and thus go some way towards bridging 
the gap between culture systems and animal models (Brown and Phillips, 2007). 
Much of the progress in this area has been driven by tissue engineering groups 
seeking substrates for the repair of nerve injuries which can also serve as culture 
models. For example, Collagen matrices have been previously utilised to engineer 
'stretch-grown' axons (Pfister et al., 2006) and magnetically axially aligned 
collagen fibrils have supported aligned neurite growth (Dubey et al., 1999). In this 
chapter the collagen (Type-I) hydrogel used in Chapter 3 was used as the basis 
for the development of a more advanced tissue engineered peripheral nerve 
culture model that supported aligned neurite growth away from the neuronal cell 
body. When dissected DRGs (complete with a section of the distal nerve trunk) 
were embedded within simple untethered collagen gels, the neurites preferentially 
grew within the nerve tissue rather than extending out into the collagen gel. In 
order to achieve growth out from the DRGs, it was necessary to provide a more 
complex external environment with aligned glial cells providing guidance cues and 
trophic support. 
A 3D tethered culture system previously developed in the laboratory of Prof Robert 
Brown (Eastwood et al., 1994; Eastwood et al., 1998) and adapted for 
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neuroscience use (Phillips et al., 2005) was chosen for further development and 
use in this study. This nerve culture system incorporated Schwann cells and 
sciatic nerve fibroblasts, which together have been shown to encourage axial 
aligned neurite growth from DRGs into the collagen gel lattice. The axial alignment 
was achieved by tethering both ends of a rectangular cell-seeded collagen gel, 
resulting in glial cell alignment parallel to the direction of principal strain. Neurites 
then extended within this aligned 3D cellular environment. 
In order to provide a robust and reproducible model system for focal PDT, this 
study optimised the key parameters necessary to achieve reliable contraction and 
alignment. Initially, mixed Schwann cell/fibroblast cultures were used to 
established that the minimum cell-seeding density required for effective collagen 
gel contraction was between 300,000 (free-floating circular gels) and 400,000 
(tethered gels) cells/ml. These parameters allowed for gel contraction within 1 to 2 
days of gel preparation. The ratio of Schwann cells to fibroblasts in these cultures 
seemed to make little difference in determining whether gels would contract. 
Despite optimal contraction being achieved in some of these tethered gels, little 
neurite prOjection was observed from either DRG explants or dissociated DRG 
cells implanted into these models before or after gel contraction. This was despite 
robust neurite growth being observed in previous stUdies under similar conditions 
(Phillips et al., 2005, Dubuisson et al., 1999, Pearson et al., 2003), and may have 
been a result of variations in for example Schwann cell culture technique. 
The initial lack of neurite outgrowth was overcome by using Satellite cells from 
DRGs rather than sciatic nerve Schwann cell cultures for seeding into the collagen 
gels. Because satellite glial cell cultures contained far fewer contaminating 
fibroblasts than sciatic nerve Schwann cell cultures, they were enriched with 5 % 
- 241 -
Chapter 5-Results 
neural fibroblasts to facilitate collagen gel contraction. This approach resulted in 
neurite growth from both DRG explants and dissociated DRG neurones. Fibroblast 
addition aided collagen gel contraction, but nerve fibroblasts are also known to 
promote some physiological properties of glial cells (Dubuisson et a/., 1999). 
Fibroblasts may possibly encourage interactions between FGF-2 and S 1 OO~ in 
activated satellite cells, which may trigger paracrine actions (neuronal 
maintenance and plasticity), in these axotomised DRG neurones (Levy Bde et a/., 
2007). 
A similar 3D tethered cell-seeded collagen (Type-I) hydrogel nerve culture system 
was reported by Dubuisson et a/. (1999) who initially assessed the contraction 
rates of free-floating circular collagen gels seeded with neural cells, similar to free-
floating gels presented in this study, and determined the need for nerve fibroblasts 
for gel contraction. Dubuisson et a/. (1999) also concluded that at least 500,000 
satellite cells/ml were needed for contraction of cell-seeded tethered collagen gels 
with final collagen concentrations of 0.3 and 1.0 mg/ml, and also shows that nerve 
fibroblasts were required for successful collagen gel contraction. Differences 
between that culture system and the one used in this study may arise from the fact 
that a lower concentration of collagen was used in gel preparations in comparison 
to this study, which used 1.6 mg/ml final concentration. These findings were also 
supported by Nirmalanandhan et al. (2006) with a modified 3D tethered 
mesenchymal stem cell (MSC)-seeded collagen (Type-I) culture system, which 
was developed in aid of constructing a successful tendon repair device. The model 
used by Nirmalanandhan et al. (2006), like in Dubuisson et a/ (1999), showed that 
above a threshold value of cell density (500,000 cells/ml) , reducing the 
concentration of collagen gels influence gel contraction kinetics more than 
equivalent increases in cell seeding density. Nirmalanandhan et a/. (2006) 
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eventually settled with the use of 500,000 cells/ml MSCs and a concentration of 
1.3 mg/ml purified bovine collagen (Type-1). 
Another potentially important observation in this study was that in addition to the 
support of neurite outgrowth in an aligned 3D glial cell environment, if cultures 
were maintained for 12 days then processed and analysed using transmission 
electron microscopy, extensive myelination ofaxons was observed (Figure 5.13). 
This work was peripheral to this PhD project and was conducted in collaboration 
with Dr James Phillips and Heather Davies; therefore it is not described in detail in 
this thesis. However, this observation, along with the optimisation of the glial cell 
environment which was reported here, suggests that this is likely to be a useful 
model for future work in assessing the effects of PDT on nervous system cells. 
Because this culture system is capable of supporting aligned neurite outgrowth 
and then maintenance ofaxons in a manner that permits glial cells to myelinate 
them (an important feature that has not been reported in this kind of culture 
system previously), it can be considered to mimic the in vivo situation and thus 
forms an accessible and exciting culture system for future experimentation. 
Focal m-THPC-mediated PDT wounding of 3D satellite cell-seeded collagen gel 
culture systems was attempted, but as with the 2D models there were limitations in 
terms of the delivery of light to a confined spot on the gel. 
For future use of these culture systems, labelling of live neurites in both 2D and 3D 
cultures would be desirable in order to determine at which time point to use model 
systems and where to direct the PDT light source in PDT wounding assays. eM-
Oil (CeIlTrk-red) was tested for its ability to labelled live neurites and was found to 
label both glial cells and neuronal cell bodies, but did not accumUlate within 
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neurites at a level sufficient for effective tracking. Alternative methods which could 
be adapted for use in tracking live neurites include the labelling and tracking of 
mitochondrial transport with MitoTracker® Green FM (MitoTrk-green) fluorescence 
dye as used in the labelling of neurites in live myenteric neurones (Vanden Berghe 
et a/., 2003) and hippocampus neurones (Hayashi et a/., 2007). Altermatively, the 
labelling and tracking of neurofilament and microtubule transport in live neurites 
with the use of innovative fluorescent probes such as NeuroMag, a neurone-
specific transfection reagent (He et a/., 2005), or more simply the use of isolated 
neurones from GFP positive rats could be tried. These live neurone markers would 
aid in focal PDT application to neurones in culture systems as illustrated in Figure 
5.15. 
5.5 Conclusions 
In conclusion, a range of nerve culture systems have been developed and adapted 
for investigating the effect of focal PDT treatment on nerves. With a little further 
refinement it is likely that some of these will provide useful means with which to 
explore the effect of PDT focally applied to one part of the neurone. In order to 
mimic the clinical situation in which a peripheral nerve might be exposed to PDT 
due to its prOXimity to a cancer treatment site (e.g. the nerves running close to the 
prostate gland), animal models have been used including rabbits and minipigs 
(KObler et a/., 2003), and dogs (Chang et a/., 1996; Chang et a/., 1997; Chang et 
a/., 1999; Dole et a/., 2005; Huang et a/., 2005). More recently, the effects of PDT 
on neural tissue in close association with vertebral metastases in murine models 
has been used to mimic these clinical situations (Burch et a/., 2005). While these 
animal models provide a good assessment of the ultimate effects of PDT on nerve 
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tissue, it is difficult to extrapolate from these studies what the direct effects of 
treatments are on neurones and glial cells. Using a culture system like those 
developed here, will enable future experiments in which the cellular environment 
can be closely controlled and monitored. These experiments would elucidate the 
mechanisms by which neurones and glial cells respond to PDT-induced damage. 
Understanding the fundamental cell biology underlying the response of neural cells 
to PDT will ultimately aid in the development of new PDT treatments, which could 
spare neural cells during cancer treatment. 
Neurites extending from DRG guided by 
aligned satellite cells/fibroblasts 
Neurite damage will be 
assessed after treatment 
Figure 5.15 
! Fine optical fibre 
i 
I 
i 
Schematic diagram of PDT application to a 3D tethered peripheral nerve culture 
model. 
Illustration shows neurites being targeted with focal PDT. Laser light can be directed at 
varied distances along the neurite or onto neuronal cell bodies with the aid of a live 
neurone marker. 
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Chapter 6: General Discussion, Future Work and Conclusions 
6.1 General discussion 
Various in vitro strategies have been used in this project to explore the effects of 
PDT on key cells of the nervous system. The focus has been on the drug m-
THPC, which had previously been shown to spare peripheral nerves in clinical and 
experimental work (Ris et al., 1996; Moore et al., 2006; Betz et al., 2007; Nyst et 
al., 2009). 
The work described in this thesis has shown that DRG neurones have the 
remarkable ability to survive PDT treatment with m-THPC under conditions which 
killed tumour cells, satellite cells and astrocytes. Using a range of culture models 
the uptake and distribution of photosensitiser within DRG neurones were 
investigated, along with 102/ROS production, and compared to other cells. 
Inconclusive results were obtained for detection of photosensitiser or 102/ROS in 
neurites, but photosensitiser was clearly accumulating within neuronal cell bodies 
and no evidence suggested that differences in uptake or distribution of 
photosensitiser could explain the observed neuronal survival. After m-THPC-
mediated PDT DRG neurones lost their neurites, but retained their ability to 
regenerate neurites. This confirmed that neurones survived m-THPC-mediated 
PDT in a manner that retained their regenerative functionality. After investigation, 
DRG neurones were shown to be reliant on intracellular glutathione synthase and 
SOD-1 antioxidant pathways for neuronal PDT resistance. Furthermore progress 
was made towards establishing culture systems for exploring the effects of PDT on 
specific neuronal compartments. 
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Along the way a number of useful novel model systems were developed. In 
particular the use of the thin collagen gels (Chapter 3), which allowed neuronal cell 
viability to be characterised within a mixed cell population and proved to be a 
robust reliable system (as verified by using a range of cells and a control 
photosensitiser, hypericin) that will be useful for future studies, (e.g. more work on 
antioxidant inhibitors, determining the mechanism by which neurites were 
damaged after PDT, the effect of PDT on neurones in isolation, or what makes m-
THPC-mediated PDT such an exceptional treatment). 
This concluding chapter discusses some possible future directions of this study; its 
contribution to knowledge in the fields of PDT and neuroscience, identifies some 
limitations of this approach, and speculates about the relevance of this work to 
clinical applications. 
If DRG neurones survive m-THPC-mediated PDT in vivo as they do in culture then 
the treatment of tumours near DRG structures should therefore not result in 
damage to the neuronal cell bodies contained within ORGs, but this study has 
indicated that these neurones may lose their neurites. This may not be a serious 
problem, since this study has also shown that these DRG neurones are able to 
regenerate their neurites after m-THPC-mediated PDT. In addition, satellite cells 
that are killed at the treatment site may be replaced by new ones, generated 
through mitosis. This type of PDT may therefore be highly useful in the treatment 
of tumours situated in close proximity to ORGs, (e.g. vertebral metastasis). The 
relevance of this study to clinical application involved a possible explanation of the 
nerve-sparing observed after m-THPC-mediated PDT treatment of head and neck , 
prostate and oesophagus cancers. 
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Focal application of m-THPC-mediated PDT to neuronal cell bodies or neurites still 
needs to be investigated, in particular the effects of PDT targeted at different 
distances away from neuronal cell bodies along neurites. The different distance of 
targeted PDT may result in different effects on ORG neurones. The neurone may 
re-grow its axon along the same path, there may be branching, or it may result in 
the death of the neuronal cell body. The culture systems developed in Chapter 5 
will provide useful tools for investigating this phenomenon in the future. 
From the literature the majority of the molecular and cellular studies in relation to 
the effect of PDT on nerves have focused on the use and effects of photosens-
mediated PDT on the spike response of crayfish nerves, their death response in 
relation to surrounding glial cells, and the neuronal-glial signalling mechanisms 
responsible for cell death (Uzdenskii et al., 2008). This study however focused on 
m-THPC-mediated PDT and has highlighted the different cell death responses that 
exist between different cell types contained in mammalian nerves. This was an 
indication of the different intracellular survival systems in these cell types, which 
may be exploited to allow selective PDT damage to one cell type while others 
survive. Even though there is a marked difference between humans and animals 
in relation to m-THPC distribution in tissue types (KObler et a/., 2003), the use of a 
rat nerve source here was more appropriate than a crayfish nerve, for predicting 
human nerve responses to PDT. 
In order to establish the mechanism/s by which ORG neurones were protected 
from the effects of m-THPC-mediated PDT, selected intracellular antioxidant 
pathways were blocked, resulting in neuronal death on exposure to m-THPC-
mediated PDT. This suggested that ORG neurones used glutathione synthase and 
SOD-1 antioxidant pathways to counteract the effects of m-THPC-mediated PDT 
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under the conditions used in this study. However, it is important to investigate the 
effect of other concentrations of these inhibitors in order to determine their optimal 
dose in inhibiting antioxidant pathways in DRG neurones. In particular, higher 
doses of 2-MeOE2 should be tried before concluding that the 500-2 antioxidant 
pathway was not involved in protecting DRG neurones. Furthermore the 
involvement of other antioxidant pathways in protecting these DRG neurones still 
needs to be investigated, (e.g. the catalase pathway). Investigating both higher 
doses of 2-MeOE2 and other commercially available antioxidant pathway inhibitors 
may well result in 100 % DRG neurone death after exposure to m-THPC-mediated 
PDT. 
Advice to other researchers undertaking similar studies as presented in this study 
would be that it is important to continue this type of research with a 
multidisciplinary approach. Without this form of investigation the progress made in 
this area of 'the effects of PDT on nerves', would be considerably less advanced. 
For example the 3D collagen gel model adapted from the field of tissue 
engineering was used to resolve a major problem in the field, cell loss after PDT 
treatment, which would have prevented neuronal sensitivity from being measured. 
A broad understanding of the field of neuroscience, combined with awareness of 
recent developments in PDT and tissue engineering research is important for 
future progress of this research. 
6.2 Future work 
6.2.1 Effect of m-THPC-mediated PDT on other neural cell types 
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This thin 3D collagen culture system would be useful in further evaluating the 
response of other neural cell types to m-THPC-mediated PDT. If this PDT is to be 
used for new clinical applications (e.g. to treat vertebral metastasis), it would be 
important to first assess neural cells response to PDT in areas such as the spinal 
cord, brain, prostate, bladder and/or oesophagus. In addition the effect of other 
photosensitisers on neural cells, (e.g. ALA induced PplX-mediated PDT, known to 
cause pain during treatment (Wiegell et al., 2003; Algermissen et al., 2003)) would 
be important in order to determine whether or not these clinically approved 
photosensitisers may also have nerve sparing properties. Also assessment of 
photosensitisers with similar properties as m-THPC could be of interest, to 
determine which feature/s of m-THPC were responsible for nerve sparing. In 
investigating nerve sparing properties of clinically approved photosensitisers, 
specific photosensitisers could be approved for use in PDT in areas rich in nerve 
structures to reduce nerve damage. 
6.2.2 Protective mechanisms of neurones 
A possible future direction for the study of neuronal survival following PDT could 
be to use N-AcetylCysteine (NAC), a precursor to GSH, which has been used on 
rat CNS co-cultures to increase the protective effect of glial cells on neurones 
(Watts et al., 2005). Our co-culture system can be used to assess the importance 
of satellite cells on the survival of neurones after PDT. We can determine the 
effects of increasing GSH levels above naturally occurring levels in culture using 
NAC. This could be followed by the assessment of satellite cells for signs of 
reduced cell death, and neurones for signs of neurite retention after PDT. 
Therefore, application of NAC in a clinical setting prior to PDT could promote 
protective effects of satellite cells on neurones at PDT treatment sites. 
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In addition to further experimentations in inhibiting or promoting antioxidant 
pathways; it would be of interest in a clinical setting to possibly introduce 
antioxidants or antioxidant generating agents which may interact with endogenous 
antioxidant pathways to increase the levels of neurone protection from PDT, (e.g. 
Bromocriptine with its neuroprotective effects against free radicals (Iwasaki et a/., 
1997); propyl gallate a synthetic antioxidant widely used in processed food and 
medicinal preparations (Han et a/., 2009); and phenolic a-tocopherol (Vitamin E) 
which has been shown to cause increase tumour cell death (HT29) while sparing 
non-tumour cells (MRC-5) (Melnikova et a/., 1999c» . This may be useful in cases 
were much higher doses of PDT are applied, which on its own may kill neurones 
or in situations in which a patient's antioxidant protective pathways might be 
suppressed due to illness or disease. However, systemic antioxidant treatment 
would have to be tried with caution since it might diminish the effectiveness of PDT 
on the killing of tumour cells. 
Further examination of the inhibition of neuronal resistance to PDT via antioxidant 
pathways would be useful in understanding how this phenomenon might translate 
to a clinical setting. Performing m-THPC-mediated PDT dose responses after 
inhibiting glutathione and SOD antioxidant pathways using other commercially 
available inhibitors could give greater insight into the mechanism for neuronal 
survival (e.g. the 800-1 inhibitor, disulfiram (Dimayuga et a/., 2007». Also, 
investigations into the protective effects of the catalase antioxidant protective 
pathway would be of interest, by using the catalase inhibitor (e.g. 3-amino-1, 2, 4-
triazole (Oyama et a/., 1994». Catalase activity has been shown to increase after 
PDT in mouse mammary carcinoma (EMT6) cells (Johnson and Pardini, 1998). 
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Despite the lack of m-THPC fluorescence detection in neurites in Chapter 3, and 
the inconclusive detection of 102/ROS after m-THPC-mediated PDT in neurites in 
Chapter 4, mass neurite loss was observed after m-THPC-mediated PDT. This 
was despite the fact that neuronal cell bodies were surviving treatment conditions. 
In a clinical setting this may result in temporary loss of nerve function, because 
these neurones retained their ability to re-grow neurites after m-THPC-mediated 
PDT and these new neurites may re-innervate nerve trunks. Also, the possible 
involvement of DR6 orphan receptors (Nikolaev et al., 2008) in the effect of m-
THPC-mediated PDT on DRG neurones would be an interesting future 
investigation. Most PDT treatments are directed at the nerve trunk, which consists 
ofaxons. The activation of DR6 receptors has been shown to cause neurite loss; if 
this receptor could be blocked, maybe a rescuing of the neurites might be possible 
during PDT treatment. Therefore, this may prevent any temporary loss of nerve 
function, due to neurite loss after PDT. 
Investigating the effect of different caspases in protecting different parts of DRG 
neurones (neuronal cell bodies or neurites), from m-THPC-mediated PDT. DRG 
neuronal cell bodies have been shown to be protected from oxidative stress by the 
involvement of caspase 3 and 7, while their neurites are protected by the 
involvement of caspase 6 (Nikolaev et al., 2008). This would be a useful future 
direction in determining further mechanisms used by neurones to protect 
themselves from cell death following exposure to oxidative stress. 
6.2.3 Detection systems 
To determine m-THPC subcellular localisation in neural cells at different incubation 
times, as well as before and after illumination, would be useful as a means of 
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determining whether differences in cell type responses are related to m-THPC 
localisation. This could be done by isolating specific organelles from neural cell 
types preloaded with m-THPC, then assessing for m-THPC fluorescence. Also, in 
order to further determine the extent to which m-THPC localises with DRG 
neurites, the use of m-THPC-monoclonal antibodies (Vrouenraets et al., 1999) or 
14C-labeled m-THPC (Obwegeser et al., 1998) could be adopted to enhance 
detection signal in neurites. In determining the localisation of m-THPC at a cellular 
level, photosensitisers approved for clinical use which display similar localisation 
could be used to obtain similar nerve sparing results as m-THPC-mediated PDT. 
In addition to the use of DCF fluorescence, 102 production can be more 
specifically detected by its phosphorescence emission at a wavelength of 1270 nm 
in solution and in cell culture (Berg, 2007). This method of detection could be used 
to determine the level of 102 generated in specific neural cell types, and in the 
compartments of the neurone (e.g. neurites versus neuronal cell bodies) after m-
THPC-mediated PDT. The type of toxic oxygen molecules generated after PDT 
may also be a factor in influencing cell type specific death response. 
6.2.4 Model development 
With further investigations into neural cells and nerve tissue, perhaps 
understanding the reasons behind nerve sparing are not too distant in the future. 
However, in order for this investigation to progress, there is a need for a nerve 
culture system in which focal PDT could be applied to specific compartments of 
neurones. This is because during clinically applied PDT treatments the nerve trunk 
(containing neurites) is the part of the nerve most frequently exposed to PDT 
treatments. For translational studies, a useful future direction would be to assess 
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this treatment in an in vivo situation because it would provide a natural 
environment in which to assess nerve damage after PDT (Le. with the involvement 
of the host circulatory and immune system in response to PDT). But, to further 
elucidate the underlying biology, culture systems are more useful, due to their 
controllable environment and the ability to monitor changes which may occur. 
The ability to label and track live neurites would be invaluable in our 2D and/or 3D 
culture systems, because it would allow us to determine when to start assays, 
where to focus the light beam for PDT and would make it possible for us to assess 
neurite response to PDT-treatments in time. Methods which could be implemented 
include the use of tritiated amino-acids which can be injected into clusters of 
neuronal cell bodies and viewed with autoradiography; horseradish peroxidase 
could be injected among a group of axon terminals (retrograde transport marker); 
or purified specific antibodies, made using an enzyme involved in a particular 
transmitter-labelled with fluorescence (Keele et al., 1989). 
6.3 Conclusions 
DRG neurones survived m-THPC-mediated PDT, but with substantial damage to 
neurites, at levels of treatment which killed both glial cells (satellite cells and 
astrocytes) and MCF-7 breast cancer tumour cells. DRG neurones were however, 
able to re-grow neurites to a similar extent as untreated neurones. Furthermore 
these DRG neurones were found to survive m-THPC-mediated PDT by the use of 
intracellular antioxidant pathways (i.e. glutathione synthase and 800-1 pathways). 
This study points to a possible role for more widespread use of m-THPC-mediated 
PDT in the treatment of tumours in close association to nerve structures, such as 
the treatment of spinal metastases. 
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Appendix 
APPENDIX·I 
TdT-FragEL™ kit Instruction 
1 00 J.l1 3 % (v/v) H202 was incubated for 5 min at room temperature to inactivate 
endogenous peroxidises. Samples were rinsed with PBS before being incubated 
with 100 J.l1 1xTdT Equilibrium Buffer for 10 to 30 min. TdT Equilibrium Buffer was 
removed and immediately 60 ~I TdT Labelling Reaction Mixture (57 ~I TdT 
Labelling Reaction Mixture and 3 ~I TdT Enzyme) were added per sample. 
Samples were covered with parafilm and incubated for 1.5 h at 370 C in a 
humidified incubator. Parafilm was removed and samples rinsed in PBS. 1 00 ~I 
Stop Solution was used to cover gels for 5 min before rinsing with PBS. 1 00 ~I 
Blocking Buffer was added and incubated for 10 min; removed, then immediately 
1 00 ~I of 1 x Conjugate was added and incubated a 30 min in a humidified 
chamber. Samples were rinsed in PBS then incubated with 1 00 ~I DAB solution 
(one tablet of DAB and one tablet of H202/Urea in 1 ml of tap water) for 10-15 min 
before finally being rinsed with dH20. Cultures were viewed under bright-field for 
DAB (apoptotic cells) and fluorescence for neurone identification using an 
Olympus BX61 fluorescence microscope. 
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